: The AMEDEO Literature Guide

Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Chronic Heart Failure

Free Subscription

Articles published in Eur J Heart Fail
Retrieve available abstracts of 1061 articles:
HTML format

Single Articles

July 2026

SOLOVEVA A, Park JJ, Apostolou EA, Bohm M, et al
Evaluation and management of heart failure patients with liver disease: European Journal of Heart Failure International Expert Position Paper.
Eur J Heart Fail. 2026 Jul 31:xuag243. doi: 10.1093.
PubMed Abstract available

MOERSDORF M, Verbeeck J, Marrouche NF, Costard-Jaeckle A, et al
Catheter ablation in end-stage heart failure with atrial fibrillation: an hierarchical endpoint analysis of the CASTLE-HTx trial.
Eur J Heart Fail. 2026 Jul 30:xuag223. doi: 10.1093.
PubMed Abstract available

ZURKAN D, Pieske B, Petutschnigg J, Verheyen N, et al
Spironolactone in the Treatment of Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Design and Baseline Characteristics of the SPIRIT-HF-DZHK08 Trial.
Eur J Heart Fail. 2026 Jul 28:xuag222. doi: 10.1093.
PubMed Abstract available

VERSNJAK J, Kuehne T, Kelm M
Response to letter regarding 'deep phenotyping of heart failure with preserved ejection fraction through multi-omics integration'.
Eur J Heart Fail. 2026 Jul 28:xuag225. doi: 10.1093.
PubMed

Correction to: Prevalence, Characteristics and Cardiovascular and Non-Cardiovascular Outcomes in Patients with Heart Failure with Supra-Normal Ejection Fraction: Insight from the JROADHF Study.
Eur J Heart Fail. 2026 Jul 27:xuag234. doi: 10.1093.
PubMed

HARING B, Iaconelli A, Perera D, Velazquez EJ, et al
Revascularization of coronary artery disease in heart failure. A European Journal of Heart Failure Expert Consensus Statement.
Eur J Heart Fail. 2026 Jul 24:xuag230. doi: 10.1093.
PubMed Abstract available

GUIDETTI F, Benson L, Lindberg F, Basile C, et al
Trends in Mortality, Heart Transplantation and Left Ventricular Assist Device use in Advanced Heart Failure between 2003 and 2022: data from the Swedish Heart Failure Registry.
Eur J Heart Fail. 2026 Jul 22:xuag241. doi: 10.1093.
PubMed Abstract available

BRUNO J, Xuejuan J, Xu Y, Basile C, et al
Short-term survival of dual SGLT2i-MRA and four-class guideline-directed medical therapy in acute heart failure.
Eur J Heart Fail. 2026 Jul 22:xuag218. doi: 10.1093.
PubMed Abstract available

ANKER MS, Lang NN, Pellicori P
Too Hot To Sleep? Circadian Temperature Control in Heart Failure.
Eur J Heart Fail. 2026 Jul 18:xuag227. doi: 10.1093.
PubMed

SALDARRIAGA C, Araiza-Garaygordobil D, Garcia-Zamora S
Heart Failure Care in Latin America.
Eur J Heart Fail. 2026 Jul 18:xuag229. doi: 10.1093.
PubMed

LABORANTE R, Bianchini E, Beer BN, Valente V, et al
A NETwork meta-analysis with COST-effectiveness evaluation of pharmacological treatments for Heart Failure with Reduced Ejection Fraction: NET-COST-HFrEF.
Eur J Heart Fail. 2026 Jul 16:xuag233. doi: 10.1093.
PubMed Abstract available

IACONELLI A, Busti M, Sensini L, Dolce P, et al
Catheter ablation of atrial fibrillation in patients with heart failure: a trial-level meta-analysis.
Eur J Heart Fail. 2026 Jul 16:xuag232. doi: 10.1093.
PubMed Abstract available

BIEGUS J, Iwanek G, Testani J, Zymlinski R, et al
Urinary Biomarker Thresholds to Detect Diuretic Resistance and Insufficient Diuretic Response in Acute Heart Failure.
Eur J Heart Fail. 2026 Jul 16:xuag216. doi: 10.1093.
PubMed Abstract available

ZHOU X, Liu H, Hua Z
Early SGLT2 Inhibition in Acute Heart Failure: When More Urine Does Not Necessarily Mean Better Decongestion.
Eur J Heart Fail. 2026 Jul 15:xuag221. doi: 10.1093.
PubMed

WEYRICH M, Ware A, Windschmitt J, Sarakpi T, et al
Response to the letter by Tang and Liu Regarding our article "Independent and Dose-Dependent Contributions of Clonal Hematopoiesis and Mosaic Loss of Y to Incident Heart Failure".
Eur J Heart Fail. 2026 Jul 15:xuag219. doi: 10.1093.
PubMed

KRESOJA KP, Stolz L, Cannata A, Rommel KP, et al
Rethinking Tricuspid Valve Regurgitation in Heart Failure - A Pathophysiology-based Holistic Approach for Individualized Patient Management.
Eur J Heart Fail. 2026 Jul 15:xuag226. doi: 10.1093.
PubMed Abstract available

KATZMANN JL, Abdelhamid M, Laufs U
Cholesterol-lowering and heart failure.
Eur J Heart Fail. 2026 Jul 14:xuag185. doi: 10.1093.
PubMed

DOCHERTY KF, Petrie MC, McKinley G, Bear G, et al
Cardiac myosin-binding protein C in community-based patients with suspected heart failure.
Eur J Heart Fail. 2026 Jul 14:xuag143. doi: 10.1093.
PubMed Abstract available

RAZAGHIZAD A, Vasques-Novoa F, Ni J, Ferreira JP, et al
PCSK9 inhibition and cardiovascular outcomes by heart failure status: a pooled analysis of SPIRE-1 and SPIRE-2.
Eur J Heart Fail. 2026 Jul 14:xuag166. doi: 10.1093.
PubMed

ELSANHOURY A, Eschenhagen T, Van Linthout S
Cardiac myosin-binding protein C, an incremental heart failure biomarker?
Eur J Heart Fail. 2026 Jul 14:xuag148. doi: 10.1093.
PubMed

LAMBRINOU E, Simpson M, Barisone M, Hill L, et al
European Society of Cardiology updated curriculum for heart failure nurses: developed by the Heart Failure Association, in collaboration with the Association of Cardiovascular Nurses and Allied Professions of the European Society of Cardiology.
Eur J Heart Fail. 2026 Jul 10:xuag077. doi: 10.1093.
PubMed Abstract available

RAKISHEVA A, Disabato G, Abreu A, Attanasio A, et al
Prevention of Heart Failure in Women: An Expert Consensus Statement on Sex-Specific Risk Factors.
Eur J Heart Fail. 2026 Jul 3:xuag215. doi: 10.1093.
PubMed Abstract available

June 2026

PACKER M
Does Phenotypic Heterogeneity in Heart Failure With Preserved Ejection Fraction Imply Mechanistic Heterogeneity? The Myth of a Phenotype-Directed Therapeutic Framework and the Mandate for a Falsifiable Hypothesis.
Eur J Heart Fail. 2026 Jun 26:xuag211. doi: 10.1093.
PubMed Abstract available

TANG Y, Liu Y
Letter regarding the article "Independent and Dose-Dependent Contributions of Clonal Hematopoiesis and Mosaic Loss of Y to Incident Heart Failure".
Eur J Heart Fail. 2026 Jun 25:xuag212. doi: 10.1093.
PubMed

RUBIS P, Winiarczyk M, Dziewiecka E, Wisniowska-Smialek S, et al
Circadian rhythms of core and skin temperature in heart failure.
Eur J Heart Fail. 2026 Jun 25:xuag199. doi: 10.1093.
PubMed

MARKWIRTH P, Hoevelmann J, Tokcan M, Haring B, et al
What's new in heart failure? June 2026.
Eur J Heart Fail. 2026 Jun 25:xuag204. doi: 10.1093.
PubMed

ZONNEVELD LEEC, Ter Maaten JM, Voors AA, Schulze C, et al
Early effects of SGLT2 inhibitors in acute heart failure: an individual patient-level meta-analysis.
Eur J Heart Fail. 2026 Jun 23:xuag184. doi: 10.1093.
PubMed Abstract available

RIEHLE L, Goetz A, Koehler K, Hiddemann M, et al
Efficacy of a Voice Biomarker for the Prediction of Heart Failure Hospitalisation: Results from the Telemedical Interventional Management in Heart Failure III (TIM-HF3) Voice Study.
Eur J Heart Fail. 2026 Jun 18:xuag203. doi: 10.1093.
PubMed

BELANGER N, Zeid S, Gieswinkel A, Kazemi-Asrar F, et al
Chronotropic response in heart failure: clinical, structural, and metabolic predictors and long-term mortality.
Eur J Heart Fail. 2026 Jun 16:xuag139. doi: 10.1093.
PubMed Abstract available

SEPP R, Mazzag B, Frigyesy R, Mihalyi K, et al
How to query administrative databases for heart failure epidemiological investigations? Rationale, design, and case definition criteria for the nation-wide HF-EPI-HUN Study.
Eur J Heart Fail. 2026 Jun 11:xuag189. doi: 10.1093.
PubMed

YILMAZ MB, Kilic ME, Biegus J, Citro R, et al
Acute Myocardial Infarction versus Acute Decompensated Heart Failure in Cardiogenic Shock: A Systematic Review and Meta-Analysis of Clinical Phenotypes and Mortality.
Eur J Heart Fail. 2026 Jun 9:xuag186. doi: 10.1093.
PubMed Abstract available

ABDIN A, Aktaa S, Abdelhamid M, Abid L, et al
Bridging the gap: adapting heart failure guidelines for resource-limited settings: A European Journal of Heart Failure expert consensus document.
Eur J Heart Fail. 2026 Jun 4:xuag142. doi: 10.1093.
PubMed Abstract available

ALNUWAYSIR RIS, Grote Beverborg N
Response to Letter regarding the article: Iron Deficiency Definitions and their Clinical and Prognostic Associations Across the Spectrum of Left Ventricular Ejection Fraction in Heart Failure.
Eur J Heart Fail. 2026 Jun 2:xuag191. doi: 10.1093.
PubMed

May 2026

WEYRICH M, Ware A, Windschmitt J, Sarakpi T, et al
Independent and Dose-Dependent Contributions of Clonal Hematopoiesis and Mosaic Loss of Y to Incident Heart Failure.
Eur J Heart Fail. 2026 May 31:xuag187. doi: 10.1093.
PubMed

FONTANA M, Cappelli F, Garcia-Pavia P, Judge DP, et al
Outpatient worsening heart failure in transthyretin amyloid cardiomyopathy: Findings from ATTRibute-CM.
Eur J Heart Fail. 2026 May 29:xuag177. doi: 10.1093.
PubMed Abstract available

SLIWA K, Verdonschot JAJ, Hoevelmann J, Macera F, et al
Cardio-Obstetrics Care: Challenging Scenarios in Heart Failure and Future Directions.
Eur J Heart Fail. 2026 May 29:xuag175. doi: 10.1093.
PubMed Abstract available

VASQUES-NOVOA F, Razaghizad A, Sharma A, Mancio J, et al
Myocardial Oedema in Heart Failure with Preserved Ejection Fraction: Preliminary Findings from the NETDiamond Cohort.
Eur J Heart Fail. 2026 May 29:xuag178. doi: 10.1093.
PubMed

HORVATH CM, Floras JS, Yatsu S, Ishiwata S, et al
Event rates of patients with stable heart failure with reduced ejection fraction and newly diagnosed obstructive or central sleep apnoea.
Eur J Heart Fail. 2026 May 28:xuag110. doi: 10.1093.
PubMed Abstract available

VAN RIJCKEGHEM P, Dieckerhoff A, Frick M, Thiele K, et al
Research Letter: Prognostic impact of MRI-derived indexed left ventricular end-diastolic volume (LVEDVi) in individuals with preserved and reduced LV ejection fraction without heart failure in the UK Biobank.
Eur J Heart Fail. 2026 May 26:xuag182. doi: 10.1093.
PubMed

BOETTGER P, Sedighi J, Sohns C, Bauersachs J, et al
Cost-effectiveness of finerenone in heart failure with mildly reduced or preserved ejection fraction - Insights from FINEARTS-HF.
Eur J Heart Fail. 2026 May 24:xuag167. doi: 10.1093.
PubMed Abstract available

LEGTENBERG S, Ter Maaten JM, Damman K
Go with the flow: targeting the lymphatic system in acute decompensated heart failure - DELTA-HF trial.
Eur J Heart Fail. 2026 May 22:xuag180. doi: 10.1093.
PubMed

ZALAWADIYA SK, Desai AS, Borlaug BA, Kiernan M, et al
Changes in Upright Hemodynamics Preceding Heart Failure Events and Other Hospitalizations.
Eur J Heart Fail. 2026 May 19:xuag165. doi: 10.1093.
PubMed Abstract available

GREENE SJ, Xu H, Chiswell K, Felker GM, et al
Median Survival Among Patients Hospitalized for Heart Failure with Reduced Ejection Fraction Prescribed Quadruple Medical Therapy.
Eur J Heart Fail. 2026 May 19:xuag172. doi: 10.1093.
PubMed

VAN DE BOVENKAMP AA, Nassiri S, de Man FS, Oosterveer FPT, et al
Intravenous IRON supplementation in Heart Failure with Preserved Ejection Fraction and iron deficiency (IRON-HFpEF): a comprehensive phase II multicentre placebo-controlled randomised clinical trial.
Eur J Heart Fail. 2026 May 18:xuag162. doi: 10.1093.
PubMed Abstract available

GARRED CH, Elmegaard M, Kober L, Schou M, et al
Reply to "Letter regarding the article 'Modification of the association between age and mortality in heart failure by frailty status".
Eur J Heart Fail. 2026 May 18:xuag173. doi: 10.1093.
PubMed

BISWAS S, Srivastava Y, Chintagumpala V
Letter regarding the article 'Modification of the association between age and mortality in heart failure by frailty status'.
Eur J Heart Fail. 2026 May 15:xuag164. doi: 10.1093.
PubMed

NEUEN BL, Lu H, Vaduganathan M, Ostrominski JW, et al
Iron deficiency and risk of heart failure and cardiovascular events in CKD: Insights from the ASCEND-ND trial.
Eur J Heart Fail. 2026 May 15:xuag171. doi: 10.1093.
PubMed Abstract available

VERKET M, Marx-Schutt K, Brunner-La Rocca HP, Muller-Wieland D, et al
Prediction or speculation: heart failure models for diabetes.
Eur J Heart Fail. 2026 May 12:xuag113. doi: 10.1093.
PubMed

FOA A, Lu H, Vaduganathan M, Claggett BL, et al
Heart rate and atrial fibrillation/flutter in HFmrEF/HFpEF: a participant-level analysis across five randomized clinical trials.
Eur J Heart Fail. 2026;28:206-216.
PubMed Abstract available

RASSAF T, Bernhard B, Lopez-Fernandez T
Heart failure, infarction, and the seed of malignancy: stepping into the era of reverse cardio-oncology.
Eur J Heart Fail. 2026 May 10:xuag067. doi: 10.1093.
PubMed

CAMILLI M, Girerd N, Ameri P, Ballacci F, et al
Incident cancer in heart failure, myocardial infarction or both: a report from a global federated research network.
Eur J Heart Fail. 2026 May 10:xuag061. doi: 10.1093.
PubMed Abstract available

LAM CSP, Contreras J, Darwesh R, Freitas Junior AF, et al
Prevalence and Predictors of High Inflammatory Risk in Heart Failure Subtypes: Findings From the Global POSEIDON Study.
Eur J Heart Fail. 2026 May 10:xuag155. doi: 10.1093.
PubMed Abstract available

HAYWOOD HB, Ikeaba U, Fonarow GC, Xu H, et al
Outpatient clinic visits before and after hospitalizations for heart failure with and without transthyretin amyloid cardiomyopathy.
Eur J Heart Fail. 2026 May 10:xuag141. doi: 10.1093.
PubMed

GAVINA C, Ferreira JP, Mendes LL, Bernardo F, et al
Anthropometric adiposity measures and natriuretic peptides in heart failure screening: population-based evidence from the PORTHOS study.
Eur J Heart Fail. 2026 May 10:xuag154. doi: 10.1093.
PubMed Abstract available

MENDIETA G, Ridker PM, Borlaug BA, Ducharme A, et al
Ziltivekimab in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the ATHENA and HERMES trials.
Eur J Heart Fail. 2026 May 10:xuag153. doi: 10.1093.
PubMed Abstract available

MIRCESCU A, Allan W, Haris M, Hurdus B, et al
Performance of prediction models for incident heart failure and heart failure hospitalization in individuals with type 2 diabetes: a systematic review and meta-analysis.
Eur J Heart Fail. 2026 May 10:xuag090. doi: 10.1093.
PubMed Abstract available

NUCHE J, Garcia-Cosio Carmena MD, Biegus J, Kereselidze Z, et al
Safety and Feasibility of the eLymTM System for Interstitial Decongestion in Acute Decompensated Heart Failure: Primary results of the DELTA-HF trial.
Eur J Heart Fail. 2026 May 10:xuag157. doi: 10.1093.
PubMed Abstract available

COIRO S, Monzo L, Boutry F, Lacomblez C, et al
Short- and Long-Term Mortality in Patients Hospitalized for Dyspnoea with Acute Heart Failure, Respiratory Infection, or Both: Insights from the PARADISE Cohort.
Eur J Heart Fail. 2026 May 10:xuag160. doi: 10.1093.
PubMed Abstract available

MILICIC D, Planinc I, Adamopoulos S, Gal TB, et al
Update on heart transplantation: a clinical consensus statement of the Advanced Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology.
Eur J Heart Fail. 2026 May 5:xuag051. doi: 10.1093.
PubMed Abstract available

CELIK A, Yilmaz MB
Letter regarding the article "The global epidemiology of heart failure: a comprehensive and contemporary review".
Eur J Heart Fail. 2026 May 4:xuag152. doi: 10.1093.
PubMed

ZHOU JY, Ball J, Nehme E, Anderson D, et al
A Prehospital Decision Support Tool for the Diagnosis of Acute Heart Failure: The RAPID-CHF Score.
Eur J Heart Fail. 2026 May 4:xuag138. doi: 10.1093.
PubMed Abstract available

HOHENDANNER F, Shah AM, Van Linthout S
From Mechanics to Mitochondria: Dyssynchronous Heart Failure as an Energetic Disease.
Eur J Heart Fail. 2026 May 2:xuag135. doi: 10.1093.
PubMed

BAUDRY G, Lacomblez C, Bresso E, Monzo L, et al
Short and long-term prognosis of hospitalization for dyspnoea based on aetiology and hospitalization ward: insights from the PARADISE cohort.
Eur J Heart Fail. 2026;28:130-140.
PubMed Abstract available

April 2026

FERREIRA JP, Marques P, Pellicori P, Anker MS, et al
Beyond Chronological Age: Why Frailty Matters in Heart Failure.
Eur J Heart Fail. 2026 Apr 28:xuag145. doi: 10.1093.
PubMed

KEIR DA, Nardone M, Guluzade NA, Keys E, et al
Discordant ventilatory and efferent sympathetic responsiveness to peripheral and central chemoreflex stimulation in heart failure with reduced ejection fraction.
Eur J Heart Fail. 2026 Apr 28:xuag127. doi: 10.1093.
PubMed

GARRED CH, Elmegaard M, Christensen DM, Friis C, et al
Modification of the association between age and mortality in heart failure by frailty status.
Eur J Heart Fail. 2026 Apr 27:xuag137. doi: 10.1093.
PubMed Abstract available

AMDAHL MB, Naser JA, Tada A, Doi S, et al
Kidney Dysfunction and Pulmonary Vascular Disease in Heart Failure with preserved Ejection Fraction.
Eur J Heart Fail. 2026 Apr 27:xuag140. doi: 10.1093.
PubMed Abstract available

SCHMID-ELLINGER V, Siegrist M, Schaller N, Isaak J, et al
Impact of multicomponent exercise training in older individuals with and without heart failure with reduced ejection fraction - the role of functional capacity and novel biomarkers.
Eur J Heart Fail. 2026 Apr 21:xuag133. doi: 10.1093.
PubMed Abstract available

NASER JA, Pislaru SV, Lin G
Reply to: Correspondence on "Impact of contemporary guideline-directed medical therapy on secondary mitral and tricuspid regurgitation in heart failure with reduced ejection fraction".
Eur J Heart Fail. 2026 Apr 20:xuag129. doi: 10.1093.
PubMed

GHANBARI F, Gopal DM, Ngo LH, Rodriguez J, et al
Exercise cardiac magnetic resonance biventricular volumetric reserve in heart failure with preserved ejection fraction.
Eur J Heart Fail. 2026 Apr 16:xuag100. doi: 10.1093.
PubMed Abstract available

WEN S, Cao B, Xiang R
Letter regarding the article 'Impact of contemporary guideline-directed medical therapy on secondary mitral and tricuspid regurgitation in heart failure with reduced ejection fraction'.
Eur J Heart Fail. 2026 Apr 15:xuag125. doi: 10.1093.
PubMed

FRAUSING MHJP, McIntyre WF, Healey JS, Kovalova T, et al
Subclinical atrial fibrillation and the risk of heart failure: insights from ARTESiA.
Eur J Heart Fail. 2026 Apr 13:xuag022. doi: 10.1093.
PubMed Abstract available

DIETL A, Iberl S, Kohler LM, Evert K, et al
Dyssynchronous heart failure: mitochondrial distribution and functions mirror regional workload and energy demand in a large-animal model of ventricular desynchronization.
Eur J Heart Fail. 2026 Apr 12:xuag112. doi: 10.1093.
PubMed Abstract available

HAMATANI Y, Ostrominski JW, Lu H, Claggett BL, et al
Effects of Finerenone Across a Range of Heart Failure Duration: A Prespecified Analysis of the FINEARTS-HF Trial.
Eur J Heart Fail. 2026 Apr 8:xuag119. doi: 10.1093.
PubMed Abstract available

FERREIRA JP, Pereira-Sousa I, Diaz SO, Saraiva F, et al
Heart Failure "Nudges" for Treatment Optimization in the Emergency Department: The Nudge HF study.
Eur J Heart Fail. 2026 Apr 8:xuag123. doi: 10.1093.
PubMed

RAKISHEVA A, Sliwa K, Bauersachs J, Petrie MC, et al
Heart Failure in Pregnancy: Where the 2025 ESC Guidelines "Cardiovascular disease and pregnancy" Illuminate-and Where Shadows Remain.
Eur J Heart Fail. 2026 Apr 8:xuag124. doi: 10.1093.
PubMed

BELDHUIS IE, Claggett BL, Neuen BL, Chatur S, et al
Spironolactone, Early Acute eGFR Changes, and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction: Insights from TOPCAT Americas.
Eur J Heart Fail. 2026 Apr 8:xuag099. doi: 10.1093.
PubMed Abstract available

BELDHUIS IE, Claggett BL, Neuen BL, Chatur S, et al
Kidney Failure Risk Equation and Risk of Kidney and Cardiovascular Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: Insights from PARADIGM-HF.
Eur J Heart Fail. 2026 Apr 8:xuag079. doi: 10.1093.
PubMed Abstract available

HENRY TD, Chung ES, Alvisi M, Murray DR, et al
AB-1002 gene therapy expressing active protein phosphatase inhibitor-1 in heart failure: Rationale and study design of the GenePHIT trial.
Eur J Heart Fail. 2026 Apr 7:xuag105. doi: 10.1093.
PubMed Abstract available

BOHM M, Abdullakutty J, Bauersachs J, Bavendiek U, et al
European Journal of Heart Failure International Expert Position Paper Utilisation, Optimisation, and Clinical Benefits of Steroidal Mineralocorticoid Receptor Antagonists in Heart Failure with a Reduced Ejection Fraction.
Eur J Heart Fail. 2026 Apr 7:xuag106. doi: 10.1093.
PubMed Abstract available

VALENTE V, Laborante R, Abdin A, Becher PM, et al
The Global Epidemiology of Heart Failure: A Comprehensive and Contemporary Review.
Eur J Heart Fail. 2026 Apr 7:xuag121. doi: 10.1093.
PubMed Abstract available

BAYES-GENIS A, Assmus B
Seeing congestion before it speaks: inferior vena cava-guided management in heart failure.
Eur J Heart Fail. 2026 Apr 1:xuag052. doi: 10.1093.
PubMed

March 2026

LEE MMY, Tomasoni D, Aimo A
What's New in Heart Failure? February 2026.
Eur J Heart Fail. 2026 Mar 31:xuag107. doi: 10.1093.
PubMed

HARIKRISHNAN S, Chopra V
Heart Failure Care in India.
Eur J Heart Fail. 2026 Mar 28:xuag094. doi: 10.1093.
PubMed

MARX-SCHUTT K, Jhund PS
Genitourinary tract infections in SGLT2 inhibitors treated heart failure patients.
Eur J Heart Fail. 2026 Mar 28:xuag097. doi: 10.1093.
PubMed

BASILE C, Lombardi C, Inciardi RM
Phenotyping tricuspid regurgitation: time to integrate left sided heart failure.
Eur J Heart Fail. 2026 Mar 28:xuag101. doi: 10.1093.
PubMed

STODKILDE-JORGENSEN N, Nielsen RR, Olesen KK, Gyldenkerne C, et al
Effect of age on 5-year excess mortality in heart failure with reduced ejection fraction.
Eur J Heart Fail. 2026 Mar 26:xuag098. doi: 10.1093.
PubMed Abstract available

VIJVER MAT, Dams OC, Voordes GHD, Verdonk RC, et al
Pancreatic Involvement During Acute Heart Failure: Insights from the AVANTI trial.
Eur J Heart Fail. 2026 Mar 20:xuag086. doi: 10.1093.
PubMed

DAMMAN K, Uriel N, Mehra MR, Testani J, et al
Long-term Safety and Performance of an Implantable IVC Sensor for Congestion-Guided Management in Heart Failure: 12-Month Results from the FUTURE-HF Trial Portfolio.
Eur J Heart Fail. 2026 Mar 17:xuag080. doi: 10.1093.
PubMed Abstract available

ROSCH S, Schober AR, Stolz L, Passoke F, et al
Left-sided heart failure determines outcomes in patients with severe tricuspid regurgitation undergoing percutaneous repair.
Eur J Heart Fail. 2026 Mar 14:xuag078. doi: 10.1093.
PubMed Abstract available

VAN DER MEER P, Voordes GHD, Vijver MAT, Mosterd A, et al
Heart failure patients with reduced or mildly reduced ejection fraction: baseline characteristics of the low-dose digoxin outcome DECISION trial.
Eur J Heart Fail. 2026 Mar 13:xuag073. doi: 10.1093.
PubMed Abstract available

RAKISHEVA A, Suleimenov E, Akanova A, Raissova A, et al
Editorial comment to: Influenza Vaccination in Acute Heart Failure: A Simple Shield for the "Vulnerable Phase".
Eur J Heart Fail. 2026 Mar 12:xuag058. doi: 10.1093.
PubMed

MARTENS P, Olivotto I, Garcia-Pavia P, Michels M, et al
Comprehensive evaluation of hypertrophic cardiomyopathy: European Journal of Heart Failure expert consensus document.
Eur J Heart Fail. 2026 Mar 12:xuag035. doi: 10.1093.
PubMed Abstract available

HAMATANI Y, Peikert A, Claggett BL, Desai AS, et al
Finerenone and Quality of Life in Heart Failure: Component-Level Analyses and Clinical Relevance of the Kansas City Cardiomyopathy Questionnaire.
Eur J Heart Fail. 2026 Mar 12:xuag062. doi: 10.1093.
PubMed Abstract available

NISHINO M, Egami Y, Mukai T, Kise M, et al
Are beta-Blockers Necessary for Patients with Heart Failure with Preserved Ejection Fraction? : PurSuit-HFpEF Registry.
Eur J Heart Fail. 2026 Mar 11:xuag071. doi: 10.1093.
PubMed Abstract available

LAUDER L, Staub D, Mahfoud F
Renal artery stenosis in heart failure: the overlooked cardiorenal culprit?
Eur J Heart Fail. 2026 Mar 9:xuag070. doi: 10.1093.
PubMed

REDDY YNV, Oduah MT, Adel F, Miranda WR, et al
Very High Dose Loop Diuretics for Worsening Heart Failure - A Randomized Pilot Trial.
Eur J Heart Fail. 2026 Mar 9:xuag069. doi: 10.1093.
PubMed

CHAI Y, Wang D
Letter regarding the article 'Beta-blockers in patients with heart failure with reduced ejection fraction and concomitant chronic obstructive pulmonary disease: Cardiovascular and respiratory outcomes'.
Eur J Heart Fail. 2026 Mar 9:xuag065. doi: 10.1093.
PubMed

BEER BN, Lindberg F, Savarese G
Letter to the Editor answering to Chai and Wang Beta-blockers in patients with heart failure with reduced ejection fraction and concomitant chronic obstructive pulmonary disease: cardiovascular and respiratory outcomes.
Eur J Heart Fail. 2026 Mar 6:xuag066. doi: 10.1093.
PubMed

SOLTANI F, Black N, Bradley J, Priestner L, et al
Characterising the heterogeneity of heart failure with preserved ejection fraction: moving beyond subgroups and distinguishing disease from risk.
Eur J Heart Fail. 2026 Mar 5:xuag056. doi: 10.1093.
PubMed Abstract available

MYHRE PL, Lindberg F, Logstrup BB, Ingimarsdottir IJ, et al
Enhancing Heart Failure Care Through Registries: Lessons Learned from Nordic Countries' Implementation of Guidelines.
Eur J Heart Fail. 2026 Mar 5:xuag060. doi: 10.1093.
PubMed Abstract available

February 2026

FERREIRA JP, Zannad F, Butler J, Filippatos G, et al
Genitourinary tract infections and SGLT2 inhibitors in heart failure: an EMPEROR-Pooled analysis.
Eur J Heart Fail. 2026 Feb 28:xuag054. doi: 10.1093.
PubMed Abstract available

GREENE SJ, Butler J, Fonarow GC
Beyond Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Where Do Additional Medical Therapies Fit?
Eur J Heart Fail. 2026 Feb 26:xuag053. doi: 10.1093.
PubMed

CEELEN DCH, Voors AA, Ter Maaten JM
Response to Letter regarding the article "Clinical profiles and prognostic impact of residual intravascular and tissue congestion in acute heart failure".
Eur J Heart Fail. 2026 Feb 26:xuag014. doi: 10.1093.
PubMed

QI X, Wang J, Chen L
Letter regarding the article "Clinical profiles and prognostic impact of residual intravascular and tissue congestion in acute heart failure".
Eur J Heart Fail. 2026 Feb 26:xuag050. doi: 10.1093.
PubMed

FOX SJ, Champsi A, Hardy EJ, Bunting KV, et al
Combination of heart failure and atrial fibrillation worsens ethnicity-related disparity: an individual patient-level meta-analysis of randomized trials.
Eur J Heart Fail. 2026 Feb 24:xuag017. doi: 10.1093.
PubMed Abstract available

YILMAZ MB, Metra M
Evidence-based medical therapy after structural interventions: when remaining proactive for heart failure medications can save lives.
Eur J Heart Fail. 2026 Feb 19:xuag001. doi: 10.1093.
PubMed

OSMANSKA J, Petrie MC, Biegus J
Severe kidney disease and heart failure therapy: a conundrum only partially resolved.
Eur J Heart Fail. 2026 Feb 19:xuag012. doi: 10.1093.
PubMed

NASER JA, Rahme SJ, Castrichini M, Ibrahim H, et al
Impact of contemporary guideline-directed medical therapy on secondary mitral and tricuspid regurgitation in heart failure with reduced ejection fraction.
Eur J Heart Fail. 2026 Feb 19:xuag047. doi: 10.1093.
PubMed Abstract available

GUZIK M, Zymlinski R, Biegus J
Sodium-glucose cotransporter-2 inhibitors in heart failure. How durable is the decongestive effect?
Eur J Heart Fail. 2026 Feb 18:xuaf019. doi: 10.1093.
PubMed

BAYES-GENIS A, Schiattarella GG
Beyond BMI: why heart failure trials must quantify adiposity, not just obesity.
Eur J Heart Fail. 2026 Feb 17:xuag046. doi: 10.1093.
PubMed

RAKISHEVA A, Biegus J, Chioncel O
Congestion in acute heart failure: a moving target in transition.
Eur J Heart Fail. 2026 Feb 17:xuaf013. doi: 10.1093.
PubMed

FOA A, Vaduganathan M, Claggett BL, Diaz R, et al
Effect of the cardiac myosin activator omecamtiv mecarbil on ventricular arrhythmias, cardiac arrest, and sudden death in heart failure with reduced ejection fraction: the GALACTIC-HF trial.
Eur J Heart Fail. 2026 Feb 12:xuag023. doi: 10.1093.
PubMed Abstract available

Correction to: An expert opinion on heart failure in hypertensive heart disease.
Eur J Heart Fail. 2026 Feb 12:xuag040. doi: 10.1093.
PubMed

GREEN D, Cleland JGF, Pellicori P, O'Keeffe H, et al
Revascularization of atherosclerotic renal artery stenosis in patients with heart failure.
Eur J Heart Fail. 2026 Feb 11:xuag042. doi: 10.1093.
PubMed Abstract available

YE B, Xu Y, Hirashima F, LeWinter MM, et al
Normal abundance of immune cells in left ventricular myocardium from patients with heart failure and preserved ejection fraction.
Eur J Heart Fail. 2026 Feb 10:xuag041. doi: 10.1093.
PubMed Abstract available

HACIL A, Piccoli M, Antakly-Hanon Y, Guglieri M, et al
Association of SGLT2 inhibitors and new-onset dementia in non-diabetic patients with heart failure.
Eur J Heart Fail. 2026 Feb 10:xuag038. doi: 10.1093.
PubMed Abstract available

SPAGNOLIN M, Fazzini L, Giaccherini C, D'Elia E, et al
Outcome trajectories in hospitalized heart failure with preserved ejection fraction: a machine learning cluster analysis.
Eur J Heart Fail. 2026 Feb 10:xuag037. doi: 10.1093.
PubMed Abstract available

HAMATANI Y, Claggett BL, Kulac IJ, Desai AS, et al
Finerenone, polypharmacy, and clinical outcomes in heart failure: pre-specified analysis from the FINEARTS-HF trial.
Eur J Heart Fail. 2026 Feb 10:xuag030. doi: 10.1093.
PubMed Abstract available

YOON M, Park JJ, Greenberg B
Finerenone and polypharmacy in heart failure with mildly reduced or preserved ejection fraction: a marker of risk, not a barrier to therapy.
Eur J Heart Fail. 2026 Feb 10:xuag025. doi: 10.1093.
PubMed

LEE J, Cheon S, Kang ES, Song J, et al
Coexistence of atrial fibrillation and metabolic dysfunction-associated steatotic liver disease as a high-risk overlap for incident heart failure in older adults.
Eur J Heart Fail. 2026 Feb 10:xuag036. doi: 10.1093.
PubMed Abstract available

WANG N, Hibbert T, Ishak S, Raftopulos N, et al
Surrogate markers of clinical endpoints in clinical trials of heart failure.
Eur J Heart Fail. 2026 Feb 6:xuag033. doi: 10.1093.
PubMed Abstract available

MONZO L, Savarese G, Mullens W, Abdelhamid M, et al
Implementation of guideline-directed medical therapy in patients with heart failure and obesity: European Journal of Heart Failure expert consensus document.
Eur J Heart Fail. 2026 Feb 4:xuag027. doi: 10.1093.
PubMed Abstract available

ALNUWAYSIR RIS, Bomer N, Anker SD, van Veldhuisen DJ, et al
Iron Deficiency Definitions and their Clinical and Prognostic Associations Across the Spectrum of Left Ventricular Ejection Fraction in Heart Failure.
Eur J Heart Fail. 2026 Feb 2:xuag031. doi: 10.1093.
PubMed Abstract available

January 2026

SCHULZ M, Laufs U
Challenges of heart failure pharmacotherapy in obesity.
Eur J Heart Fail. 2026 Jan 30:xuag011. doi: 10.1093.
PubMed

SLIWA K, Viljoen C, Hoevelmann J, Rakisheva A, et al
Access to medical care globally for patients with peripartum cardiomyopathy: a clinical consensus statement of the Heart Failure Association of the ESC.
Eur J Heart Fail. 2026 Jan 29:xuag024. doi: 10.1093.
PubMed Abstract available

LIANG Y, Wang X, Meng Z
Commentary on 'effect of glucagon-like peptide-1 receptor agonists on heart failure outcomes and cardiovascular death across varying cardiovascular-kidney-metabolic comorbidity'.
Eur J Heart Fail. 2026 Jan 23:xuaf022. doi: 10.1093.
PubMed

RUBIS P, Dziewiecka E, Banys R, Lisiecka M, et al
Effects of sodium-glucose cotransporter 2 inhibitors on cardiac metabolism, assessed by phosphorus magnetic resonance spectroscopy, in patients with heart failure.
Eur J Heart Fail. 2026 Jan 23:xuag026. doi: 10.1093.
PubMed

AIMO A, Tomasoni D, Fontana M
Possible ways of building trial-level evidence for heart failure therapies in cardiac amyloidosis.
Eur J Heart Fail. 2026 Jan 21:xuag019. doi: 10.1093.
PubMed

NUNEZ-MARIN G, de la Espriella R, Llacer P, Palau P, et al
Prognostic value of early changes in NT-proBNP across left ventricular ejection fraction status in acute heart failure.
Eur J Heart Fail. 2026 Jan 21:xuag018. doi: 10.1093.
PubMed Abstract available

BIEGUS J, Bayes-Genis A, von Haehling S, Kosmala W, et al
Contemporary heart failure evidence in 2025: a joint summary of key trials from the European Journal of Heart Failure and ESC Heart Failure Journal.
Eur J Heart Fail. 2026 Jan 17:xuag015. doi: 10.1093.
PubMed Abstract available

DHONT S, Bertrand PB
Heart rate modulation in heart failure with preserved ejection fraction: lessons from nature.
Eur J Heart Fail. 2026 Jan 17:xuag016. doi: 10.1093.
PubMed

EL-HADIDI S, Lindberg F, Benson L, Uijl A, et al
Magnitude of and outcome associated with inappropriate prescribing in heart failure with reduced ejection fraction: an analysis of 50 348 patients from the Swedish Heart Failure Registry.
Eur J Heart Fail. 2026 Jan 14:xuaf026. doi: 10.1093.
PubMed Abstract available

BEER BN, Kellner C, Sundermeyer J, Besch L, et al
Balancing blood pressure and catecholamine support is critical in heart failure-related cardiogenic shock patients.
Eur J Heart Fail. 2026 Jan 14:xuag009. doi: 10.1093.
PubMed Abstract available

BAYES-GENIS A, Codina P, Santiago E, Ruiz-Cueto M, et al
Real-world improved, remission, and recovered heart failure: long-term follow-up outcomes.
Eur J Heart Fail. 2026 Jan 14:xuaf024. doi: 10.1093.
PubMed

CHIMURA M, Jhund PS, Henderson AD, Claggett BL, et al
Efficacy of finerenone in patients with heart failure and mildly reduced or preserved ejection fraction: a prespecified analysis of heart rate and heart rhythm in the FINEARTS-HF trial.
Eur J Heart Fail. 2026 Jan 14:xuag008. doi: 10.1093.
PubMed Abstract available

CHIMURA M, Docherty KF, Jhund PS, Yang M, et al
Mitral regurgitation in patients with heart failure and reduced ejection fraction: insights from GALACTIC-HF.
Eur J Heart Fail. 2026 Jan 14:xuag007. doi: 10.1093.
PubMed Abstract available

ONO R, Chimura M, Docherty KF, Jhund PS, et al
Dipstick proteinuria and outcomes in patients with heart failure and reduced ejection fraction: insights from GALACTIC-HF.
Eur J Heart Fail. 2026 Jan 13:xuag003. doi: 10.1093.
PubMed Abstract available

DIEZ J, Gonzalez A, Kirabo A, Verdecchia P, et al
An expert opinion on heart failure in hypertensive heart disease.
Eur J Heart Fail. 2026 Jan 13:xuag004. doi: 10.1093.
PubMed Abstract available

IVARS-OBERMEIER N, Llorens P, Castells X, Muller C, et al
Effect of influenza vaccination in patients with decompensated heart failure: a systematic review and meta-analysis.
Eur J Heart Fail. 2026 Jan 12:xuaf025. doi: 10.1093.
PubMed Abstract available

CAMPBELL RT, Osmanska J, Docherty KF, Ahmed FZ, et al
SUBCUT HF II: rationale and design of a multicentre randomized controlled trial of SUBCUTaneous furosemide to support early discharge in patients admitted to hospital due to Heart Failure.
Eur J Heart Fail. 2026 Jan 12:xuaf018. doi: 10.1093.
PubMed Abstract available

VASQUES-NOVOA F, Ferreira JP, Mancio J, Marques P, et al
Myocardial fibrosis in heart failure with preserved ejection fraction: integrating circulating collagen fragments and cardiac magnetic resonance mapping.
Eur J Heart Fail. 2026 Jan 12:xuaf020. doi: 10.1093.
PubMed

SHEN L, Shen L, Cheang I, Yao W, et al
The efficacy and safety of qiliqiangxin according to baseline ejection fraction in patients with heart failure and reduced ejection fraction in QUEST.
Eur J Heart Fail. 2026 Jan 12:xuaf017. doi: 10.1093.
PubMed Abstract available

IWANEK G, Zymlinski R, Guzik M, Gajewski P, et al
The impact of volume and sodium chloride supplementation on diuretic response during decongestion of decompensated heart failure patients.
Eur J Heart Fail. 2026 Jan 12:xuaf023. doi: 10.1093.
PubMed Abstract available

SIDDIQI TJ, Khan MS, Fonarow GC, Butler J, et al
Reply to commentary on 'effect of glucagon-like peptide-1 receptor agonists on heart failure outcomes and cardiovascular death across varying cardiovascular kidney-metabolic comorbidity'.
Eur J Heart Fail. 2026 Jan 8:xuaf004. doi: 10.1093.
PubMed

SANDERSON JE, Cleland JGF
The current classification of heart failure is obsolete.
Eur J Heart Fail. 2026 Jan 8:xuaf010. doi: 10.1093.
PubMed

BUNTING KV, Tica O, Champsi A, Perrett M, et al
Erythropoiesis-stimulating agents to reduce heart failure hospitalization: a systematic review and meta-analysis.
Eur J Heart Fail. 2026 Jan 8:xuaf012. doi: 10.1093.
PubMed Abstract available

VON PETER A, Stolte T, Goetzinger F, Reichl JJ, et al
Incidence and management of heart failure phenotypes in patients undergoing transcatheter aortic valve implantation.
Eur J Heart Fail. 2026 Jan 8:xuaf015. doi: 10.1093.
PubMed

December 2025

INCIARDI RM, Volterrani M, Savarese G, Vaduganathan M, et al
Contemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM-HF registry.
Eur J Heart Fail. 2025 Dec 17. doi: 10.1002/ejhf.70074.
PubMed Abstract available

ABDIN A, Bauersachs J, Abdelhamid M, Aktaa S, et al
Pharmacologic pitfalls in heart failure: A guide to drugs that may cause or exacerbate heart failure. A European Journal of Heart Failure expert consensus document.
Eur J Heart Fail. 2025 Dec 11. doi: 10.1002/ejhf.70087.
PubMed Abstract available

FIORETTI F, Praderio A, Nodari S, Metra M, et al
Combination diuretic therapy in acute heart failure: A systematic review and meta-analysis.
Eur J Heart Fail. 2025 Dec 10. doi: 10.1002/ejhf.70094.
PubMed Abstract available

ZONNEVELD LEEC, Beldhuis IE, Qin H, van Veldhuisen DJ, et al
Outpatient loop diuretic use and the effect of natriuresis-guided diuretic therapy: A prespecified sub-analysis of the PUSH-AHF study.
Eur J Heart Fail. 2025;27:3111-3122.
PubMed Abstract available

VERSTRAELEN TE, van Lint FHM, de Brouwer R, Proost VM, et al
Age-related penetrance of phospholamban p.Arg14del cardiomyopathy.
Eur J Heart Fail. 2025;27:3269-3277.
PubMed Abstract available

ROBINSON DH, Peter K, McFadyen JD
Shear-induced dysregulation of haemostasis during extracorporeal membrane oxygenation: From cells to circuit.
Eur J Heart Fail. 2025;27:3352-3365.
PubMed Abstract available

BAYES-GENIS A, Cai A, Liu Y, Pandey A, et al
Impact of canagliflozin on heart stress and outcomes: Pooled insights from CREDENCE and CANVAS.
Eur J Heart Fail. 2025;27:2887-2896.
PubMed Abstract available

November 2025

MONZO L, Savarese G, Mullens W, Abdin A, et al
Pharmacological treatment for patients with obesity and heart failure: Focus on glucagon-like peptide-1 receptor agonists. European Journal of Heart Failure expert consensus document.
Eur J Heart Fail. 2025 Nov 27. doi: 10.1002/ejhf.70082.
PubMed Abstract available

PANDEY A, Moroney M, Verma S, Borlaug BA, et al
Effects of semaglutide in obesity-related heart failure with preserved ejection fraction across the age spectrum: Findings from the STEP-HFpEF programme.
Eur J Heart Fail. 2025 Nov 25. doi: 10.1002/ejhf.70049.
PubMed Abstract available

RAVIKULAN R, Chavali S, Gunton JE, De Pasquale CG, et al
Glucagon-like peptide-1 receptor agonists reduce atrial fibrillation among patients with heart failure with preserved and mildly reduced ejection fraction - a meta-analysis of randomized controlled trials.
Eur J Heart Fail. 2025 Nov 11. doi: 10.1002/ejhf.70085.
PubMed Abstract available

CEELEN DCH, Ter Maaten JM, Voordes GHD, Cotter G, et al
Clinical profiles and prognostic impact of residual intravascular and tissue congestion in acute heart failure.
Eur J Heart Fail. 2025 Nov 11. doi: 10.1002/ejhf.70091.
PubMed Abstract available

SAVARESE G, Lindberg F, Cannata A, Adamo M, et al
Adherence to guideline-directed medical treatments in heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Cardiovascular Pharmacotherapy.
Eur J Heart Fail. 2025 Nov 9. doi: 10.1002/ejhf.70090.
PubMed Abstract available

INCIARDI RM, Lu H, Claggett BL, Desai AS, et al
Finerenone in patients with severe heart failure: The FINEARTS-HF trial.
Eur J Heart Fail. 2025 Nov 4. doi: 10.1002/ejhf.70083.
PubMed Abstract available

BYTYQI V, Kannenkeril D, Kolwelter J, Linz P, et al
Short- and mid-term effects of empagliflozin on sodium balance and fluid regulation in chronic heart failure.
Eur J Heart Fail. 2025 Nov 4. doi: 10.1002/ejhf.70078.
PubMed Abstract available

BAYES-GENIS A, Pagnesi M, Metra M
Reply to the letter regarding the article 'Remote pulmonary artery pressure-guided management of patients with heart failure: A clinical consensus statement of the Heart Failure Association (HFA) of the ESC'.
Eur J Heart Fail. 2025 Nov 3. doi: 10.1002/ejhf.70086.
PubMed

ZEMRAK F, Fernandez OG, Marshall WH 5th
Letter regarding the article 'Remote pulmonary artery pressure-guided management of patients with heart failure: A clinical consensus statement of the Heart Failure Association (HFA) of the ESC'.
Eur J Heart Fail. 2025 Nov 3. doi: 10.1002/ejhf.70088.
PubMed

KOBAYASHI M, Bozkurt B, Myhre PL, Lopez Azor JC, et al
Urinary markers in heart failure - types, timing and thresholds. European Journal of Heart Failure expert consensus document.
Eur J Heart Fail. 2025 Nov 3. doi: 10.1002/ejhf.70079.
PubMed Abstract available

TOKCAN M, Hoevelmann J, Markwirth P, Haring B, et al
What's new in heart failure? November 2025.
Eur J Heart Fail. 2025;27:1947-1949.
PubMed

ZHANG Y, Chi F, Zhu R, Hu L, et al
Impact of misclassification bias on interpretation of finerenone efficacy in chronic obstructive pulmonary disease and heart failure with mildly reduced or preserved ejection fraction: A critical appraisal of the FINEARTS-HF subanalysis.
Eur J Heart Fail. 2025;27:2658.
PubMed

SUNDERMEYER J, Li S, Ton VK, Kataria R, et al
Impact of comorbidity burden on outcome in patients with cardiogenic shock: A Cardiogenic Shock Working Group analysis.
Eur J Heart Fail. 2025;27:2244-2258.
PubMed Abstract available

October 2025

ILIADIS C, Adamo M, Rudolph V, Karam N, et al
European Journal of Heart Failure expert consensus statement on transcatheter treatment of mitral regurgitation in heart failure.
Eur J Heart Fail. 2025 Oct 30. doi: 10.1002/ejhf.70043.
PubMed Abstract available

MAZON-RUIZ J, Banegas-Deras EJ, Fernandez-Rodriguez JM, Domingo M, et al
The chloride paradigm shift in heart failure: From neglected ion to keystone of precision diuretic therapy.
Eur J Heart Fail. 2025 Oct 29. doi: 10.1002/ejhf.70081.
PubMed Abstract available

CHIONCEL O, Savarese G, Laroche C, Amir O, et al
Global Registries and Surveys Programme-Heart Failure (GRASP-HF): Rationale, study design and research implications.
Eur J Heart Fail. 2025 Oct 22. doi: 10.1002/ejhf.70065.
PubMed Abstract available

LUEDDE M, Agewall S, Ambrosio G, Bayes-Genis A, et al
European Journal of Heart Failure consensus statement. Heart failure pharmacotherapy for patients with heart failure with reduced ejection fraction and concomitant atrial fibrillation: Review of evidence and call to action.
Eur J Heart Fail. 2025 Oct 22. doi: 10.1002/ejhf.70069.
PubMed Abstract available

STRAW S, Martens P, Mewton N, Witte KK, et al
The problem with hospitalization endpoints in heart failure trials.
Eur J Heart Fail. 2025 Oct 21. doi: 10.1002/ejhf.70070.
PubMed

CHANG HC, Huang WM, Lin LY, Lee CW, et al
A U-shaped relationship between left ventricular ejection fraction and risk of worsening heart failure.
Eur J Heart Fail. 2025 Oct 20. doi: 10.1002/ejhf.70061.
PubMed Abstract available

TOPS LF, Aimo A, Adamopoulos S, Bonios M, et al
Multimodality imaging in advanced heart failure. A clinical consensus statement of the Heart Failure Association of the ESC. Part 2: Mechanical circulatory support and heart transplantation.
Eur J Heart Fail. 2025 Oct 14. doi: 10.1002/ejhf.70018.
PubMed Abstract available

AIMO A, Tops LF, Adamopoulos S, Bonios M, et al
Multimodality imaging in advanced heart failure. A clinical consensus statement of the Heart Failure Association of the ESC. Part 1: Multimodality imaging for the evaluation of patients with advanced heart failure.
Eur J Heart Fail. 2025 Oct 14. doi: 10.1002/ejhf.3762.
PubMed Abstract available

ECHEVERRIA LE, Demacq C, Gimpelewicz C, McMurray JJV, et al
Reply to the letter regarding the article 'Sacubitril/valsartan versus enalapril in chronic Chagas cardiomyopathy with heart failure: Baseline characteristics of the PARACHUTE-HF trial'.
Eur J Heart Fail. 2025 Oct 14. doi: 10.1002/ejhf.70062.
PubMed

XIONG D
Letter regarding the article 'Sacubitril/valsartan versus enalapril in chronic Chagas cardiomyopathy with heart failure: Baseline characteristics of the PARACHUTE-HF trial'.
Eur J Heart Fail. 2025 Oct 14. doi: 10.1002/ejhf.70058.
PubMed

BIEGUS J, Iwanek G, Zymlinski R
Reply to the letter 'Sodium chloride versus glucose solute as a volume replacement therapy for more effective decongestion in acute heart failure: It is probably just the chloride'.
Eur J Heart Fail. 2025 Oct 13. doi: 10.1002/ejhf.70066.
PubMed

CARRIZALES-SEPULVEDA EF, Flores-Ramirez R
Sodium chloride versus glucose solute as a volume replacement therapy for more effective decongestion in acute heart failure: It is probably just the chloride! Letter regarding the article 'Sodium chloride versus glucose solute as a volume replacement
Eur J Heart Fail. 2025 Oct 13. doi: 10.1002/ejhf.70063.
PubMed

BOZKURT B
Rising burden of heart failure: An urgent global public health concern.
Eur J Heart Fail. 2025 Oct 13. doi: 10.1002/ejhf.70068.
PubMed

ICHIHARA YK, Shiraishi Y, Sawano M, Kohno T, et al
Physician-reported reasons for not prescribing guideline-directed medical therapy in heart failure with reduced ejection fraction: A prospective registry analysis.
Eur J Heart Fail. 2025 Oct 13. doi: 10.1002/ejhf.70067.
PubMed

KINOSHITA H, Sugino H, Kodama M, Saito M, et al
The addition of vericiguat to sacubitril/valsartan improved the composite endpoint. Add a finishing touch on heart failure medical therapy by vericiguat as secret ingredient.
Eur J Heart Fail. 2025 Oct 9. doi: 10.1002/ejhf.70059.
PubMed

ROMERO-GONZALEZ G, Husain-Syed F, Ronco C
Letter regarding the article 'Urinary sodium analysis: The key to effective diuretic titration? European Journal of Heart Failure expert consensus document'.
Eur J Heart Fail. 2025 Oct 5. doi: 10.1002/ejhf.70027.
PubMed

MEEKERS E
Reply to the letter regarding the article 'Urinary sodium analysis: The key to effective diuretic titration? European Journal of Heart Failure expert consensus document'.
Eur J Heart Fail. 2025 Oct 5. doi: 10.1002/ejhf.70032.
PubMed

FERREIRA JP, Vaduganathan M, Claggett BL, Kulac I, et al
Interplay of serum potassium and kidney function with finerenone in heart failure with mildly reduced or preserved ejection fraction: Findings from FINEARTS-HF.
Eur J Heart Fail. 2025 Oct 2. doi: 10.1002/ejhf.70052.
PubMed Abstract available

TAY WT, Teng TK, Ouwerkerk W, Cleland JGF, et al
Global patterns of polypharmacy after acute heart failure hospitalization: Prevalence and outcomes from the REPORT-HF registry.
Eur J Heart Fail. 2025 Oct 1. doi: 10.1002/ejhf.70056.
PubMed Abstract available

CODINA P, Lee MMY, Tomasoni D, Aimo A, et al
What's new in heart failure? October 2025.
Eur J Heart Fail. 2025;27:1803-1806.
PubMed

September 2025

MENTZ RJ, Butler J, McMullan CJ, Wojdyla DM, et al
Blood pressure, safety and clinical efficacy of vericiguat in chronic heart failure with reduced ejection fraction: Insights from the VICTOR trial.
Eur J Heart Fail. 2025 Sep 29. doi: 10.1002/ejhf.70033.
PubMed Abstract available

COTTER G, Biegus J, Fudim M, Miro O, et al
Acute heart failure care - a consensus series of an international experts' group.
Eur J Heart Fail. 2025 Sep 28. doi: 10.1002/ejhf.70057.
PubMed Abstract available

GIGLI M, Verdonschot JAJ, Garcia-Pavia P, Stolfo D, et al
Future development of arrhythmogenic risk scores in patients with heart failure and inherited dilated cardiomyopathy. A scientific statement of the Heart Failure Association of the ESC.
Eur J Heart Fail. 2025 Sep 24. doi: 10.1002/ejhf.70042.
PubMed Abstract available

SEFEROVIC PM, Polovina M, Krejci J, Merkely B, et al
Contemporary implementation of guideline-directed medical and device therapies in heart failure: Insights from the Central/Eastern Europe Quality of Care Centres Survey.
Eur J Heart Fail. 2025 Sep 24. doi: 10.1002/ejhf.70031.
PubMed Abstract available

ZHOU J, Jin X, Xu Y, Xie Z, et al
Nationwide implementation of heart failure therapies: National Heart Failure Center Accreditation Program (HF-CAP) in China.
Eur J Heart Fail. 2025 Sep 22. doi: 10.1002/ejhf.70035.
PubMed Abstract available

HARADA T, Reddy YNV, Sorimachi H, Obokata M, et al
Dynamic tricuspid regurgitation in heart failure with preserved ejection fraction.
Eur J Heart Fail. 2025 Sep 22. doi: 10.1002/ejhf.70050.
PubMed Abstract available

SIDDIQI TJ, Khan MS, Waqas SA, Van Spall HGC, et al
Effect of glucagon-like peptide-1 receptor agonists on heart failure outcomes and cardiovascular death across varying cardiovascular-kidney-metabolic comorbidity.
Eur J Heart Fail. 2025 Sep 22. doi: 10.1002/ejhf.70048.
PubMed Abstract available

VERSNJAK J, Kuehne T, Fahjen P, Jovanovic N, et al
Deep phenotyping of heart failure with preserved ejection fraction through multi-omics integration.
Eur J Heart Fail. 2025 Sep 22. doi: 10.1002/ejhf.70041.
PubMed Abstract available

KNIERIM M, Hartmann N, Maurer W, Pabel S, et al
Atrial fibrillation in end-stage heart failure: Cellular mechanisms behind CASTLE-HTx.
Eur J Heart Fail. 2025 Sep 17. doi: 10.1002/ejhf.70051.
PubMed

BOHM M, Butler J, Abdin A, Filippatos G, et al
Heart failure outcomes and empagliflozin effects in patients with heart failure and reduced ejection fraction in sinus rhythm or atrial fibrillation: Data from EMPEROR-Reduced.
Eur J Heart Fail. 2025 Sep 16. doi: 10.1002/ejhf.70021.
PubMed Abstract available

KOBAYASHI M, Duarte K, Ferreira JP, Baudry G, et al
An individual treatment effect approach to predict response to mineralocorticoid receptor antagonists in patients with heart failure and reduced ejection fraction.
Eur J Heart Fail. 2025 Sep 16. doi: 10.1002/ejhf.70047.
PubMed Abstract available

ADAMO M, Pagnesi M, Chioncel O, Bayes-Genis A, et al
Management of aortic stenosis and chronic heart failure: A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC.
Eur J Heart Fail. 2025 Sep 15. doi: 10.1002/ejhf.70023.
PubMed Abstract available

Correction to "Use of guideline-recommended medical therapy in patients with heart failure and chronic kidney disease: from physician's prescriptions to patient's dispensations, medication adherence and persistence".
Eur J Heart Fail. 2025 Sep 15. doi: 10.1002/ejhf.70016.
PubMed

KERAMIDA K, Lopez-Fernandez T, Anker MS, Petrie MC, et al
Heart failure with preserved ejection fraction in cancer patients and survivors. A scientific statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-Oncology.
Eur J Heart Fail. 2025 Sep 12. doi: 10.1002/ejhf.70005.
PubMed Abstract available

BEER BN, Benson L, Basile C, Schrage B, et al
Beta-blockers in patients with heart failure with reduced ejection fraction and concomitant chronic obstructive pulmonary disease: Cardiovascular and respiratory outcomes.
Eur J Heart Fail. 2025 Sep 11. doi: 10.1002/ejhf.70046.
PubMed Abstract available

SHAH P, Bekfani T, Rubis P, Clark AL, et al
Potential therapeutic effects of warming on patients with heart failure.
Eur J Heart Fail. 2025 Sep 9. doi: 10.1002/ejhf.70011.
PubMed

CAMPAIN J, Wakeham DJ, Dias K, MacNamara JP, et al
Distinct blood volume and left ventricular adaptation to severe obesity in middle-aged adults at risk for heart failure.
Eur J Heart Fail. 2025 Sep 9. doi: 10.1002/ejhf.70037.
PubMed Abstract available

IVANOVSKI M, Mrak M, Meznar AZ, Jan M, et al
The CONDUCT-AF trial: Rationale and design of a prospective, randomized, multicentre study comparing conduction system and biventricular pacing in patients undergoing atrioventricular node ablation for heart failure with atrial fibrillation.
Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70013.
PubMed Abstract available

CHANG HC, Gau SY
Letter regarding the article 'Association between antecedent myocardial infarction and heart failure with preserved versus reduced ejection fraction'.
Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70045.
PubMed

ALMESNED MA, van Essen BJ, Voors AA, Lipsic E, et al
Reply to the letter regarding the article 'Association between antecedent myocardial infarction and heart failure with preserved versus reduced ejection fraction'.
Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70044.
PubMed

OSTROMINSKI JW, Claggett BL, Desai AS, Jhund PS, et al
Finerenone according to insulin resistance in heart failure: Insights from the FINEARTS-HF trial.
Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70034.
PubMed Abstract available

BARAKAT MF, Amaral N, Brayson D, Amin-Youssef G, et al
Ferric derisomaltose augments intrinsic skeletal muscle electron transport chain activity in heart failure: A FERRIC-HF II molecular substudy.
Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70028.
PubMed Abstract available

NASSIRI S, Voordes GHD, Handoko ML, Voors AA, et al
Reply to the letter regarding the article 'Effects of geranylgeranylacetone on diastolic and microvascular function in patients with heart failure with a preserved ejection fraction: A phase 2, randomized, placebo-controlled, crossover trial'.
Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70038.
PubMed

YANG Z, Kou L, Liao S
Letter regarding the article 'Effects of geranylgeranylacetone on diastolic and microvascular function in patients with heart failure with a preserved ejection fraction: A phase 2, randomized, placebo-controlled, crossover trial'.
Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70039.
PubMed

ECHEVERRIA LE, Bocchi E, Demacq C, de Barros E Silva PGM, et al
Sacubitril/valsartan versus enalapril in chronic Chagas cardiomyopathy with heart failure: Baseline characteristics of the PARACHUTE-HF trial.
Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70026.
PubMed Abstract available

KEMPF T, Fuge J, Bauersachs J
Reply to the letter regarding the article 'Oral ferric maltol improves iron deficiency anaemia in patients with chronic heart failure'.
Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70029.
PubMed

SUN P
Letter regarding the article 'Oral ferric maltol improves iron deficiency anaemia in patients with chronic heart failure'.
Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70024.
PubMed

REIMER JENSEN AM, Ross JC, Arthur V, Hall ME, et al
Integrated trajectories of systolic and diastolic function differentially associate with risk for heart failure with preserved and reduced ejection fraction and proteomic profiles.
Eur J Heart Fail. 2025 Sep 2. doi: 10.1002/ejhf.70015.
PubMed Abstract available

BUNTING KV, Champsi A, Gill SK, Saadeh K, et al
Low-dose digoxin improves cardiac function in patients with heart failure, preserved ejection fraction and atrial fibrillation - the RATE-AF randomized trial.
Eur J Heart Fail. 2025 Sep 2. doi: 10.1002/ejhf.70022.
PubMed Abstract available

AIMO A, Vergaro G, Pastore MC, Tomasoni D, et al
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study.
Eur J Heart Fail. 2025 Sep 1. doi: 10.1002/ejhf.70030.
PubMed

HOEVELMANN J, Markwirth P, Tokcan M, Haring B, et al
What's new in heart failure? September 2025.
Eur J Heart Fail. 2025;27:1603-1605.
PubMed

Correction to 'What's New in Heart Failure? May-June 2024' , 'What's New in Heart Failure? June-July 2024', 'What's New in Heart Failure? August-September 2024', 'The Month in Heart Failure! September 2024', 'What's New in Heart Failure? October
Eur J Heart Fail. 2025;27:1793-1794.
PubMed

August 2025

FAUCHIER L, Lochon L, Lenormand T, Pierre B, et al
Cardiovascular outcomes with tirzepatide in heart failure with preserved ejection fraction associated with obesity.
Eur J Heart Fail. 2025 Aug 29. doi: 10.1002/ejhf.70012.
PubMed

BEGGS SAS, Petrie MC, Wright S, Connelly DT, et al
Why do people with heart failure die? Rationale and design of the RHYTHM-HF study.
Eur J Heart Fail. 2025 Aug 29. doi: 10.1002/ejhf.70014.
PubMed Abstract available

ANKER MS, Mahabadi AA, Totzeck M, Tewes M, et al
Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: Rationale and design of the EMPATICC trial.
Eur J Heart Fail. 2025 Aug 26. doi: 10.1002/ejhf.3799.
PubMed Abstract available

PANDEY A, Segar MW, Keshvani N, Llacer P, et al
Diuretic resistance and the efficacy of hydrochlorothiazide in acute decompensated heart failure: A post-hoc analysis of the CLOROTIC trial.
Eur J Heart Fail. 2025 Aug 26. doi: 10.1002/ejhf.70002.
PubMed Abstract available

HARM T, Keren A, Borst O
Parvovirus B19 - more than a bystander in the prognosis of non-ischaemic heart failure.
Eur J Heart Fail. 2025 Aug 26. doi: 10.1002/ejhf.70008.
PubMed

JEAN SS, Lai CC
Letter regarding the article 'Incident heart failure is common and underrecognized in patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease'.
Eur J Heart Fail. 2025 Aug 26. doi: 10.1002/ejhf.3769.
PubMed

WEGERMANN K, Fudim M
Reply to the letter regarding the article 'Incident heart failure is common and underrecognized in patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease'.
Eur J Heart Fail. 2025 Aug 26. doi: 10.1002/ejhf.3777.
PubMed

PETRIE MC, Cherney DZI, Desai AS, Testani JM, et al
Sodium zirconium cyclosilicate, hyperkalaemia, and spironolactone optimization in heart failure with reduced ejection fraction: The REALIZE-K open-label run-in phase.
Eur J Heart Fail. 2025 Aug 20. doi: 10.1002/ejhf.3787.
PubMed

BAUDRY G, Crespo-Leiro MG, Delmas C, Guidetti F, et al
Identifying and overcoming barriers to referral in advanced heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC.
Eur J Heart Fail. 2025 Aug 17. doi: 10.1002/ejhf.70003.
PubMed Abstract available

ZUIN M, Temporelli PL, Metra M, Savarese G, et al
Heart failure-attributed mortality in Europe, 2012-2021.
Eur J Heart Fail. 2025 Aug 17. doi: 10.1002/ejhf.70001.
PubMed Abstract available

ROSANO GMC, Bayes-Genis A, Kinugawa K, Teerlink JR, et al
Healthcare system deficiencies should never be employed as justification for delivering sub-standard care to heart failure patients. Letter regarding the article 'Serial assessment of left ventricular ejection fraction for the management of heart fail
Eur J Heart Fail. 2025 Aug 15. doi: 10.1002/ejhf.3772.
PubMed

PALAZZUOLI A, Pellicori P, Cleland JGF
Reply to 'Healthcare system deficiencies should never be employed as justification for delivering sub-standard care to heart failure patients'.
Eur J Heart Fail. 2025 Aug 15. doi: 10.1002/ejhf.3770.
PubMed

BUTT JH, McMurray JJV
Reply to 'Impact of misclassification bias on interpretation of finerenone efficacy in chronic obstructive pulmonary disease and heart failure with mildly reduced/preserved ejection fraction: A critical appraisal of the FINEARTS-HF sub-analysis'.
Eur J Heart Fail. 2025 Aug 15. doi: 10.1002/ejhf.3804.
PubMed

MALGIE J, Wilde MI, Koudstaal S, Denham R, et al
Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HF.
Eur J Heart Fail. 2025 Aug 14. doi: 10.1002/ejhf.70006.
PubMed Abstract available

GREENE SJ, Sauer AJ, Bohm M, Bozkurt B, et al
Management of patients with heart failure at high risk of hyperkalaemia: The CARE-HK in HF registry.
Eur J Heart Fail. 2025 Aug 11. doi: 10.1002/ejhf.3800.
PubMed Abstract available

UDELSON JE, Goldsmith SR, Burkhoff D, Colorado P, et al
A multicentre, randomized, double-blind, active and placebo-controlled study of pecavaptan, a dual V1a/V2 vasopressin receptor antagonist, in patients with acute heart failure: The AVANTI trial.
Eur J Heart Fail. 2025 Aug 11. doi: 10.1002/ejhf.3801.
PubMed Abstract available

STOCKER TJ, Geisler T, Rottbauer W, Lubos E, et al
Rationale and design of the TRIC-I-HF-DZHK24 (TRICuspid Intervention in Heart Failure) trial.
Eur J Heart Fail. 2025 Aug 11. doi: 10.1002/ejhf.3795.
PubMed Abstract available

BURGOS LM, Baro Vila R, Goyeneche A, Costabel JP, et al
Residual congestion defined by HFA-ESC multiparametric criteria and 90-day outcomes in worsening heart failure.
Eur J Heart Fail. 2025 Aug 11. doi: 10.1002/ejhf.70004.
PubMed

ALMESNED MA, van Essen BJ, Emmens JE, Tromp J, et al
Association between antecedent myocardial infarction and heart failure with preserved versus reduced ejection fraction.
Eur J Heart Fail. 2025 Aug 6. doi: 10.1002/ejhf.3788.
PubMed

WEERTS J, Tica O, Aranyo J, Basile C, et al
Atrial cardiomyopathy: From healthy atria to atrial failure. A clinical consensus statement of the Heart Failure Association of the ESC.
Eur J Heart Fail. 2025 Aug 5. doi: 10.1002/ejhf.3782.
PubMed Abstract available

KESSLER T, Winkler M, Bayes-Genis A
Embryonic transcripts in heart failure: Time for reprogrammed thinking?
Eur J Heart Fail. 2025 Aug 4. doi: 10.1002/ejhf.3794.
PubMed

AIMO A, Codina P, Lee MMY, Tomasoni D, et al
What's new in heart failure? August 2025.
Eur J Heart Fail. 2025;27:1375-1378.
PubMed

LUPI L, Antonioli E, Praderio A, Villaschi A, et al
Aetiological phenotypes of atrial and ventricular secondary tricuspid regurgitation and their prognostic implications: insights from the CARE-TR registry.
Eur J Heart Fail. 2025;27:1549-1558.
PubMed Abstract available

KANEKO T, Murata A, Amano M, Sato Y, et al
Characteristics, determinants, and prognostic impact of severe tricuspid regurgitation in patients with atrial functional mitral regurgitation: Insights from the REVEAL-AFMR registry.
Eur J Heart Fail. 2025;27:1539-1548.
PubMed Abstract available

NOUHRAVESH N, Gunn AH, Cyr D, Hernandez AF, et al
Sacubitril/valsartan versus valsartan initiation in patients naive to renin-angiotensin system inhibitors: Insights from PARAGLIDE-HF.
Eur J Heart Fail. 2025;27:1418-1425.
PubMed Abstract available

July 2025

KARAKAS M, Friede T, Butler J, Talha KM, et al
Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomes.
Eur J Heart Fail. 2025 Jul 31. doi: 10.1002/ejhf.3742.
PubMed Abstract available

SUN R, Kong D, Jiang T
Expanding the horizon of medication adherence strategies in acutely decompensated heart failure. Letter regarding the article 'Medication adherence in patients with acutely decompensated heart failure: A cross-sectional study in the emergency departme
Eur J Heart Fail. 2025 Jul 29. doi: 10.1002/ejhf.3805.
PubMed

KUNZ M, Schulz M, Mahfoud F
Reply to 'Expanding the horizon of medication adherence strategies in acutely decompensated heart failure'.
Eur J Heart Fail. 2025 Jul 29. doi: 10.1002/ejhf.3803.
PubMed

BAUMEIER C, Starlinger J, Aleshcheva G, Wiegleb G, et al
Improved risk assessment in parvovirus B19-positive patients with heart failure by multiparametric analysis of endomyocardial biopsy using machine learning methods.
Eur J Heart Fail. 2025 Jul 28. doi: 10.1002/ejhf.3798.
PubMed Abstract available

NASSIRI S, Voordes GHD, van Heerebeek L, van Raalte DH, et al
Effects of geranylgeranylacetone on diastolic and microvascular function in patients with heart failure with a preserved ejection fraction: A phase 2, randomized, placebo-controlled, crossover trial.
Eur J Heart Fail. 2025 Jul 28. doi: 10.1002/ejhf.3711.
PubMed Abstract available

KAUFMANN CC, Ahmed A, Harbich PF, Auer L, et al
Prognostic impact of frailty at admission and in-hospital changes of frailty status in elderly patients with acute heart failure.
Eur J Heart Fail. 2025 Jul 25. doi: 10.1002/ejhf.3779.
PubMed Abstract available

CREMER S, von Scheidt M, Kirschbaum K, Tombor L, et al
Prognostic significance of somatic mutations in myeloid cells of men with chronic heart failure - interaction between loss of Y chromosome and clonal haematopoiesis.
Eur J Heart Fail. 2025 Jul 24. doi: 10.1002/ejhf.3778.
PubMed Abstract available

CAMPBELL RT, Petrie MC, Docherty KF, Brooksbank KJM, et al
Artificial intelligence fully automated analysis of handheld echocardiography in real-world patients with suspected heart failure.
Eur J Heart Fail. 2025 Jul 24. doi: 10.1002/ejhf.3783.
PubMed Abstract available

BIEGUS J, Ponikowski P
Reply to the letter regarding the article 'Sodium chloride versus glucose solute as a volume replacement therapy for more effective decongestion in acute heart failure (SOLVRED-AHF): A prospective, randomized, mechanistic study'.
Eur J Heart Fail. 2025 Jul 23. doi: 10.1002/ejhf.3792.
PubMed

BAUDRY G, Pereira O, Roubille F, Girerd N, et al
Reply to 'Beyond pharmacotherapy: Addressing system-level barriers in women's heart failure care'.
Eur J Heart Fail. 2025 Jul 23. doi: 10.1002/ejhf.3793.
PubMed

ZHANG H, Gao W
Beyond pharmacotherapy: Addressing system-level barriers in women's heart failure care. Letter regarding the article 'Sex-based differences in heart failure management and outcomes: Insights from the French-DataHF cohort'.
Eur J Heart Fail. 2025 Jul 23. doi: 10.1002/ejhf.3791.
PubMed

PRAKASH ES
Letter regarding the article 'Sodium chloride versus glucose solute as a volume replacement therapy for more effective decongestion in acute heart failure (SOLVRED-AHF): A prospective, randomized, mechanistic study'.
Eur J Heart Fail. 2025 Jul 23. doi: 10.1002/ejhf.3790.
PubMed

BIEGUS J, Zymlinski R, Ponikowski P
Reply to 'Is sodium chloride supplementation ready for clinical practice in acute heart failure?'.
Eur J Heart Fail. 2025 Jul 21. doi: 10.1002/ejhf.3773.
PubMed

KEMPF T, Geller W, Fuge J, Sandu MA, et al
Oral ferric maltol improves iron deficiency anaemia in patients with chronic heart failure.
Eur J Heart Fail. 2025 Jul 21. doi: 10.1002/ejhf.3789.
PubMed

MASUDA Y, Yamamoto I
Is sodium chloride supplementation ready for clinical practice in acute heart failure? Letter regarding the article 'Sodium chloride versus glucose solute as a volume replacement therapy for more effective decongestion in acute heart failure (SOLVRED-
Eur J Heart Fail. 2025 Jul 21. doi: 10.1002/ejhf.3765.
PubMed

RAKISHEVA A, Farmakis D, Attanasio A, Genis AB, et al
Prevention of cancer therapy-related cardiac dysfunction and heart failure in cancer patients and survivors. A Clinical Consensus Statement of the Heart Failure Association, the European Association of Preventive Cardiology of the ESC, and the ESC Cou
Eur J Heart Fail. 2025 Jul 18. doi: 10.1002/ejhf.3753.
PubMed Abstract available

TOMASONI D, Adamo M, Hausleiter J, Pezzola E, et al
Heart failure hospitalizations and clinical outcomes in patients undergoing tricuspid transcatheter edge-to-edge repair: Insights from EuroTR.
Eur J Heart Fail. 2025 Jul 18. doi: 10.1002/ejhf.3757.
PubMed Abstract available

LEE S, Claggett BL, Fang JC, Mitchell GF, et al
Changes in cardiac structure and function are associated with health-related quality of life in heart failure patients with reduced ejection fraction: Results from the EVALUATE-HF trial.
Eur J Heart Fail. 2025 Jul 18. doi: 10.1002/ejhf.3760.
PubMed Abstract available

GIRERD N, Sandrin L, de Ledinghen V, Mebazaa A, et al
Reply to the letter regarding the article 'Liver stiffness measurement for non-invasive assessment of central venous pressure in patients with heart failure: A multicentre pilot study'.
Eur J Heart Fail. 2025 Jul 17. doi: 10.1002/ejhf.3785.
PubMed

WANG Y, Yang Z, Liao S
Letter regarding the article 'Liver stiffness measurement for non-invasive assessment of central venous pressure in patients with heart failure: A multicentre pilot study'.
Eur J Heart Fail. 2025 Jul 17. doi: 10.1002/ejhf.3784.
PubMed

AMERI P, Costa P, Benson L, Stolfo D, et al
Characteristics and outcomes of patients with heart failure and history of malignancy: Data from Swedish Heart Failure Registry and the National Cancer Register.
Eur J Heart Fail. 2025 Jul 17. doi: 10.1002/ejhf.3775.
PubMed Abstract available

BEYHOFF N, Braun VM, Kirchner M, Finnigan LEM, et al
Computational modelling of myocardial metabolism in patients with advanced heart failure.
Eur J Heart Fail. 2025 Jul 15. doi: 10.1002/ejhf.3746.
PubMed Abstract available

RAME JE, Schmitto JD, Kosevic DN, Kovacevic-Preradovic T, et al
Cardio-microcurrent device treatment for heart failure with reduced ejection fraction: Results from the C-MIC II open-label randomized controlled trial.
Eur J Heart Fail. 2025 Jul 15. doi: 10.1002/ejhf.3763.
PubMed Abstract available

BIEGUS J, Iwanek G, Ponikowski P
Reply to 'Sodium chloride supplementation in acute heart failure: A closer look at SOLVRED-AHF'.
Eur J Heart Fail. 2025 Jul 15. doi: 10.1002/ejhf.3771.
PubMed

OKAZAKI T, Yaegashi Y
Sodium chloride supplementation in acute heart failure: A closer look at SOLVRED-AHF. Letter regarding the article 'Sodium chloride versus glucose solute as a volume replacement therapy for more effective decongestion in acute heart failure (SOLVRED-A
Eur J Heart Fail. 2025 Jul 15. doi: 10.1002/ejhf.3767.
PubMed

PACKER M, Butler J, Ferreira JP, Siddiqi TJ, et al
Coordinated expression of BMP10/ALK1/endoglin-proteins that drive embryonic cardiac and vascular morphogenesis-in patients with heart failure: The EMPEROR Program.
Eur J Heart Fail. 2025 Jul 14. doi: 10.1002/ejhf.3764.
PubMed Abstract available

BHATTI T
Letter regarding the article 'Heart failure in patients with a systemic right ventricle: A multicentre study with long-term follow-up'.
Eur J Heart Fail. 2025 Jul 14. doi: 10.1002/ejhf.3747.
PubMed

ANSARI RAMANDI MM, van Melle JP, Voors AA
Reply to the letter regarding the article 'Heart failure in patients with a systemic right ventricle: A multicentre study with long-term follow-up'.
Eur J Heart Fail. 2025 Jul 14. doi: 10.1002/ejhf.3750.
PubMed

KUNZ M, Schaar JM, Welker KR, Lauder L, et al
Medication adherence in patients with acutely decompensated heart failure: A cross-sectional study in the emergency department (ADHF-ED).
Eur J Heart Fail. 2025 Jul 10. doi: 10.1002/ejhf.3756.
PubMed Abstract available

SAKATA Y, Nochioka K, Yasuda S, Shimokawa H, et al
Reply to the letter regarding the article 'Clinical and plasma proteomic characterization of heart failure with supranormal left ventricular ejection fraction: An emerging entity of heart failure'.
Eur J Heart Fail. 2025 Jul 10. doi: 10.1002/ejhf.3740.
PubMed

BOGOVIKU J, Nguyen TD, Westphal JG, Haertel F, et al
Effects of empagliflozin on uric acid levels during acute heart failure recompensation: A sub-analysis of the EMPAG-HF trial (Effects of Empagliflozin on Diuresis and Renal Function in Patients with Acute Decompensated Heart Failure).
Eur J Heart Fail. 2025 Jul 9. doi: 10.1002/ejhf.3723.
PubMed Abstract available

KOK TF, van Essen BJ, Yang Y, Gansevoort RT, et al
Serially measured urinary albumin excretion is strongly associated with incident heart failure with preserved ejection fraction.
Eur J Heart Fail. 2025 Jul 7. doi: 10.1002/ejhf.3739.
PubMed

TANAKA TD, Shiraishi Y, Kang R, Kohno T, et al
Residual pulmonary hypertension and clinical outcomes in acute decompensated heart failure patients stratified by left ventricular ejection fraction.
Eur J Heart Fail. 2025 Jul 4. doi: 10.1002/ejhf.3755.
PubMed Abstract available

KALOGEROPOULOS AP, Hameed I, Anker SD, Bayes-Genis A, et al
Changes in natriuretic peptide levels following patiromer-enabled optimization of medical therapy in heart failure: A post hoc analysis of the DIAMOND study.
Eur J Heart Fail. 2025 Jul 3. doi: 10.1002/ejhf.3754.
PubMed Abstract available

GERAEDS CBG, Bruninx A, Dekker ALAJ, Barandiaran Aizpurua A, et al
Exploring safety of down-titrating diuretics in heart failure management.
Eur J Heart Fail. 2025 Jul 2. doi: 10.1002/ejhf.3714.
PubMed Abstract available

FERREIRA JP, Marques P, Brugts JJ
Down-titrating diuretics in heart failure.
Eur J Heart Fail. 2025 Jul 2. doi: 10.1002/ejhf.3726.
PubMed

Abstracts of the Heart Failure 2025, 17-20 May 2025, Belgrade, Serbia.
Eur J Heart Fail. 2025;27 Suppl 2:3-542.
PubMed

MARKWIRTH P, Hoevelmann J, Tokcan M, Haring B, et al
What's new in heart failure? July 2025.
Eur J Heart Fail. 2025;27:1155-1158.
PubMed

QUATAERT I, Blondeel M, Trenson S, Ingelaere S, et al
Incidences and clinical outcomes of patients with a single or dual chamber implantable cardioverter-defibrillator developing an indication for cardiac resynchronization therapy.
Eur J Heart Fail. 2025;27:1262-1269.
PubMed Abstract available

KAYE DM, Wang XS, Koay YC, Li M, et al
Mechanical unloading is accompanied by reverse metabolic remodelling in the failing heart: Identification of a novel citraconate-mediated pathway.
Eur J Heart Fail. 2025;27:1342-1352.
PubMed Abstract available

KRAMMER T, Baier MJ, Hegner P, Zschiedrich T, et al
Cardioprotective effects of semaglutide on isolated human ventricular myocardium.
Eur J Heart Fail. 2025;27:1315-1325.
PubMed Abstract available

LONGINOW J, Mirzai S, Chen PH, Hanna M, et al
Skeletal muscle and subcutaneous fat quantity as prognostic indicators in cardiac amyloidosis.
Eur J Heart Fail. 2025;27:1294-1303.
PubMed Abstract available

June 2025

VAN VELDHUISEN DJ, Van der Meer P
A second wind for digitalis glycosides in heart failure?
Eur J Heart Fail. 2025 Jun 30. doi: 10.1002/ejhf.3743.
PubMed

BIMA P, Wussler D, Lopez-Ayala P, Belkin M, et al
Acute dyspnoea in cancer patients: Prevalence of acute heart failure, resource use and diagnostic accuracy of natriuretic peptides.
Eur J Heart Fail. 2025 Jun 30. doi: 10.1002/ejhf.3752.
PubMed Abstract available

IBE T, Demmer RT, Harada T, Doi S, et al
Prognostic significance of unintentional weight loss in heart failure with preserved ejection fraction.
Eur J Heart Fail. 2025 Jun 26. doi: 10.1002/ejhf.3745.
PubMed Abstract available

GOUDA P, Alemayehu W, Voors AA, Lam CSP, et al
Implantable cardioverter-defibrillators in ischaemic versus non-ischaemic heart failure: Insights from the VICTORIA trial.
Eur J Heart Fail. 2025 Jun 20. doi: 10.1002/ejhf.3731.
PubMed Abstract available

BAUDRY G, Pereira O, Roubille F, Villaceque M, et al
Sex-based differences in heart failure management and outcomes: Insights from the French-DataHF cohort.
Eur J Heart Fail. 2025 Jun 20. doi: 10.1002/ejhf.3733.
PubMed Abstract available

CHENG Y, Peng H, Sun Y, Qin L, et al
Letter regarding the article 'Clinical and plasma proteomic characterization of heart failure with supranormal left ventricular ejection fraction: An emerging entity of heart failure'.
Eur J Heart Fail. 2025 Jun 18. doi: 10.1002/ejhf.3734.
PubMed

DOI S, Tada A, Harada T, Naser JA, et al
Determinants of submaximal exercise intolerance in patients with heart failure and preserved ejection fraction: Insights from the lactate threshold.
Eur J Heart Fail. 2025 Jun 18. doi: 10.1002/ejhf.3729.
PubMed Abstract available

HULOT JS, Ter Maaten JM, Bayes-Genis A, Halliday BP, et al
Heart failure improvement, remission, and recovery: A European Journal of Heart Failure expert consensus document.
Eur J Heart Fail. 2025 Jun 18. doi: 10.1002/ejhf.3732.
PubMed Abstract available

VAN DEN EYNDE J, Verbrugge FH
Water and electrolyte homeostasis during decongestion in heart failure.
Eur J Heart Fail. 2025 Jun 18. doi: 10.1002/ejhf.3727.
PubMed Abstract available

TOCCHETTI CG, Gonzalez A, Backs J, Pollesello P, et al
How to facilitate seamless translation from basic concepts to new heart failure drugs. A scientific statement of the Heart Failure Association of the ESC.
Eur J Heart Fail. 2025 Jun 18. doi: 10.1002/ejhf.3709.
PubMed Abstract available

SEFEROVIC PM, Polovina M, Savarese G, Milinkovic I, et al
The European heart failure management resources, treatment reimbursement and activities of professional and patient organizations.
Eur J Heart Fail. 2025 Jun 17. doi: 10.1002/ejhf.3691.
PubMed Abstract available

GIRERD N, Biegus J, Janas A, Buszman P, et al
Liver stiffness measurement for non-invasive assessment of central venous pressure in patients with heart failure: A multicentre pilot study.
Eur J Heart Fail. 2025 Jun 16. doi: 10.1002/ejhf.3722.
PubMed Abstract available

FRAGASSO G, Stolfo D, Anker MS, Bayes-Genis A, et al
The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESC.
Eur J Heart Fail. 2025 Jun 16. doi: 10.1002/ejhf.3703.
PubMed Abstract available

BENGEL P, Sossalla S
Letter regarding the article 'Guideline-directed medical therapy for heart failure in arrhythmia-induced cardiomyopathy with improved left ventricular ejection fraction'.
Eur J Heart Fail. 2025 Jun 11. doi: 10.1002/ejhf.3712.
PubMed

LUO Y, Caliskan K
Reply to the letter regarding the article 'Minimization or withdrawal of oral pharmacotherapy in chronic heart failure patients with improved myocardial function: A systematic review'.
Eur J Heart Fail. 2025 Jun 11. doi: 10.1002/ejhf.3713.
PubMed

DING J, Li J, Li Y
Letter regarding the article 'Minimization or withdrawal of oral pharmacotherapy in chronic heart failure patients with improved myocardial function: A systematic review'.
Eur J Heart Fail. 2025 Jun 11. doi: 10.1002/ejhf.3717.
PubMed

INCIARDI RM, Vaduganathan M, Claggett B, AbouEzzeddine OF, et al
Application of a transthyretin amyloid cardiomyopathy score to heart failure with mildly reduced or preserved ejection fraction.
Eur J Heart Fail. 2025 Jun 9. doi: 10.1002/ejhf.3698.
PubMed Abstract available

TOMASONI D, Benson L, Gatti P, Villaschi A, et al
Cardiac resynchronization therapy for enabling guideline-directed medical therapy optimization in heart failure.
Eur J Heart Fail. 2025 Jun 5. doi: 10.1002/ejhf.3719.
PubMed Abstract available

PALAZZUOLI A, Pellicori P, Cleland JGF
Serial assessment of left ventricular ejection fraction for the management of heart failure: Unnecessary and unrealistic?
Eur J Heart Fail. 2025 Jun 5. doi: 10.1002/ejhf.3716.
PubMed

BIEGUS J, Iwanek G, Testani J, Zymlinski R, et al
Sodium chloride versus glucose solute as a volume replacement therapy for more effective decongestion in acute heart failure (SOLVRED-AHF): A prospective, randomized, mechanistic study.
Eur J Heart Fail. 2025 Jun 2. doi: 10.1002/ejhf.3708.
PubMed Abstract available

SOLOVEVA A, Fedorova D, Kuchinskaia S, Rakisheva A, et al
Profiling hypotension in heart failure based on office, orthostatic and ambulatory blood pressure measurements.
Eur J Heart Fail. 2025 Jun 2. doi: 10.1002/ejhf.3715.
PubMed

LEE MMY, Codina P, Tomasoni D, Aimo A, et al
What's new in heart failure? June 2025.
Eur J Heart Fail. 2025;27:935-939.
PubMed

BRAUN VM, Foryst-Ludwig A, Landmesser U, Baczko I, et al
Cancer therapy-related cardiotoxicity is associated with distinct alterations of the myocardial lipidome.
Eur J Heart Fail. 2025;27:1056-1066.
PubMed Abstract available

CHATUR S, Vaduganathan M, Fletcher RA, Perkovic V, et al
Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: A participant-level pooled analysis of the CANVAS and CREDENCE trials.
Eur J Heart Fail. 2025;27:994-1002.
PubMed Abstract available

May 2025

SEFEROVIC PM, Polovina M, Savarese G, Milinkovic I, et al
Insights into the European heart failure epidemiology.
Eur J Heart Fail. 2025 May 30. doi: 10.1002/ejhf.3710.
PubMed Abstract available

SUNDERMEYER J, Kellner C, Beer BN, Besch L, et al
Kidney injury in patients with heart failure-related cardiogenic shock: Results from an international, multicentre cohort study.
Eur J Heart Fail. 2025 May 28. doi: 10.1002/ejhf.3701.
PubMed Abstract available

BAUDRY G, Li G, Wang R, Newton RAV, et al
Global heart failure epidemiology versus enrolment in pivotal trials: A formidable mismatch.
Eur J Heart Fail. 2025 May 28. doi: 10.1002/ejhf.3707.
PubMed Abstract available

BOZKURT B, Rossignol P, Vassalotti JA
Albuminuria as a diagnostic criterion and a therapeutic target in heart failure and other cardiovascular disease.
Eur J Heart Fail. 2025 May 27. doi: 10.1002/ejhf.3683.
PubMed Abstract available

GREENE SJ, Kaltenbach LA, Fonarow GC, Chiswell K, et al
Clinical and financial implications of inpatient and outpatient management of worsening heart failure.
Eur J Heart Fail. 2025 May 26. doi: 10.1002/ejhf.3702.
PubMed Abstract available

LI JW, Wang J, Chen Y, Yang H, et al
Longitudinal blood pressure and cardiovascular outcomes in heart failure: An individual patient data pooling analysis of clinical trials.
Eur J Heart Fail. 2025 May 24. doi: 10.1002/ejhf.3706.
PubMed Abstract available

LEFER DJ, Sharp TE 3rd, Scarborough AL, Haydel AG, et al
Renal denervation improves cardiac function and exercise duration in a miniswine model of heart failure with preserved ejection fraction.
Eur J Heart Fail. 2025 May 22. doi: 10.1002/ejhf.3700.
PubMed Abstract available

ANKER SD, Robertson M, McMurray JJV, Jhund PS, et al
Recurrent event analyses in patients receiving maintenance dialysis and the effect of higher- versus lower-dose chronic intravenous iron therapy: A report focusing on heart failure events from the PIVOTAL trial.
Eur J Heart Fail. 2025 May 20. doi: 10.1002/ejhf.3670.
PubMed Abstract available

WEGERMANN K, Chouairi F, Karachaliou GS, Ahlers C, et al
Incident heart failure is common and underrecognized in patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease.
Eur J Heart Fail. 2025 May 19. doi: 10.1002/ejhf.3697.
PubMed Abstract available

BAVENDIEK U, Thomas NH, Berliner D, Liu X, et al
DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure (DIGIT-HF): Baseline characteristics compared to recent randomized controlled heart failure trials.
Eur J Heart Fail. 2025 May 19. doi: 10.1002/ejhf.3679.
PubMed Abstract available

MEEKERS E, Martens P, Knevels R, Miseur M, et al
Home-based urinary sodium monitoring via point-of-care testing for personalized diuretic titration in heart failure management: The EASY-STOP study.
Eur J Heart Fail. 2025 May 19. doi: 10.1002/ejhf.3693.
PubMed Abstract available

WEERTS J, Barandiaran Aizpurua A, Patel RB, van de Bovenkamp AA, et al
A simplified approach for diagnosing heart failure with preserved ejection fraction by assessing the left atrium and natriuretic peptides.
Eur J Heart Fail. 2025 May 19. doi: 10.1002/ejhf.3651.
PubMed Abstract available

GREENE SJ, Corda S, McMullan CJ, Palombo G, et al
Safety and tolerability of a 5 mg starting dose of vericiguat among patients with heart failure: The VELOCITY study.
Eur J Heart Fail. 2025 May 19. doi: 10.1002/ejhf.3699.
PubMed Abstract available

CUNNINGHAM JW, Claggett BL, Vaduganathan M, Desai AS, et al
Effects of finerenone on natriuretic peptide levels in heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial.
Eur J Heart Fail. 2025 May 16. doi: 10.1002/ejhf.3694.
PubMed Abstract available

CHIMURA M, Yang M, Henderson AD, Jhund PS, et al
Anaemia in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trial.
Eur J Heart Fail. 2025 May 16. doi: 10.1002/ejhf.3682.
PubMed Abstract available

KAPELIOS CJ, Liori S, Bonios M, Abraham WT, et al
Effect of pulmonary artery pressure-guided management on outcomes of patients with heart failure outside clinical trials: A systematic review and meta-analysis of real-world evidence with the CardioMEMS Heart Failure System.
Eur J Heart Fail. 2025 May 13. doi: 10.1002/ejhf.3687.
PubMed Abstract available

PONIKOWSKA B, Biegus J
Reply to the letter regarding the article 'Lower extremity lymphatic flow is associated with diuretic response in acute heart failure'.
Eur J Heart Fail. 2025 May 12. doi: 10.1002/ejhf.3690.
PubMed

YANG C, Gao B, Huang J
Letter regarding the article 'Lower extremity lymphatic flow is associated with diuretic response in acute heart failure'.
Eur J Heart Fail. 2025 May 12. doi: 10.1002/ejhf.3686.
PubMed

STOLLBERGER C, Finsterer J, Schneider B
Assessing heart failure after surgical occlusion of the left atrial appendage. Letter regarding the article 'Heart failure after left atrial appendage occlusion: Insights from the LAAOS III randomized trial'.
Eur J Heart Fail. 2025 May 8. doi: 10.1002/ejhf.3663.
PubMed

KRISAI P, Whitlock RP, Healey JS
Reply to 'Assessing heart failure after surgical occlusion of the left atrial appendage'.
Eur J Heart Fail. 2025 May 8. doi: 10.1002/ejhf.3666.
PubMed

LIM HS, Damman K, Baudry G, Cikes M, et al
Donor heart allocation systems in Europe. A scientific statement of the Heart Failure Association of the ESC.
Eur J Heart Fail. 2025 May 7. doi: 10.1002/ejhf.3681.
PubMed Abstract available

SAVARESE G, Schiattarella GG, Lindberg F, Anker MS, et al
Heart failure and obesity: Translational approaches and therapeutic perspectives. A scientific statement of the Heart Failure Association of the ESC.
Eur J Heart Fail. 2025 May 6. doi: 10.1002/ejhf.3676.
PubMed Abstract available

CHIONCEL O, Mebazaa A, Farmakis D, Abdelhamid M, et al
Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
Eur J Heart Fail. 2025 May 4. doi: 10.1002/ejhf.3673.
PubMed Abstract available

PAILLARD M, Abdellatif M, Andreadou I, Bar C, et al
Mitochondrial targets in ischaemic heart disease and heart failure, and their potential for a more efficient clinical translation. A scientific statement of the ESC Working Group on Cellular Biology of the Heart and the ESC Working Group on Myocardial
Eur J Heart Fail. 2025 May 4. doi: 10.1002/ejhf.3674.
PubMed Abstract available

RUBIS P, Piorkowski A, Winiarczyk M, Nurzynska K, et al
Video thermography uncovers relationship between volume status and temperature in heart failure.
Eur J Heart Fail. 2025 May 4. doi: 10.1002/ejhf.3680.
PubMed Abstract available

WEISS AJ, Maigrot JA, Tong MZY, Thuita L, et al
Time-varying analyses of survival and outcomes in patients with HeartMate 3 left ventricular assist devices.
Eur J Heart Fail. 2025;27:822-829.
PubMed Abstract available

WANG X, Pabon MA, Cikes M, Jering K, et al
Sex differences in cardiac structure and function following acute myocardial infarction: Insights from the PARADISE-MI echocardiographic substudy.
Eur J Heart Fail. 2025;27:788-799.
PubMed Abstract available

April 2025

KONDO T, Jhund PS, Henderson AD, Claggett BL, et al
The efficacy of finerenone on hierarchical composite endpoint analysed using win statistics in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of FINEARTS-HF.
Eur J Heart Fail. 2025 Apr 29. doi: 10.1002/ejhf.3669.
PubMed Abstract available

ANKER SD, Friede T, Butler J, Talha KM, et al
Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure (FAIR-HF2-DZHK05) trial: Baseline characteristics and comparison to other relevant clinical trials.
Eur J Heart Fail. 2025 Apr 29. doi: 10.1002/ejhf.3658.
PubMed Abstract available

BAYES-GENIS A, Pagnesi M, Codina P, Abraham WT, et al
Remote pulmonary artery pressure-guided management of patients with heart failure: A clinical consensus statement of the Heart Failure Association (HFA) of the ESC.
Eur J Heart Fail. 2025 Apr 27. doi: 10.1002/ejhf.3619.
PubMed Abstract available

ANSARI RAMANDI MM, Budts W, Roos-Hesselink JW, Helbing WA, et al
Heart failure in patients with a systemic right ventricle: A multicentre study with long-term follow-up.
Eur J Heart Fail. 2025 Apr 25. doi: 10.1002/ejhf.3664.
PubMed Abstract available

ROSANO GMC, Teerlink JR, Kinugawa K, Bayes-Genis A, et al
The use of left ventricular ejection fraction in the diagnosis and management of heart failure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC, the Heart Failure Society of America (HFSA), and the Japanese Heart Failu
Eur J Heart Fail. 2025 Apr 22. doi: 10.1002/ejhf.3646.
PubMed Abstract available

BUTT JH, Solomon SD, Vaduganathan M, van Veldhuisen DJ, et al
Mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction according to body weight.
Eur J Heart Fail. 2025 Apr 21. doi: 10.1002/ejhf.3665.
PubMed Abstract available

LUO Y, Xiao W, Sener YZ, Meijers WC, et al
Minimization or withdrawal of oral pharmacotherapy in chronic heart failure patients with improved myocardial function: A systematic review.
Eur J Heart Fail. 2025 Apr 20. doi: 10.1002/ejhf.3652.
PubMed Abstract available

SAKATA Y, Nochioka K, Yasuda S, Ishida K, et al
Clinical and plasma proteomic characterization of heart failure with supranormal left ventricular ejection fraction: An emerging entity of heart failure.
Eur J Heart Fail. 2025 Apr 15. doi: 10.1002/ejhf.3654.
PubMed Abstract available

BAYES-GENIS A, Anderson L, Harding E, Metra M, et al
Late diagnosis in cancer sparks outrage-so why not heart failure?
Eur J Heart Fail. 2025 Apr 15. doi: 10.1002/ejhf.3667.
PubMed

BUTT JH, Jhund PS, Henderson AD, Claggett BL, et al
Finerenone, chronic obstructive pulmonary disease, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trial.
Eur J Heart Fail. 2025 Apr 13. doi: 10.1002/ejhf.3661.
PubMed Abstract available

BUTT JH, Jhund PS, Henderson AD, Claggett BL, et al
Finerenone, glycaemic status, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trial.
Eur J Heart Fail. 2025 Apr 10. doi: 10.1002/ejhf.3649.
PubMed Abstract available

BOZKURT B, Mullens W, Leclercq C, Russo AM, et al
Cardiac rhythm devices in heart failure with reduced ejection fraction - role, timing, and optimal use in contemporary practice. European Journal of Heart Failure expert consensus document.
Eur J Heart Fail. 2025 Apr 9. doi: 10.1002/ejhf.3641.
PubMed Abstract available

KARAKASIS P, Lefkou E, Pamporis K, Heymans S, et al
Reply to the letter regarding the article 'Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta-analysis'.
Eur J Heart Fail. 2025 Apr 9. doi: 10.1002/ejhf.3660.
PubMed

HUANG J
Letter regarding the article 'Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta-analysis'.
Eur J Heart Fail. 2025 Apr 9. doi: 10.1002/ejhf.3659.
PubMed

PONIKOWSKA B, Zymlinski R, Fudim M, Ponikowska B, et al
Lower extremity lymphatic flow is associated with diuretic response in acute heart failure.
Eur J Heart Fail. 2025 Apr 7. doi: 10.1002/ejhf.3655.
PubMed Abstract available

SUTHAHAR N, Mourmans SGJ, Achten A, Aboumsallem JP, et al
Peroxiredoxin-4, a marker of systemic oxidative stress, is associated with incident heart failure.
Eur J Heart Fail. 2025 Apr 6. doi: 10.1002/ejhf.3653.
PubMed Abstract available

AMIR O, Adamopoulos S, Burri H, Bayes-Genis A, et al
Cardiac implantable electronic and other monitoring devices in continuous-flow left ventricular assist device patients. A clinical consensus statement of the Heart Failure Association and the European Heart Rhythm Association of the ESC.
Eur J Heart Fail. 2025 Apr 1. doi: 10.1002/ejhf.3635.
PubMed Abstract available

CHEDID EL HELOU M, Nandar PP, Tereshchenko LG, Jacob M, et al
Factors associated with the use of guideline-directed medical therapy in patients with left ventricular assist device.
Eur J Heart Fail. 2025;27:650-655.
PubMed Abstract available

BOCCHINO PP, Frea S, Sacco A, Bertaina M, et al
Organ perfusion pressure predicts outcomes in cardiogenic shock patients.
Eur J Heart Fail. 2025;27:659-668.
PubMed Abstract available

LUSEBRINK E, Lanz H, Kellnar A, Karam N, et al
Management of acute decompensated valvular heart disease.
Eur J Heart Fail. 2025;27:630-649.
PubMed Abstract available

March 2025

ABDIN A, Kulenthiran S, Komajda M, Borer JS, et al
Ivabradine improves win ratios of heart failure outcomes in patients with reduced ejection fraction - insights from the SHIFT trial.
Eur J Heart Fail. 2025 Mar 30. doi: 10.1002/ejhf.3648.
PubMed

LAUFS U, Greene SJ, Schulz M
Time for a new perspective on polypharmacy in heart failure.
Eur J Heart Fail. 2025 Mar 27. doi: 10.1002/ejhf.3650.
PubMed

GORENEK B, Wijnmaalen AP, Goette A, Mert GO, et al
Ventricular arrhythmias in acute heart failure. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Heart Rhythm Association (EHRA) and the Heart Failure Association (HFA) of the ESC.
Eur J Heart Fail. 2025 Mar 19. doi: 10.1002/ejhf.3645.
PubMed Abstract available

STOLFO D, Iacoviello M, Chioncel O, Anker MS, et al
How to handle polypharmacy in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC.
Eur J Heart Fail. 2025 Mar 17. doi: 10.1002/ejhf.3642.
PubMed Abstract available

VOLTERRANI M, Halasz G, Adamopoulos S, Agostoni PG, et al
Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of Cardiology.
Eur J Heart Fail. 2025 Mar 12. doi: 10.1002/ejhf.3440.
PubMed Abstract available

VOORRIPS SN, Palm CL, Saucedo-Orozco H, Mahmoud B, et al
Myocardial ketone body oxidation contributes to empagliflozin-induced improvements in cardiac contractility in murine heart failure.
Eur J Heart Fail. 2025 Mar 11. doi: 10.1002/ejhf.3633.
PubMed Abstract available

INCIARDI RM, Steven D, Savarese G
The role of kidney disease progression in heart failure prognosis: Bridging the evidence gap for optimal management.
Eur J Heart Fail. 2025 Mar 11. doi: 10.1002/ejhf.3643.
PubMed

GHIGO A, Ameri P, Asnani A, Bertero E, et al
Update on preclinical models of cancer therapy-related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellula
Eur J Heart Fail. 2025 Mar 11. doi: 10.1002/ejhf.3636.
PubMed Abstract available

KARAKASIS P, Lefkou E, Pamporis K, Farmakis D, et al
Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta-analysis.
Eur J Heart Fail. 2025 Mar 10. doi: 10.1002/ejhf.3637.
PubMed Abstract available

SENNI M, Paruchuru P, Shi V, Bohm M, et al
Safety and tolerability of sacubitril/valsartan in chronic heart failure and reduced ejection fraction: Results from the open-label extension of the PARADIGM-HF study.
Eur J Heart Fail. 2025 Mar 9. doi: 10.1002/ejhf.3634.
PubMed

O'CONNOR FK, Sabapathy S, Sharma P, Roberts L, et al
Acute lower-limb heating improves exercise performance in individuals with heart failure with reduced ejection fraction.
Eur J Heart Fail. 2025 Mar 5. doi: 10.1002/ejhf.3638.
PubMed

CLELAND JGF, Friday J, Iaconelli A, Kaur N, et al
If a patient does not require treatment with loop diuretics, do they really have heart failure?
Eur J Heart Fail. 2025 Mar 4. doi: 10.1002/ejhf.3628.
PubMed

ZAHIR ANJUM D, Garred CH, Carlson N, Fosbol E, et al
Kidney status and events preceding death in heart failure: A real-world nationwide study.
Eur J Heart Fail. 2025 Mar 2. doi: 10.1002/ejhf.3631.
PubMed Abstract available

HFA Winter Research Meeting on Translational Heart Failure 2025 In collaboration with the ESC Working Group on Myocardial Function.
Eur J Heart Fail. 2025;27 Suppl 1:3-29.
PubMed

HOEVELMANN J, Markwirth P, Tokcan M, Haring B, et al
What's new in heart failure? March 2025.
Eur J Heart Fail. 2025;27:409-411.
PubMed

PETRIE MC, Udell JA, Anker SD, Harrington J, et al
Empagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: A pre-specified analysis of the EMPACT-MI trial.
Eur J Heart Fail. 2025;27:577-588.
PubMed Abstract available

AMIR O, Elbaz-Greener G, Carasso S, Claggett B, et al
Association between body mass index and clinical outcomes in patients with acute myocardial infarction and reduced systolic function: Analysis of PARADISE-MI trial data.
Eur J Heart Fail. 2025;27:558-565.
PubMed Abstract available

NEVES JS, Leite AR, Mentz RJ, Holman RR, et al
Cardiovascular outcomes with exenatide in type 2 diabetes according to ejection fraction: The EXSCEL trial.
Eur J Heart Fail. 2025;27:540-551.
PubMed Abstract available

February 2025

MEEKERS E, Dauw J, Ter Maaten JM, Martens P, et al
Urinary sodium analysis: The key to effective diuretic titration? European Journal of Heart Failure expert consensus document.
Eur J Heart Fail. 2025 Feb 27. doi: 10.1002/ejhf.3632.
PubMed Abstract available

SKOURI H, Girerd N, Monzo L, Petrie MC, et al
Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC.
Eur J Heart Fail. 2025 Feb 26. doi: 10.1002/ejhf.3618.
PubMed Abstract available

FERREIRA JP, Vasques-Novoa F, Angermann CE, Biegus J, et al
Low blood pressure and the effect of empagliflozin in acute heart failure: An EMPULSE analysis.
Eur J Heart Fail. 2025 Feb 20. doi: 10.1002/ejhf.3626.
PubMed Abstract available

BIEGUS J, Palazzuoli A, Greene SJ
Effect of finerenone across the stages of heart failure: From prevention to treatment.
Eur J Heart Fail. 2025 Feb 17. doi: 10.1002/ejhf.3606.
PubMed

PACKER M, Butler J
The win ratio for trials for heart failure: academic desperation or investigator decadence?
Eur J Heart Fail. 2025 Feb 16. doi: 10.1002/ejhf.3608.
PubMed

SALDARRIAGA CI, Zannad F, McMullan CJ, Xing A, et al
Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trial.
Eur J Heart Fail. 2025 Feb 16. doi: 10.1002/ejhf.3598.
PubMed Abstract available

ABDIN A, Izzat MB, Alsaadi AR, Katbeh A, et al
Heart failure guideline implementation in developing countries: A testimony from Syria.
Eur J Heart Fail. 2025 Feb 13. doi: 10.1002/ejhf.3625.
PubMed

MACGOWAN H, Brown OI, Drozd M, Walker AMN, et al
Comorbidity trajectories before and after the diagnosis of heart failure: A UK Biobank cohort study.
Eur J Heart Fail. 2025 Feb 11. doi: 10.1002/ejhf.3601.
PubMed Abstract available

HOEVELMANN J, Petrie MC, Haring B
Alcohol and heart failure: A complex relationship!
Eur J Heart Fail. 2025 Feb 11. doi: 10.1002/ejhf.3607.
PubMed

BACMEISTER L, Codina P, Westermann D
Man versus machine in advanced heart failure: Can artificial intelligence beat clinicians?
Eur J Heart Fail. 2025 Feb 11. doi: 10.1002/ejhf.3609.
PubMed

NUNEZ J, Minana G, de la Espriella R, Zegri-Reiriz I, et al
Salt repletion and diuretic response: The role of serum chloride. A post-hoc analysis of the SALT-HF trial on furosemide and hypertonic saline solution administration in ambulatory patients with worsening heart failure.
Eur J Heart Fail. 2025 Feb 11. doi: 10.1002/ejhf.3597.
PubMed Abstract available

INCIARDI RM, Bayes-Genis A
Growth differentiation factor-15: A promising biomarker for early detection of pre-heart failure.
Eur J Heart Fail. 2025 Feb 10. doi: 10.1002/ejhf.3613.
PubMed

ZHANG F, Li J
Letter regarding the article 'Efficacy and safety of angiotensin receptor-neprilysin inhibition in heart failure patients with end-stage kidney disease on maintenance dialysis: A systematic review and meta-analysis'.
Eur J Heart Fail. 2025 Feb 10. doi: 10.1002/ejhf.3612.
PubMed

NGUYEN DV, Le TN, Nguyen HTT
Reply to the letter regarding the article 'Efficacy and safety of angiotensin receptor-neprilysin inhibition in heart failure patients with end-stage kidney disease on maintenance dialysis: A systematic review and meta-analysis'.
Eur J Heart Fail. 2025 Feb 10. doi: 10.1002/ejhf.3610.
PubMed

ASSMUS B, Rakisheva A
Unacceptably high mortality and readmission rates 5 years after heart failure hospitalization: The need to optimize long-term heart failure care by addressing diverse healthcare resources.
Eur J Heart Fail. 2025 Feb 4. doi: 10.1002/ejhf.3600.
PubMed

TOMASONI D, Codina P, Lee MMY, Aimo A, et al
What's new in heart failure? February 2025.
Eur J Heart Fail. 2025;27:185-189.
PubMed

January 2025

ANKER SD, Friede T, Butler J, Talha KM, et al
Rationale and design of the FAIR-HF2-DZHK05 trial: Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure.
Eur J Heart Fail. 2025 Jan 28. doi: 10.1002/ejhf.3574.
PubMed Abstract available

GIRERD N, Jhund P
Withdrawal of medical therapy for heart failure after rhythm control in arrhythmia-induced cardiomyopathy-a call for caution.
Eur J Heart Fail. 2025 Jan 27. doi: 10.1002/ejhf.3594.
PubMed

BUTLER J, Kahwash R, Khan MS, Gerritse B, et al
Continuous risk monitoring and management of heart failure: Rationale and design of the ALLEVIATE-HF trial.
Eur J Heart Fail. 2025 Jan 27. doi: 10.1002/ejhf.3595.
PubMed Abstract available

CHOUAIRI F, Fudim M, Savarese G, Szabo B, et al
Utility of loop diuretics as a marker of risk in clinical trials of heart failure with preserved ejection fraction: Analysis from the Swedish Heart Failure Registry.
Eur J Heart Fail. 2025 Jan 23. doi: 10.1002/ejhf.3578.
PubMed Abstract available

GONZALEZ-JUANATEY JR, Otero-Garcia O, Bohm M
Beta-blockers and heart failure with mildly reduced and preserved ejection fraction. A personalized approach beyond the heart failure syndrome phenotypes is needed.
Eur J Heart Fail. 2025 Jan 21. doi: 10.1002/ejhf.3588.
PubMed

QIN H, van Essen BJ, Ter Maaten JM, Voors AA, et al
Alcohol consumption and incident heart failure in men and women.
Eur J Heart Fail. 2025 Jan 20. doi: 10.1002/ejhf.3587.
PubMed Abstract available

DE LATHAUWER ILJ, Nieuwenhuys WW, Hafkamp F, Regis M, et al
Remote patient monitoring in heart failure: A comprehensive meta-analysis of effective programme components for hospitalization and mortality reduction.
Eur J Heart Fail. 2025 Jan 20. doi: 10.1002/ejhf.3568.
PubMed Abstract available

CHIARITO M, Stolfo D, Villaschi A, Sartori S, et al
Predicting survival in patients with severe heart failure: Risk score validation in the HELP-HF cohort.
Eur J Heart Fail. 2025 Jan 20. doi: 10.1002/ejhf.3585.
PubMed Abstract available

STORK S, Hartner G, Lawson C
The expanding role of heart failure nurses: A call for harmonized standards across Europe.
Eur J Heart Fail. 2025 Jan 20. doi: 10.1002/ejhf.3572.
PubMed

GIRERD N, Barbet V, Seronde MF, Benchimol H, et al
Association of a remote monitoring programme with all-cause mortality and hospitalizations in patients with heart failure: National-scale, real-world evidence from a 3-year propensity score analysis of the TELESAT-HF study.
Eur J Heart Fail. 2025 Jan 14. doi: 10.1002/ejhf.3563.
PubMed Abstract available

PANDEY A, Kolkailah AA, McGuire DK, Frederich RC, et al
Heart failure outcomes captured by adverse event reporting in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial.
Eur J Heart Fail. 2025 Jan 10. doi: 10.1002/ejhf.3511.
PubMed Abstract available

OSMANSKA J, Docherty KF, Berry C, Jhund PS, et al
Cardiovascular magnetic resonance-estimated pulmonary capillary wedge pressure, congestion markers, and effect of empagliflozin in patients with heart failure with reduced ejection fraction and dysglycaemia (SUGAR-DM-HF).
Eur J Heart Fail. 2025 Jan 10. doi: 10.1002/ejhf.3570.
PubMed Abstract available

SHAHIM A, Linde C, Savarese G, Dahlstrom U, et al
Implementation of guideline-recommended therapies in heart failure with reduced ejection fraction according to heart failure duration: An analysis of 55 581 patients from the Swedish Heart Failure (SwedeHF) Registry.
Eur J Heart Fail. 2025 Jan 9. doi: 10.1002/ejhf.3565.
PubMed Abstract available

SAVARESE G, Basile C, Adamo M, Anker SD, et al
Registries on transcatheter edge-to-edge repair in heart failure: Current evidence and future perspectives.
Eur J Heart Fail. 2025 Jan 8. doi: 10.1002/ejhf.3573.
PubMed Abstract available

CHANG KC, Su TH, Wu CK, Huang SC, et al
Metabolic dysfunction-associated steatotic liver disease is associated with increased risks of heart failure.
Eur J Heart Fail. 2025 Jan 8. doi: 10.1002/ejhf.3567.
PubMed Abstract available

MARKWIRTH P, Hoevelmann J, Tokcan M, Haring B, et al
What's new in heart failure? January 2025.
Eur J Heart Fail. 2025;27:1-4.
PubMed

December 2024

GIRERD N, Emrich I, Ferreira JP
Applying the 'touch-and-go' concept to mineralocorticoid receptor antagonists: A paradigm shift in routine heart failure management.
Eur J Heart Fail. 2024 Dec 26. doi: 10.1002/ejhf.3564.
PubMed

GROTE BEVERBORG N, Alnuwaysir RIS, Markousis-Mavrogenis G, Hoes MF, et al
The transcriptional profile of iron deficiency in patients with heart failure: Heme-sparing and reduced immune processes.
Eur J Heart Fail. 2024 Dec 26. doi: 10.1002/ejhf.3562.
PubMed Abstract available

Correction to "Cause-specific death in heart failure across the ejection fraction spectrum: a comprehensive assessment of over 100 000 patients in the Swedish heart failure registry".
Eur J Heart Fail. 2024 Dec 26. doi: 10.1002/ejhf.3554.
PubMed

Correction to "Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HF".
Eur J Heart Fail. 2024 Dec 19. doi: 10.1002/ejhf.3561.
PubMed

COTTER G, Davison B, Janiak P, Edwards C, et al
Observational study for multiparametric assessment of cardiac congestion in outpatient worsening heart failure (EVOLUTION).
Eur J Heart Fail. 2024 Dec 18. doi: 10.1002/ejhf.3555.
PubMed Abstract available

DOMINGUEZ-RODRIGUEZ LM, Dobarro D, Iglesias-Otero C, Crespo-Leiro MG, et al
Guideline-directed medical therapy for heart failure in arrhythmia-induced cardiomyopathy with improved left ventricular ejection fraction.
Eur J Heart Fail. 2024 Dec 18. doi: 10.1002/ejhf.3556.
PubMed Abstract available

WANG X, Vardeny O, Claggett B, Vaduganathan M, et al
Effect of sacubitril/valsartan in heart failure with preserved ejection fraction across the age spectrum in PARAGON-HF.
Eur J Heart Fail. 2024 Dec 15. doi: 10.1002/ejhf.3535.
PubMed Abstract available

LEONG DP, Joseph PG, Dokainish H, Stork S, et al
The risk of death according to left ventricular ejection fraction and right ventricular dilatation in 17 321 adults with heart failure from 40 high-, middle- and low-income countries - A Global Congestive Heart Failure (G-CHF) study.
Eur J Heart Fail. 2024 Dec 15. doi: 10.1002/ejhf.3550.
PubMed Abstract available

INCIARDI RM, Riccardi M, Savarese G, Metra M, et al
Tailoring medical therapy for heart failure with preserved ejection fraction.
Eur J Heart Fail. 2024 Dec 15. doi: 10.1002/ejhf.3558.
PubMed

VOORS AA, Metra M, Postmus D, Greenberg BH, et al
End-organ protective effect of serelaxin in patients hospitalized for heart failure: Results of the biomarker substudy of Relaxin in Acute Heart Failure-2 (RELAX-AHF-2).
Eur J Heart Fail. 2024 Dec 12. doi: 10.1002/ejhf.3551.
PubMed Abstract available

MONZO L, Bresso E, Dickstein K, Pitt B, et al
Machine learning approach to identify phenotypes in patients with ischaemic heart failure with reduced ejection fraction.
Eur J Heart Fail. 2024 Dec 10. doi: 10.1002/ejhf.3547.
PubMed Abstract available

SUN G, Fosbol EL, Faurschou M, Schou M, et al
Long-term rate of heart failure in patients with autoimmune disease: A nationwide cohort study.
Eur J Heart Fail. 2024 Dec 9. doi: 10.1002/ejhf.3541.
PubMed Abstract available

ZELDIN L, Eichler JBS, Teruya SL, Weinsaft AY, et al
Outpatient worsening of heart failure and mortality in transthyretin amyloid cardiomyopathy.
Eur J Heart Fail. 2024 Dec 5. doi: 10.1002/ejhf.3540.
PubMed Abstract available

KESHVANI N, Rizvi S, Segar MW, Miller JW, et al
Diuretic efficiency of a single dose of subcutaneous versus oral furosemide after heart failure hospitalization across diuretic resistance strata: A pilot randomized controlled trial.
Eur J Heart Fail. 2024 Dec 2. doi: 10.1002/ejhf.3537.
PubMed Abstract available

CODINA P, Lee MMY, Tomasoni D, Aimo A, et al
What's new in heart failure? December 2024.
Eur J Heart Fail. 2024;26:2477-2481.
PubMed

ECHEVERRIA LE, Serrano-Garcia AY, Rojas LZ, Berrios-Barcenas EA, et al
Mechanisms behind the high mortality rate in chronic Chagas cardiomyopathy: Unmasking a three-headed monster.
Eur J Heart Fail. 2024;26:2502-2514.
PubMed Abstract available

November 2024

TOKCAN M, Hoevelmann J, Markwirth P, Emrich I, et al
What's new in heart failure? November 2024.
Eur J Heart Fail. 2024 Nov 28. doi: 10.1002/ejhf.3538.
PubMed

DE BIASE N, Del Punta L, L'Hoyes W, Pellicori P, et al
Associations of iron deficiency with cardiac function, congestion, exercise capacity and prognosis in heart failure.
Eur J Heart Fail. 2024 Nov 28. doi: 10.1002/ejhf.3534.
PubMed Abstract available

PERIN EC, Borow KM, Henry TD, Jenkins M, et al
Mesenchymal precursor cells reduce mortality and major morbidity in ischaemic heart failure with inflammation: DREAM-HF.
Eur J Heart Fail. 2024 Nov 26. doi: 10.1002/ejhf.3522.
PubMed Abstract available

WECKBACH LT, Stolz L, Doldi PM, Glaser H, et al
Relevance of residual tricuspid regurgitation for right ventricular reverse remodelling after tricuspid valve intervention in patients with severe tricuspid regurgitation and right-sided heart failure.
Eur J Heart Fail. 2024 Nov 26. doi: 10.1002/ejhf.3529.
PubMed Abstract available

LANDUCCI L, Faxen UL, Benson L, Dahlstrom U, et al
Discontinuation and reinitiation of mineralocorticoid receptor antagonists in patients with heart failure and reduced ejection fraction.
Eur J Heart Fail. 2024 Nov 26. doi: 10.1002/ejhf.3523.
PubMed Abstract available

PAGNESI M, Metra M
Reply to 'Malnutrition and severe heart failure in real-world study settings'.
Eur J Heart Fail. 2024 Nov 26. doi: 10.1002/ejhf.3525.
PubMed

KRISAI P, Belley-Cote EP, McIntyre WF, Wong J, et al
Heart failure after left atrial appendage occlusion: Insights from the LAAOS III randomized trial.
Eur J Heart Fail. 2024 Nov 25. doi: 10.1002/ejhf.3536.
PubMed Abstract available

VAN LINTHOUT S, Stellos K, Giacca M, Bertero E, et al
State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases.
Eur J Heart Fail. 2024 Nov 22. doi: 10.1002/ejhf.3516.
PubMed Abstract available

GHOSSEIN-DOHA C, Thilaganathan B, Vaught AJ, Briller JE, et al
Hypertensive pregnancy disorder, an under-recognized women specific risk factor for heart failure?
Eur J Heart Fail. 2024 Nov 19. doi: 10.1002/ejhf.3520.
PubMed Abstract available

BAUDRY G, Girerd N, Cikes M, Crespo-Leiro MG, et al
Knowledge and application of ESC/HFA guidelines in the management of advanced heart failure.
Eur J Heart Fail. 2024 Nov 19. doi: 10.1002/ejhf.3530.
PubMed Abstract available

SHARIF SM, Smith JR, Borlaug BA, Olson TP, et al
Association between locomotor muscle quality and cardiac function during exercise in heart failure with preserved ejection fraction.
Eur J Heart Fail. 2024 Nov 19. doi: 10.1002/ejhf.3528.
PubMed Abstract available

GUPTA SD, Butt JH, McMurray EGM, Talebi A, et al
Effects of sacubitril/valsartan according to background beta-blocker therapy in patients with heart failure and reduced ejection fraction: Insights from PARADIGM-HF.
Eur J Heart Fail. 2024 Nov 19. doi: 10.1002/ejhf.3515.
PubMed Abstract available

WU MC, Yang SC, Gau SY
Malnutrition and severe heart failure in real-world study settings. Letter regarding the article 'Impact of malnutrition in patients with severe heart failure'.
Eur J Heart Fail. 2024 Nov 19. doi: 10.1002/ejhf.3524.
PubMed

KARACAN MN, Yafasova A, Fosbol EL, Tas A, et al
Long-term risk of heart failure in patients with postoperative atrial fibrillation following non-cardiac surgery: Insights from a nationwide cohort.
Eur J Heart Fail. 2024 Nov 12. doi: 10.1002/ejhf.3518.
PubMed Abstract available

THYAGATURU H, Abugrin M, Awad M, Mensah SA, et al
Psychological distress in heart failure patients: Implications for healthcare utilization and expenditure.
Eur J Heart Fail. 2024 Nov 11. doi: 10.1002/ejhf.3517.
PubMed Abstract available

TANAKA A, Imai T, Kida K, Matsue Y, et al
Angiotensin receptor-neprilysin inhibition and combination use of guideline-directed medical therapies in acute heart failure.
Eur J Heart Fail. 2024 Nov 11. doi: 10.1002/ejhf.3526.
PubMed

SOHNS C, Fink T, Crijns HJGM, Costard-Jaeckle A, et al
Preventive catheter ablation for ventricular arrhythmias in patients with end-stage heart failure referred for heart transplantation evaluation: Rationale for and design of the CASTLE-VT trial.
Eur J Heart Fail. 2024 Nov 11. doi: 10.1002/ejhf.3512.
PubMed Abstract available

HILL L, Girerd N, Castiello T, Jaarsma T, et al
Examining the clinical role and educational preparation of heart failure nurses across Europe. A survey of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) and the Association of Cardiovascular Nursing and Allied Profess
Eur J Heart Fail. 2024 Nov 8. doi: 10.1002/ejhf.3519.
PubMed Abstract available

OSTROMINSKI JW, Seferovic PM, Selvaraj S
Metabolic dysfunction: An important driver of incident heart failure with preserved and reduced ejection fraction.
Eur J Heart Fail. 2024 Nov 8. doi: 10.1002/ejhf.3507.
PubMed

LAUDER L, Pfister O, Mahfoud F
Contextualizing heart rate: Visit-to-visit fluctuations and their impact on prognosis in heart failure.
Eur J Heart Fail. 2024 Nov 8. doi: 10.1002/ejhf.3513.
PubMed

AVERBUCH T, Lee SF, Zagorski B, Pandey A, et al
Long-term clinical outcomes and healthcare resource utilization in male and female patients following hospitalization for heart failure.
Eur J Heart Fail. 2024 Nov 5. doi: 10.1002/ejhf.3499.
PubMed Abstract available

SUNDSTROM J, Lindholm D
Reply to 'The patterns and changes of heart failure treatment in the last years of life still need further study'.
Eur J Heart Fail. 2024 Nov 5. doi: 10.1002/ejhf.3514.
PubMed

CAO TH, Voors AA, Ng LL
Reply to the letter regarding the article 'Heart failure with improved versus persistently reduced left ventricular ejection fraction: A comparison of the BIOSTAT-CHF (European) study with the ASIAN-HF registry'.
Eur J Heart Fail. 2024 Nov 4. doi: 10.1002/ejhf.3482.
PubMed

BAUDRY G, Metra M, Delmas C
Reply to the letter regarding the article 'Are mechanical circulatory supports the forgotten aspect in the implementation of therapies for heart failure?'.
Eur J Heart Fail. 2024 Nov 3. doi: 10.1002/ejhf.3489.
PubMed

DORR M, Bohm M, Erdmann E, Gross S, et al
Multicentre, randomized, double-blind, prospective study on the effects of ImmunoAdSorptiOn on cardiac function in patients with Dilated CardioMyopathy (IASO-DCM): Rationale and design.
Eur J Heart Fail. 2024;26:2464-2473.
PubMed Abstract available

MIHALJ M, Reineke D, Just IA, Mulzer J, et al
Association between caseload volume and outcomes in left ventricular assist device implantations - a EUROMACS analysis.
Eur J Heart Fail. 2024;26:2400-2409.
PubMed Abstract available

October 2024

ZHAO Y, Shen Z
The patterns and changes of heart failure treatment in the last years of life still need further study. Letter regarding the article 'Heart failure treatment in the last years of life: A nationwide study of 364 000 individuals'.
Eur J Heart Fail. 2024 Oct 31. doi: 10.1002/ejhf.3508.
PubMed

REDDY YNV, Butler J, Anstrom KJ, Blaustein RO, et al
Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trial.
Eur J Heart Fail. 2024 Oct 30. doi: 10.1002/ejhf.3501.
PubMed Abstract available

DIEDEN A, Girerd N, Ottosson F, Molvin J, et al
Proteomic biomarkers and pathway analysis for progression to heart failure in three epidemiological representative cohorts.
Eur J Heart Fail. 2024 Oct 28. doi: 10.1002/ejhf.3502.
PubMed Abstract available

LINDBERG F, Benson L, Dahlstrom U, Lund LH, et al
Trends in heart failure mortality in Sweden between 1997 and 2022.
Eur J Heart Fail. 2024 Oct 28. doi: 10.1002/ejhf.3506.
PubMed Abstract available

SAVAGE HO, McBeath K, Hogan J, MacKay-Thomas L, et al
The 25in25 initiative: A novel transformative project to reduce mortality due to heart failure by 25% in the next 25 years.
Eur J Heart Fail. 2024 Oct 25. doi: 10.1002/ejhf.3496.
PubMed

FOLEY PW, Kalra PR, Cleland JGF, Petrie MC, et al
Effect of correcting iron deficiency on the risk of serious infection in heart failure: Insights from the IRONMAN trial.
Eur J Heart Fail. 2024 Oct 25. doi: 10.1002/ejhf.3504.
PubMed Abstract available

ZIEROTH S, Giraldo CIS, Pinto F, Anker SD, et al
Applicability of heart failure clinical practice guidelines in low- and middle-income countries.
Eur J Heart Fail. 2024 Oct 25. doi: 10.1002/ejhf.3485.
PubMed Abstract available

ANKER MS, Porthun J, Bayes-Genis A, Van Linthout S, et al
Time for differential weight management in heart failure.
Eur J Heart Fail. 2024 Oct 25. doi: 10.1002/ejhf.3495.
PubMed

GIRERD N, Voors AA, Ter Maaten J
Exploring the role of hypertonic saline in ambulatory heart failure management: One size does not fit all?
Eur J Heart Fail. 2024 Oct 24. doi: 10.1002/ejhf.3500.
PubMed

SCIACCA V, Sohns C, Crijns HJGM, Marrouche NF, et al
Effects of atrial fibrillation ablation on arrhythmia burden and ventricular function in end-stage heart failure: Lessons from CASTLE-HTx.
Eur J Heart Fail. 2024 Oct 24. doi: 10.1002/ejhf.3505.
PubMed Abstract available

SALVADOR-CASABON JM, Lacambra-Blasco I, Perez-Calvo JI
Letter regarding the article 'Heart failure with improved versus persistently reduced left ventricular ejection fraction: A comparison of the BIOSTAT-CHF (European) study with the ASIAN-HF registry'.
Eur J Heart Fail. 2024 Oct 24. doi: 10.1002/ejhf.3493.
PubMed

LU H, Claggett BL, Packer M, Pfeffer MA, et al
Visit-to-visit changes in heart rate in heart failure: A pooled participant-level analysis of the PARADIGM-HF and PARAGON-HF trials.
Eur J Heart Fail. 2024 Oct 22. doi: 10.1002/ejhf.3487.
PubMed Abstract available

CUI F, Zheng L, Zhang J, Tang L, et al
Long-term exposure to fine particulate matter constituents, genetic susceptibility, and incident heart failure among 411 807 adults.
Eur J Heart Fail. 2024 Oct 22. doi: 10.1002/ejhf.3486.
PubMed Abstract available

COTTER G, Davison BA, Freund Y, Mebazaa A, et al
Reply to 'Is it possible to establish a threshold to define the inflammatory risk of acute heart failure patients?' Letter regarding the article 'Burst steroid therapy for acute heart failure: The CORTAHF randomized, open-label, pilot trial'.
Eur J Heart Fail. 2024 Oct 22. doi: 10.1002/ejhf.3491.
PubMed

CAMILLI M
Is it possible to establish a threshold to define the inflammatory risk of acute heart failure patients? Letter regarding the article 'Burst steroid therapy for acute heart failure: the CORTAHF randomized, open-label, pilot trial'.
Eur J Heart Fail. 2024 Oct 22. doi: 10.1002/ejhf.3494.
PubMed

MARTIN AC
Letter regarding the article 'Are mechanical circulatory supports the forgotten aspect in the implementation of therapies for heart failure?'.
Eur J Heart Fail. 2024 Oct 22. doi: 10.1002/ejhf.3484.
PubMed

ZHU L, Liu J, Zhao H
A clinical classification method with outstanding advantages for quickly identifying hazardous types: Letter regarding the article 'Acute heart failure congestion and perfusion status - impact of the clinical classification on in-hospital and long-ter
Eur J Heart Fail. 2024 Oct 18. doi: 10.1002/ejhf.3479.
PubMed

LEE MMY, Codina P, Tomasoni D, Aimo A, et al
What's new in heart failure? October 2024.
Eur J Heart Fail. 2024 Oct 14. doi: 10.1002/ejhf.3492.
PubMed

NOUHRAVESH N, Greene SJ, Clare R, Wojdyla D, et al
Diuretic dosing and outcomes with torsemide and furosemide following hospitalization for heart failure: The TRANSFORM-HF trial.
Eur J Heart Fail. 2024 Oct 4. doi: 10.1002/ejhf.3458.
PubMed Abstract available

IACONELLI A, Emrich I, Pellicori P, Cleland JGF, et al
Managing congestive heart failure: It is mostly about water, not salt!
Eur J Heart Fail. 2024 Oct 3. doi: 10.1002/ejhf.3457.
PubMed

MOLINER-ABOS C, Calvo-Barcelo M, Sole-Gonzalez E, Borrellas Martin A, et al
Revascularization and outcomes in ischaemic left ventricular dysfunction after heart failure admission: The RevascHeart study.
Eur J Heart Fail. 2024 Oct 2. doi: 10.1002/ejhf.3463.
PubMed Abstract available

SEGAR MW, Usman MS, Patel KV, Khan MS, et al
Development and validation of a machine learning-based approach to identify high-risk diabetic cardiomyopathy phenotype.
Eur J Heart Fail. 2024;26:2183-2192.
PubMed Abstract available

KEENE D, Kaza N, Srinivasan D, Ali N, et al
Predictors of the efficacy of His bundle pacing in patients with a prolonged PR interval: A stratified analysis of the HOPE-HF randomized controlled trial.
Eur J Heart Fail. 2024;26:2261-2268.
PubMed Abstract available

September 2024

CHENG L, Hammersley D, Ragavan A, Javed S, et al
Long-term follow-up of the TRED-HF trial: Implications for therapy in patients with dilated cardiomyopathy and heart failure remission.
Eur J Heart Fail. 2024 Sep 30. doi: 10.1002/ejhf.3475.
PubMed Abstract available

BRANDT M, Cotter G, Wenzel P
Delivering more evidence for the specificities of heart failure with improved ejection fraction: New answers, new questions.
Eur J Heart Fail. 2024 Sep 27. doi: 10.1002/ejhf.3434.
PubMed

CHRISTODORESCU R, Geavlete O, Ferrini M, Kumler T, et al
Translating the 2021 ESC heart failure guideline recommendations in daily practice: Results from a heart failure survey. A scientific statement of the ESC Council for Cardiology Practice and the Heart Failure Association of the ESC.
Eur J Heart Fail. 2024 Sep 24. doi: 10.1002/ejhf.3444.
PubMed Abstract available

HOEVELMANN J, Volterrani M, Emrich IE
Barriers to the implementation of heart failure therapy in the elderly: Let's accept the challenge!
Eur J Heart Fail. 2024 Sep 24. doi: 10.1002/ejhf.3449.
PubMed

ABDIN A, Abdin AD, Merone G, Aljundi W, et al
Cardio-ocular syndrome: Retinal microvascular changes in acutely decompensated heart failure.
Eur J Heart Fail. 2024 Sep 24. doi: 10.1002/ejhf.3474.
PubMed Abstract available

NG ACT, Dong X, Koepp KE, Obokata M, et al
Sexual dimorphism in the relationships between intramyocardial fat, myocardial fibrosis, and exercise intolerance in heart failure with preserved ejection fraction.
Eur J Heart Fail. 2024 Sep 24. doi: 10.1002/ejhf.3473.
PubMed

HARING B, Abdin A, Bohm M
Clonal haematopoiesis of indeterminate potential: A new biomarker for heart failure patients? Potential lessons to be learned from cardio-oncology.
Eur J Heart Fail. 2024 Sep 24. doi: 10.1002/ejhf.3466.
PubMed

MIRO O, Ivars N, Espinosa B, Jacob J, et al
Effect of seasonal influenza and COVID-19 vaccination on severity and long-term outcomes of patients with heart failure decompensations.
Eur J Heart Fail. 2024 Sep 24. doi: 10.1002/ejhf.3469.
PubMed Abstract available

PABON MA, Vaduganathan M, Claggett BL, Chatur S, et al
In-hospital course of patients with heart failure with improved ejection fraction in the DELIVER trial.
Eur J Heart Fail. 2024 Sep 19. doi: 10.1002/ejhf.3410.
PubMed Abstract available

WOOD N, Witte KK, Bowen TS
Reply to the letter regarding the article 'Sodium-glucose cotransporter 2 inhibitors influence skeletal muscle pathology in patients with heart failure and reduced ejection fraction'.
Eur J Heart Fail. 2024 Sep 18. doi: 10.1002/ejhf.3442.
PubMed

STOLLBERGER C, Finsterer J, Schneider B
Letter regarding the article 'Sodium-glucose cotransporter 2 inhibitors influence skeletal muscle pathology in patients with heart failure and reduced ejection fraction'.
Eur J Heart Fail. 2024 Sep 18. doi: 10.1002/ejhf.3441.
PubMed

KUSTER GM, Assmus B, Mahfoud F
Myeloperoxidase: Reviving an old ally for immunomodulation in heart failure?
Eur J Heart Fail. 2024 Sep 18. doi: 10.1002/ejhf.3468.
PubMed

LUND LH, James S, DeVore AD, Anstrom KJ, et al
The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and design.
Eur J Heart Fail. 2024 Sep 16. doi: 10.1002/ejhf.3453.
PubMed Abstract available

WU CY, Shah BR, Sharma A, Sheng Y, et al
Timing of sodium-glucose cotransporter 2 inhibitor initiation and post-discharge outcomes in acute heart failure with diabetes: A population-based cohort study.
Eur J Heart Fail. 2024 Sep 12. doi: 10.1002/ejhf.3464.
PubMed Abstract available

LUND LH, Crespo-Leiro MG, Laroche C, Zaliaduonyte D, et al
Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction - the ESC EORP Heart Failure III Registry.
Eur J Heart Fail. 2024 Sep 10. doi: 10.1002/ejhf.3445.
PubMed Abstract available

NGUYEN DV, Le TN, Truong BQ, Nguyen HTT, et al
Efficacy and safety of angiotensin receptor-neprilysin inhibition in heart failure patients with end-stage kidney disease on maintenance dialysis: A systematic review and meta-analysis.
Eur J Heart Fail. 2024 Sep 9. doi: 10.1002/ejhf.3454.
PubMed Abstract available

ABDIN A, Aimo A, Hoevelmann J, Haring B, et al
The month in heart failure! September 2024.
Eur J Heart Fail. 2024 Sep 9. doi: 10.1002/ejhf.3465.
PubMed

INCIARDI RM, Staal L, Davison B, Lombardi CM, et al
Impact of age on clinical outcomes and response to serelaxin in patients with acute heart failure: An analysis from the RELAX-AHF-2 trial.
Eur J Heart Fail. 2024 Sep 6. doi: 10.1002/ejhf.3451.
PubMed Abstract available

DOHERTY DJ, Abdin A, Docherty KF
Heart failure medical therapy in the last years of life: Prognosis and practicalities.
Eur J Heart Fail. 2024 Sep 3. doi: 10.1002/ejhf.3450.
PubMed

KAZE AD, Bertoni AG, Fox ER, Hall ME, et al
Metabolic dysfunction and incidence of heart failure subtypes among Black individuals: The Jackson Heart Study.
Eur J Heart Fail. 2024 Sep 3. doi: 10.1002/ejhf.3447.
PubMed Abstract available

MYHRE PL, Berge K, Orn S
Reply to the letter regarding the article 'Changes in 6-min walk test is an independent predictor of death in chronic heart failure with reduced ejection fraction'.
Eur J Heart Fail. 2024 Sep 2. doi: 10.1002/ejhf.3448.
PubMed

FIORI E, Magri D, Iacovoni A
Letter regarding the article 'Changes in 6-min walk test is an independent predictor of death in chronic heart failure with reduced ejection fraction'.
Eur J Heart Fail. 2024 Sep 2. doi: 10.1002/ejhf.3456.
PubMed

LU H, Claggett BL, Packer M, Pfeffer MA, et al
Sacubitril/valsartan reduces incident anaemia and iron therapy utilization in heart failure: The PARAGON-HF trial.
Eur J Heart Fail. 2024 Sep 1. doi: 10.1002/ejhf.3414.
PubMed Abstract available

MC CAUSLAND FR, McGrath MM, Claggett BL, Barkoudah E, et al
Acute changes in kidney function and outcomes following an acute myocardial infarction: Insights from PARADISE-MI.
Eur J Heart Fail. 2024;26:1984-1992.
PubMed Abstract available

ABDIN A, Kondo T, Bohm M, Jhund PS, et al
Effects of dapagliflozin according to QRS duration across the spectrum of left ventricular ejection fraction: An analysis of DAPA-HF and DELIVER.
Eur J Heart Fail. 2024;26:1952-1963.
PubMed Abstract available

August 2024

SUNDSTROM J, Gustafsson S, Cars T, Lindholm D, et al
Heart failure treatment in the last years of life: A nationwide study of 364 000 individuals.
Eur J Heart Fail. 2024 Aug 31. doi: 10.1002/ejhf.3426.
PubMed Abstract available

MATSUMOTO S, Henderson AD, Shen L, Kondo T, et al
Beta-blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction.
Eur J Heart Fail. 2024 Aug 31. doi: 10.1002/ejhf.3383.
PubMed Abstract available

VAN VELDHUISEN DJ, Rienstra M, Mosterd A, Alings AM, et al
Efficacy and safety of low-dose digoxin in patients with heart failure. Rationale and design of the DECISION trial.
Eur J Heart Fail. 2024 Aug 30. doi: 10.1002/ejhf.3428.
PubMed Abstract available

COTTER G, Davison BA, Freund Y, Voors AA, et al
Burst steroid therapy for acute heart failure: The CORTAHF randomized, open-label, pilot trial.
Eur J Heart Fail. 2024 Aug 30. doi: 10.1002/ejhf.3452.
PubMed Abstract available

KERAMIDA K, Farmakis D, Rakisheva A, Tocchetti CG, et al
The right heart in patients with cancer. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology.
Eur J Heart Fail. 2024 Aug 28. doi: 10.1002/ejhf.3412.
PubMed

ZOCCA E, Cocianni D, Barbisan D, Perotto M, et al
Dynamic evolution of tricuspid regurgitation during hospitalization in patients with acute decompensated heart failure.
Eur J Heart Fail. 2024 Aug 27. doi: 10.1002/ejhf.3433.
PubMed Abstract available

LOPASCHUK GD, Sun Q, Ketema EB
Glycolysis in heart failure with preserved ejection fraction.
Eur J Heart Fail. 2024 Aug 27. doi: 10.1002/ejhf.3432.
PubMed

HOLM H, Magnusson M, Jujic A, Lagrange J, et al
Association of ventricular-arterial coupling with biomarkers involved in heart failure pathophysiology - the STANISLAS cohort.
Eur J Heart Fail. 2024 Aug 27. doi: 10.1002/ejhf.3411.
PubMed Abstract available

FINK T, Sciacca V, Kirchhof P, Sommer P, et al
Contemporary trends of atrial fibrillation management in heart failure patients: Do we practice what we preach?
Eur J Heart Fail. 2024 Aug 27. doi: 10.1002/ejhf.3431.
PubMed

LAENENS D, Zegkos T, Kamperidis V, Wong RCC, et al
Heart failure risk assessment in patients with hypertrophic cardiomyopathy based on the H(2)FPEF score.
Eur J Heart Fail. 2024 Aug 27. doi: 10.1002/ejhf.3413.
PubMed Abstract available

GIANNITSIS E, Frey N, Jhund PS
Improving the rate of heart failure with improved ejection fraction.
Eur J Heart Fail. 2024 Aug 22. doi: 10.1002/ejhf.3427.
PubMed

BIEGUS J, Cotter G, Metra M, Ponikowski P, et al
Decongestion in acute heart failure: Is it time to change diuretic-centred paradigm?
Eur J Heart Fail. 2024 Aug 21. doi: 10.1002/ejhf.3423.
PubMed Abstract available

GUIDETTI F, Giraldo CIS, Shchendrygina A, Kida K, et al
Differences in heart failure with preserved ejection fraction management between care providers: an international survey.
Eur J Heart Fail. 2024 Aug 21. doi: 10.1002/ejhf.3416.
PubMed Abstract available

YANG M, Kondo T, Anand IS, de Boer RA, et al
Clinical characteristics and outcomes of patients aged 80 years and over with heart failure: Need for better treatment.
Eur J Heart Fail. 2024 Aug 21. doi: 10.1002/ejhf.3417.
PubMed Abstract available

XIE S, Xu L, Zhang F, Xiao H, et al
Letter regarding the article 'Left ventricular volume and maximal functional capacity in heart failure with preserved ejection fraction: Size matters'.
Eur J Heart Fail. 2024 Aug 18. doi: 10.1002/ejhf.3436.
PubMed

DE LA ESPRIELLA R, Palau P, Guazzi M, Nunez J, et al
Reply to the letter regarding the article 'Left ventricular volume and maximal functional capacity in heart failure with preserved ejection fraction: Size matters'.
Eur J Heart Fail. 2024 Aug 18. doi: 10.1002/ejhf.3439.
PubMed

ABDIN A, Jhund PS
Implementation of guideline-directed medical therapy for heart failure: Progress achieved, work ahead!
Eur J Heart Fail. 2024 Aug 18. doi: 10.1002/ejhf.3438.
PubMed

BUTT JH, Thune JJ, Nielsen JC, Haarbo J, et al
Anthropometric measures and long-term mortality in non-ischaemic heart failure with reduced ejection fraction: Questioning the obesity paradox.
Eur J Heart Fail. 2024 Aug 18. doi: 10.1002/ejhf.3424.
PubMed Abstract available

HU Y, Li Z, Zhang Y
Empagliflozin and glucagon-like peptide-1 receptor agonists: The brothers for heart failure? Letter regarding the article 'Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSE'.
Eur J Heart Fail. 2024 Aug 18. doi: 10.1002/ejhf.3419.
PubMed

TRIMARCHI G, Panichella G, Aimo A
Heart failure with preserved ejection fraction risk after aortic coarctation surgery: The hidden threat.
Eur J Heart Fail. 2024 Aug 18. doi: 10.1002/ejhf.3420.
PubMed

BAUDRY G, Metra M, Delmas C
Are mechanical circulatory supports the forgotten aspect in the implementation of therapies for heart failure?
Eur J Heart Fail. 2024 Aug 15. doi: 10.1002/ejhf.3422.
PubMed

DOLDI PM, Stolz L, Hausleiter J
Unravelling the complexity of heart failure with preserved ejection fraction and secondary mitral regurgitation.
Eur J Heart Fail. 2024 Aug 15. doi: 10.1002/ejhf.3430.
PubMed

HAMMERSLEY DJ, Mukhopadhyay S, Chen X, Jones RE, et al
Precision prediction of heart failure events in patients with dilated cardiomyopathy and mildly reduced ejection fraction using multi-parametric cardiovascular magnetic resonance.
Eur J Heart Fail. 2024 Aug 15. doi: 10.1002/ejhf.3425.
PubMed Abstract available

FERREIRA JP, Voors AA
Reply to 'Empagliflozin and glucagon-like peptide-1 receptor agonists: The brothers for heart failure?'.
Eur J Heart Fail. 2024 Aug 15. doi: 10.1002/ejhf.3415.
PubMed

MEEKERS E, Martens P, Dauw J, Gruwez H, et al
Nurse-led diuretic titration via a point-of-care urinary sodium sensor in patients with acute decompensated heart failure (EASY-HF): A single-centre, randomized, open-label study.
Eur J Heart Fail. 2024 Aug 14. doi: 10.1002/ejhf.3429.
PubMed Abstract available

KOLEINI N, Meddeb M, Zhao L, Keykhaei M, et al
Landscape of glycolytic metabolites and their regulating proteins in myocardium from human heart failure with preserved ejection fraction.
Eur J Heart Fail. 2024 Aug 9. doi: 10.1002/ejhf.3389.
PubMed Abstract available

CAO TH, Tay WT, Jones DJL, Cleland JGF, et al
Heart failure with improved versus persistently reduced left ventricular ejection fraction: A comparison of the BIOSTAT-CHF (European) study with the ASIAN-HF registry.
Eur J Heart Fail. 2024 Aug 9. doi: 10.1002/ejhf.3378.
PubMed Abstract available

SLIWA K, Rakisheva A, Viljoen C, Pfeffer T, et al
Living with peripartum cardiomyopathy: A statement from the Heart Failure Association and the Association of Cardiovascular Nursing and Allied Professions of the European Society of Cardiology.
Eur J Heart Fail. 2024 Aug 8. doi: 10.1002/ejhf.3377.
PubMed Abstract available

KAZMI S, Kambhampati C, Rigby AS, Cleland JGF, et al
Disease progression in chronic heart failure is linear: Insights from multistate modelling.
Eur J Heart Fail. 2024 Aug 6. doi: 10.1002/ejhf.3400.
PubMed Abstract available

ANDERSON KP
The electrocardiogram in heart failure trials: Missing in action.
Eur J Heart Fail. 2024 Aug 6. doi: 10.1002/ejhf.3392.
PubMed

TOCCHETTI CG, Farmakis D, Koop Y, Andres MS, et al
Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology.
Eur J Heart Fail. 2024 Aug 1. doi: 10.1002/ejhf.3340.
PubMed Abstract available

VALENTE V, Ferrannini G, Benson L, Gatti P, et al
Characterizing atrial fibrillation in patients with and without heart failure across the ejection fraction spectrum: Incidence, prevalence, and treatment strategies.
Eur J Heart Fail. 2024 Aug 1. doi: 10.1002/ejhf.3402.
PubMed Abstract available

HOEVELMANN J, Markwirth P, Tokcan M, Haring B, et al
What's new in heart failure? August-September 2024.
Eur J Heart Fail. 2024;26:1665-1668.
PubMed

July 2024

TROMP J, Lam CSP, Alemayehu W, de Filippi CR, et al
Biomarker profiles associated with reverse ventricular remodelling in patients with heart failure and a reduced ejection fraction: Insights from the echocardiographic substudy of the VICTORIA trial.
Eur J Heart Fail. 2024 Jul 30. doi: 10.1002/ejhf.3397.
PubMed Abstract available

LEE MMY, Petrie MC, Cleland JGF, Donnelly P, et al
Administration of ferric derisomaltose for iron deficiency and heart failure during hospital admission or at the clinic - insights from the IRONMAN trial.
Eur J Heart Fail. 2024 Jul 30. doi: 10.1002/ejhf.3394.
PubMed

TENG TK, Yiu KH, Tromp J
Global perspectives on heart failure with preserved ejection fraction: Unravelling regional variations in a complex syndrome.
Eur J Heart Fail. 2024 Jul 30. doi: 10.1002/ejhf.3407.
PubMed

STOLFO D, Benson L, Lindberg F, Dahlstrom U, et al
Status and timing of angiotensin receptor-neprilysin inhibitor implementation in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure Registry.
Eur J Heart Fail. 2024 Jul 30. doi: 10.1002/ejhf.3404.
PubMed Abstract available

HATTORI Y, Ihara M
Adrenomedullin as a marker of hypoxia, not hypoperfusion. Letter regarding the article 'Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRO
Eur J Heart Fail. 2024 Jul 30. doi: 10.1002/ejhf.3406.
PubMed

DE LA ESPRIELLA R, Palau P, Losito M, Crisci G, et al
Left ventricular volume and maximal functional capacity in heart failure with preserved ejection fraction: Size matters.
Eur J Heart Fail. 2024 Jul 30. doi: 10.1002/ejhf.3401.
PubMed Abstract available

HOEVELMANN J, Markwirth P, Tokcan M, Haring B, et al
What's new in heart failure? August-September 2024.
Eur J Heart Fail. 2024 Jul 26. doi: 10.1002/ejhf.3399.
PubMed

MYHRE PL, Kleiven O, Berge K, Grundtvig M, et al
Changes in 6-min walk test is an independent predictor of death in chronic heart failure with reduced ejection fraction.
Eur J Heart Fail. 2024 Jul 26. doi: 10.1002/ejhf.3391.
PubMed Abstract available

COBO MARCOS M, de la Espriella R, Comin-Colet J, Zegri-Reiriz I, et al
Efficacy and safety of hypertonic saline therapy in ambulatory patients with heart failure: The SALT-HF trial.
Eur J Heart Fail. 2024 Jul 26. doi: 10.1002/ejhf.3390.
PubMed Abstract available

BELDHUIS IE, Heerspink HJL, Voors AA
Can the novel aldosterone inhibiting drug balcinrenone reduce hyperkalaemia and worsening renal function compared to steroidal mineralocorticoid receptor antagonists in heart failure?
Eur J Heart Fail. 2024 Jul 22. doi: 10.1002/ejhf.3387.
PubMed

CULIC V
Sex hormones and heart failure. Letter regarding the article 'Pre-diagnostic free androgen and estradiol levels influence heart failure risk in both women and men: A prospective cohort study in the UK Biobank'.
Eur J Heart Fail. 2024 Jul 18. doi: 10.1002/ejhf.3384.
PubMed

LIM J, Wong JYY
Reply to 'Sex hormones and heart failure'.
Eur J Heart Fail. 2024 Jul 18. doi: 10.1002/ejhf.3385.
PubMed

PARWANI AS, Kaab S, Friede T, Tilz RR, et al
Catheter-based ablation to improve outcomes in patients with atrial fibrillation and heart failure with preserved ejection fraction: Rationale and design of the CABA-HFPEF-DZHK27 trial.
Eur J Heart Fail. 2024 Jul 18. doi: 10.1002/ejhf.3373.
PubMed Abstract available

ABOU KAMAR S, Bracun V, El-Qendouci M, Bomer N, et al
Association of baseline and longitudinal changes in insulin-like growth factor-binding protein-7 with the risk of incident heart failure: Data from the PREVEND study.
Eur J Heart Fail. 2024 Jul 17. doi: 10.1002/ejhf.3328.
PubMed Abstract available

REDDY YNV, Sundaram V
Predicting worsening heart failure with preserved ejection fraction from non-invasive exercise testing.
Eur J Heart Fail. 2024 Jul 17. doi: 10.1002/ejhf.3380.
PubMed

PELLICORI P, Cuthbert JJ, Clark AL, Cleland JGF, et al
Managing water and salt balance in heart failure: Is there anything else to consider other than diet and diuretics?
Eur J Heart Fail. 2024 Jul 17. doi: 10.1002/ejhf.3374.
PubMed

BOCCHI EA, Biselli B, Guimaraes GV
Dilemmas in recommending exercise for prevention of heart failure with preserved ejection fraction.
Eur J Heart Fail. 2024 Jul 16. doi: 10.1002/ejhf.3364.
PubMed

EGBE AC, Reddy YNV, Ali AE, Younis A, et al
Clinical features, haemodynamics, and outcomes of heart failure with preserved ejection fraction in coarctation of aorta.
Eur J Heart Fail. 2024 Jul 16. doi: 10.1002/ejhf.3379.
PubMed Abstract available

ABDIN A, Wilkinson C, Aktaa S, Bohm M, et al
European Society of Cardiology quality indicators update for the care and outcomes of adults with heart failure. The Heart Failure Association of the ESC.
Eur J Heart Fail. 2024 Jul 12. doi: 10.1002/ejhf.3376.
PubMed Abstract available

FERREIRA JP, Blatchford JP, Teerlink JR, Kosiborod MN, et al
Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSE.
Eur J Heart Fail. 2024 Jul 9. doi: 10.1002/ejhf.3369.
PubMed Abstract available

PATERSON MA, Pilbrow AP, Frampton CM, Cameron VA, et al
Plasma soluble fms-like tyrosine kinase-1, placental growth factor, and vascular endothelial growth factor system gene variants as predictors of survival in heart failure.
Eur J Heart Fail. 2024 Jul 9. doi: 10.1002/ejhf.3368.
PubMed Abstract available

CAMILLI M, Ballacci F, Rossi VA, Cannata A, et al
Iron deficiency and supplementation in patients with heart failure: Results from the IRON-HF international survey.
Eur J Heart Fail. 2024 Jul 4. doi: 10.1002/ejhf.3356.
PubMed Abstract available

BIANCUCCI M, Barbiero R, Pennella B, Cannata A, et al
Hypoalbuminaemia and heart failure: A practical review of current evidence.
Eur J Heart Fail. 2024 Jul 4. doi: 10.1002/ejhf.3363.
PubMed Abstract available

SUC G, Iung B
Aortic valve disease and heart failure with mildly reduced ejection fraction: New insights and pending questions.
Eur J Heart Fail. 2024 Jul 4. doi: 10.1002/ejhf.3360.
PubMed

BAUERSACHS J, Berliner D
Navigating between Scylla and Charybdis: Diuretics during pregnancy - as much as needed, but the least possible.
Eur J Heart Fail. 2024;26:1571-1573.
PubMed

BAYES-GENIS A, Greene SJ
Bio-adrenomedullin: A weak biomarker for a STRONG patient.
Eur J Heart Fail. 2024;26:1493-1494.
PubMed

HAEBEL L, Fuge J, Kuehn C, Hoeper MM, et al
Survival and ability to return to work 1 year after extracorporeal membrane oxygenation for acute heart or lung failure.
Eur J Heart Fail. 2024;26:1604-1605.
PubMed

VAN DER ZANDE JA, Greutmann M, Tobler D, Ramlakhan KP, et al
Diuretics in pregnancy: Data from the ESC Registry of Pregnancy and Cardiac disease (ROPAC).
Eur J Heart Fail. 2024;26:1561-1570.
PubMed Abstract available

June 2024

PANICHELLA G, Tomasoni D, Aimo A
Identifying reliable biomarkers for pulmonary congestion: Toward a close yet sustainable heart failure follow-up.
Eur J Heart Fail. 2024 Jun 28. doi: 10.1002/ejhf.3357.
PubMed

AIMO A, Codina P, Lee MMY, Tomasoni D, et al
What's new in heart failure? June-July 2024.
Eur J Heart Fail. 2024 Jun 28. doi: 10.1002/ejhf.3371.
PubMed

TROMP J, Ouwerkerk W
Left atrial enlargement and biomarker profiles: Time for integration of biomarkers and echocardiography in heart failure prevention.
Eur J Heart Fail. 2024 Jun 27. doi: 10.1002/ejhf.3353.
PubMed

REDDY YNV, Sundaram V
Towards more practical phenotyping in heart failure with preserved ejection fraction.
Eur J Heart Fail. 2024 Jun 26. doi: 10.1002/ejhf.3359.
PubMed

LASSEN MCH, Ostrominski JW, Claggett BL, Packer M, et al
Cardiovascular-kidney-metabolic overlap in heart failure with preserved ejection fraction: Cardiac structure and function, clinical outcomes, and response to sacubitril/valsartan in PARAGON-HF.
Eur J Heart Fail. 2024 Jun 26. doi: 10.1002/ejhf.3304.
PubMed Abstract available

VADUGANATHAN M, Cannon CP, Jardine MJ, Heerspink HJL, et al
Effects of canagliflozin on total heart failure events across the kidney function spectrum: Participant-level pooled analysis from the CANVAS Program and CREDENCE trial.
Eur J Heart Fail. 2024 Jun 26. doi: 10.1002/ejhf.3292.
PubMed Abstract available

KITZMAN DW, Lewis GD, Pandey A, Borlaug BA, et al
A novel controlled metabolic accelerator for the treatment of obesity-related heart failure with preserved ejection fraction: Rationale and design of the Phase 2a HuMAIN trial.
Eur J Heart Fail. 2024 Jun 26. doi: 10.1002/ejhf.3305.
PubMed Abstract available

Correction to "Iron deficiency in heart failure: Screening, prevalence, incidence and outcome data from the Swedish Heart Failure Registry and the Stockholm CREAtinine measurements collaborative project".
Eur J Heart Fail. 2024 Jun 23. doi: 10.1002/ejhf.3344.
PubMed

WUSSLER D, Belkin M, Shrestha S, Wernicke H, et al
Incremental value of C-reactive protein to the MEESSI acute heart failure risk score.
Eur J Heart Fail. 2024 Jun 23. doi: 10.1002/ejhf.3349.
PubMed Abstract available

COTTER G, Pagnesi M, Davison B
C-reactive protein, inflammation and short-term mortality in acute heart failure.
Eur J Heart Fail. 2024 Jun 23. doi: 10.1002/ejhf.3361.
PubMed

INCIARDI RM, Vaduganathan M, Lombardi CM, Gussago C, et al
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry.
Eur J Heart Fail. 2024 Jun 23. doi: 10.1002/ejhf.3260.
PubMed Abstract available

YANG M, Kondo T, Jhund PS, Alcocer-Gamba MA, et al
Geographical variation in patient characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction.
Eur J Heart Fail. 2024 Jun 23. doi: 10.1002/ejhf.3352.
PubMed Abstract available

MEERKIN D, Perl L, Hasin T, Petriashvili S, et al
Physician-directed patient self-management in heart failure using left atrial pressure: Interim insights from the VECTOR-HF I and IIa studies.
Eur J Heart Fail. 2024 Jun 20. doi: 10.1002/ejhf.3338.
PubMed Abstract available

BRUGTS JJ
Remote haemodynamic monitoring and the next step: Involving the patient in the self-management of heart failure.
Eur J Heart Fail. 2024 Jun 20. doi: 10.1002/ejhf.3355.
PubMed

SCHUPP T, Abel N, Schmidberger M, Hopfner MK, et al
Prevalence and prognosis of aortic valve diseases in patients hospitalized with heart failure with mildly reduced ejection fraction.
Eur J Heart Fail. 2024 Jun 19. doi: 10.1002/ejhf.3337.
PubMed Abstract available

SEFEROVIC PM, Paulus WJ, Rosano G, Polovina M, et al
Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases.
Eur J Heart Fail. 2024 Jun 19. doi: 10.1002/ejhf.3347.
PubMed Abstract available

ANGERMANN CE
Don't put too much weight on weight telemonitoring in high-risk heart failure patients!
Eur J Heart Fail. 2024 Jun 19. doi: 10.1002/ejhf.3346.
PubMed

NOUHRAVESH N, Garg J, Rockhold FW, De Pasquale CG, et al
Characterization of serum phosphate levels over time with intravenous ferric carboxymaltose versus placebo as treatment for heart failure with reduced ejection fraction and iron deficiency: An exploratory prospective substudy from HEART-FID.
Eur J Heart Fail. 2024 Jun 19. doi: 10.1002/ejhf.3348.
PubMed Abstract available

LAUFS U, Wachter R
Implementation of guideline-directed medical therapy for heart failure.
Eur J Heart Fail. 2024 Jun 19. doi: 10.1002/ejhf.3343.
PubMed

SIMONENKO M, Hansen D, Niebauer J, Volterrani M, et al
Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of
Eur J Heart Fail. 2024 Jun 19. doi: 10.1002/ejhf.3185.
PubMed Abstract available

VOORDES G, Davison B, Biegus J, Edwards C, et al
Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HF.
Eur J Heart Fail. 2024 Jun 14. doi: 10.1002/ejhf.3336.
PubMed Abstract available

CARRETE A, Codina P, Bayes-Genis A
Influence of temperature on haemodynamic changes in heart failure: A CardioMEMS pulmonary artery monitoring analysis.
Eur J Heart Fail. 2024 Jun 14. doi: 10.1002/ejhf.3331.
PubMed

PITT B, Rossignol P
When chronic kidney disease (CKD) intersects with heart failure: Insights and implications of the identification of KDIGO-defined CKD in 1.4 million U.S. Veterans with heart failure.
Eur J Heart Fail. 2024 Jun 10. doi: 10.1002/ejhf.3298.
PubMed

CHOI KH, Kang D, Park H, Park TK, et al
In-hospital and long-term outcomes of cardiogenic shock complicating myocardial infarction versus heart failure.
Eur J Heart Fail. 2024 Jun 10. doi: 10.1002/ejhf.3333.
PubMed Abstract available

ADAMOPOULOS S, Bonios M, Ben Gal T, Gustafsson F, et al
Right heart failure with left ventricular assist devices: Preoperative, perioperative and postoperative management strategies. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC.
Eur J Heart Fail. 2024 Jun 10. doi: 10.1002/ejhf.3323.
PubMed Abstract available

MONZO L, Kovar J, Borlaug BA, Benes J, et al
Circulating beta-hydroxybutyrate levels in advanced heart failure with reduced ejection fraction: Determinants and prognostic impact.
Eur J Heart Fail. 2024 Jun 10. doi: 10.1002/ejhf.3324.
PubMed Abstract available

ANKER SD, Friede T, von Bardeleben RS, Butler J, et al
Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials.
Eur J Heart Fail. 2024 Jun 7. doi: 10.1002/ejhf.3286.
PubMed Abstract available

NAITO A, Kagami K, Yuasa N, Harada T, et al
Prognostic utility of cardiopulmonary exercise testing with simultaneous exercise echocardiography in heart failure with preserved ejection fraction.
Eur J Heart Fail. 2024 Jun 6. doi: 10.1002/ejhf.3334.
PubMed Abstract available

HARADA T, Naser JA, Tada A, Doi S, et al
Cardiac function, haemodynamics, and valve competence with exercise in patients with heart failure with preserved ejection fraction and mild to moderate secondary mitral regurgitation.
Eur J Heart Fail. 2024 Jun 4. doi: 10.1002/ejhf.3322.
PubMed Abstract available

VON STEIN P, Iliadis C
EXPANDing horizons: Optimizing heart failure management following transcatheter edge-to-edge repair of mitral regurgitation.
Eur J Heart Fail. 2024 Jun 4. doi: 10.1002/ejhf.3327.
PubMed

PASCUAL-FIGAL D, Nunez Villota J, Perez-Martinez MT, Gonzalez-Juanatey JR, et al
Colchicine in acute heart failure: Rationale and design of a randomized double-blind placebo-controlled trial (COLICA).
Eur J Heart Fail. 2024 Jun 4. doi: 10.1002/ejhf.3300.
PubMed Abstract available

CANNATA A, Mizani MA, Bromage DI, Piper SE, et al
A nationwide, population-based study on specialized care for acute heart failure throughout the COVID-19 pandemic.
Eur J Heart Fail. 2024 Jun 4. doi: 10.1002/ejhf.3306.
PubMed Abstract available

ALLACH Y, Barry-Loncq de Jong M, Clephas PRD, van Gent MWF, et al
Serial cardiac biomarkers, pulmonary artery pressures and traditional parameters of fluid status in relation to prognosis in patients with chronic heart failure: Design and rationale of the BioMEMS study.
Eur J Heart Fail. 2024 Jun 2. doi: 10.1002/ejhf.3303.
PubMed Abstract available

AIMO A, Codina P, Lee MMY, Tomasoni D, et al
What's new in heart failure? May-June 2024.
Eur J Heart Fail. 2024;26:1273-1277.
PubMed

VELICKI L, Popovic D, Okwose NC, Preveden A, et al
Sacubitril/valsartan for the treatment of non-obstructive hypertrophic cardiomyopathy: An open label randomized controlled trial (SILICOFCM).
Eur J Heart Fail. 2024;26:1361-1368.
PubMed Abstract available

STRAW S, Flett A, Witte KK
Which patients with non-ischaemic cardiomyopathy should receive a defibrillator?
Eur J Heart Fail. 2024;26:1432-1434.
PubMed

DAMMAN K, Beldhuis IE, van der Meer P, Krikken JA, et al
Renal function and natriuresis-guided diuretic therapy - a pre-specified analysis from the PUSH-AHF trial.
Eur J Heart Fail. 2024;26:1347-1357.
PubMed Abstract available

GREENE SJ, Chambers R, Lerman JB, Harrington J, et al
Sacubitril/valsartan and cardiovascular biomarkers among patients with recent COVID-19 infection: The PARACOR-19 randomized clinical trial.
Eur J Heart Fail. 2024;26:1393-1398.
PubMed Abstract available

May 2024

CISNEROS-BARROSO E, Rossello X
Sodium-glucose cotransporter 2 inhibitors in acute and chronic coronary syndrome with and without heart failure.
Eur J Heart Fail. 2024 May 29. doi: 10.1002/ejhf.3321.
PubMed

PAGNESI M, Serafini L, Chiarito M, Stolfo D, et al
Impact of malnutrition in patients with severe heart failure.
Eur J Heart Fail. 2024 May 29. doi: 10.1002/ejhf.3285.
PubMed Abstract available

PABON MA, Vaduganathan M, Lam CSP
Is the optimal dose of heart failure medical therapy different in women and men?
Eur J Heart Fail. 2024 May 27. doi: 10.1002/ejhf.3320.
PubMed

LAM CSP, Kober L, Kuwahara K, Lund LH, et al
Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trial.
Eur J Heart Fail. 2024 May 23. doi: 10.1002/ejhf.3294.
PubMed Abstract available

ROSANO GMC, Stolfo D, Anderson L, Abdelhamid M, et al
Differences in presentation, diagnosis and management of heart failure in women. A scientific statement of the Heart Failure Association of the ESC.
Eur J Heart Fail. 2024 May 23. doi: 10.1002/ejhf.3284.
PubMed Abstract available

SAVARESE G, Lindberg F, Cannata A, Chioncel O, et al
How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESC.
Eur J Heart Fail. 2024 May 22. doi: 10.1002/ejhf.3295.
PubMed Abstract available

BUTLER J, Arshad MS, Khan MS
Role of anti-obesity drugs in heart failure regardless of ejection fraction.
Eur J Heart Fail. 2024 May 16. doi: 10.1002/ejhf.3224.
PubMed

PECK KH, Dulay MS, Hameed S, Rosano G, et al
Intentional weight loss in overweight and obese patients with heart failure: A systematic review.
Eur J Heart Fail. 2024 May 16. doi: 10.1002/ejhf.3270.
PubMed Abstract available

KITTIPIBUL V, Mentz RJ, Clare RM, Wojdyla DM, et al
On-treatment analysis of torsemide versus furosemide for patients hospitalized for heart failure: A post-hoc analysis of TRANSFORM-HF.
Eur J Heart Fail. 2024 May 15. doi: 10.1002/ejhf.3293.
PubMed Abstract available

LASSEN MCH, Ostrominski JW, Inzucchi SE, Claggett BL, et al
Effect of dapagliflozin in patients with diabetes and heart failure with mildly reduced or preserved ejection fraction according to background glucose-lowering therapy: A pre-specified analysis of the DELIVER trial.
Eur J Heart Fail. 2024 May 15. doi: 10.1002/ejhf.3269.
PubMed Abstract available

VADUGANATHAN M, Claggett BL, Lam CSP, Pitt B, et al
Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS-HF trial.
Eur J Heart Fail. 2024 May 14. doi: 10.1002/ejhf.3253.
PubMed Abstract available

VILLASCHI A, Chiarito M, Pagnesi M, Stolfo D, et al
Frailty according to the 2019 HFA-ESC definition in patients at risk for advanced heart failure: Insights from the HELP-HF registry.
Eur J Heart Fail. 2024 May 14. doi: 10.1002/ejhf.3234.
PubMed Abstract available

CURTAIN JP, Talebi A, McIntosh A, McConnachie A, et al
Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: CONGEST-HF.
Eur J Heart Fail. 2024 May 13. doi: 10.1002/ejhf.3290.
PubMed Abstract available

ESQUIVEL GAYTAN A, Bomer N, Grote Beverborg N, van der Meer P, et al
404-error "Disease not found": Unleashing the translational potential of -omics approaches beyond traditional disease classification in heart failure research.
Eur J Heart Fail. 2024 May 13. doi: 10.1002/ejhf.3268.
PubMed Abstract available

PANICHELLA G, Tomasoni D, Aimo A
Insulin-like growth factor binding protein-7 in heart failure: The challenge of moving from risk prediction to a biomarker-guided management.
Eur J Heart Fail. 2024 May 13. doi: 10.1002/ejhf.3287.
PubMed

RICCARDI M, Borlaug BA, Inciardi RM
Mitral regurgitation and heart failure with preserved ejection fraction: Should we treat the muscle, the valve, or both?
Eur J Heart Fail. 2024 May 13. doi: 10.1002/ejhf.3288.
PubMed

VERBRUGGE FH
Pushing the limits of natriuresis for poor kidneys in acute heart failure?
Eur J Heart Fail. 2024 May 13. doi: 10.1002/ejhf.3278.
PubMed

ASSMUS B, Sossalla S
What we claim to do and what we really do - a discrepancy in heart failure treatment.
Eur J Heart Fail. 2024 May 13. doi: 10.1002/ejhf.3279.
PubMed

MALGIE J, Wilde MI, Clephas PRD, Emans ME, et al
Contemporary guideline-directed medical therapy in de novo, chronic, and worsening heart failure patients: First data from the TITRATE-HF study.
Eur J Heart Fail. 2024 May 12. doi: 10.1002/ejhf.3267.
PubMed Abstract available

KARACAN MN, Doi SN, Yafasova A, Thune JJ, et al
New York Heart Association functional class and implantable cardioverter-defibrillator in non-ischaemic heart failure with reduced ejection fraction: Extended follow-up of the DANISH trial.
Eur J Heart Fail. 2024 May 11. doi: 10.1002/ejhf.3239.
PubMed Abstract available

SOLOMON SD, Ostrominski JW, Vaduganathan M, Claggett B, et al
Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial.
Eur J Heart Fail. 2024 May 11. doi: 10.1002/ejhf.3266.
PubMed Abstract available

PACKER M
Iron homeostasis, recycling and vulnerability in the stressed kidney: A neglected dimension of iron-deficient heart failure.
Eur J Heart Fail. 2024 May 10. doi: 10.1002/ejhf.3238.
PubMed Abstract available

PACKER M, Anker SD, Butler J, Cleland JGF, et al
Critical re-evaluation of the identification of iron deficiency states and effective iron repletion strategies in patients with chronic heart failure.
Eur J Heart Fail. 2024 May 10. doi: 10.1002/ejhf.3237.
PubMed Abstract available

ABDIN A, Kulenthiran S
Improvements in quality of heart failure randomized controlled trials: Progress and persisting challenges!
Eur J Heart Fail. 2024 May 10. doi: 10.1002/ejhf.3289.
PubMed

KESSLER M, Rottbauer W, von Bardeleben RS, Grasso C, et al
Impact of heart failure hospitalizations on clinical outcomes after mitral transcatheter edge-to-edge repair: Results from the EXPAND study.
Eur J Heart Fail. 2024 May 10. doi: 10.1002/ejhf.3250.
PubMed Abstract available

MEBAZAA A, Davison BA, Biegus J, Edwards C, et al
Reduced congestion and improved response to a fluid/sodium challenge in chronic heart failure patients after initiation of sacubitril/valsartan: The NATRIUM-HF study.
Eur J Heart Fail. 2024 May 9. doi: 10.1002/ejhf.3265.
PubMed Abstract available

SALAH HM, Fudim M
Guideline-directed medical therapy in patients with heart failure with preserved ejection fraction and polypharmacy: Do not be afraid.
Eur J Heart Fail. 2024 May 7. doi: 10.1002/ejhf.3283.
PubMed

WANG N, Rueter P, Ng M, Chandramohan S, et al
Echocardiographic predictors of cardiovascular outcome in heart failure with preserved ejection fraction.
Eur J Heart Fail. 2024 May 7. doi: 10.1002/ejhf.3271.
PubMed Abstract available

PANICHELLA G, Tomasoni D, Aimo A
Metabolomics to predict heart failure development: A new frontier?
Eur J Heart Fail. 2024 May 7. doi: 10.1002/ejhf.3281.
PubMed

Correction to "Sex differences in proteomic correlates of coronary microvascular dysfunction among patients with heart failure and preserved ejection fraction".
Eur J Heart Fail. 2024 May 7. doi: 10.1002/ejhf.3282.
PubMed

YANG M, Kondo T, Talebi A, Jhund PS, et al
Dapagliflozin and quality of life measured using the EuroQol 5-dimension questionnaire in patients with heart failure with reduced and mildly reduced/preserved ejection fraction.
Eur J Heart Fail. 2024 May 3. doi: 10.1002/ejhf.3263.
PubMed Abstract available

STOLZ L, Hausleiter J
Under pressure: Advances in device-based heart failure therapy for patients with preserved or mildly reduced ejection fraction.
Eur J Heart Fail. 2024 May 3. doi: 10.1002/ejhf.3277.
PubMed

ZAHIR ANJUM D, Strange JE, Fosbol E, Garred CH, et al
Use of medical therapy and risk of clinical events according to frailty in heart failure patients - A real-life cohort study.
Eur J Heart Fail. 2024 May 3. doi: 10.1002/ejhf.3249.
PubMed Abstract available

WOLSK E
Is it worth tying the knot? The lifelong commitment between heart failure patients and pulmonary artery pressure monitoring.
Eur J Heart Fail. 2024 May 3. doi: 10.1002/ejhf.3275.
PubMed

PATEL SS, Raman VK, Zhang S, Deedwania P, et al
Identification and outcomes of KDIGO-defined chronic kidney disease in 1.4 million U.S. Veterans with heart failure.
Eur J Heart Fail. 2024 May 3. doi: 10.1002/ejhf.3210.
PubMed Abstract available

FUJIMOTO Y, Matsue Y
Seeking ways to address non-cardiovascular death in patients with heart failure.
Eur J Heart Fail. 2024 May 2. doi: 10.1002/ejhf.3280.
PubMed

FERRARI A, Stolfo D, Uijl A, Orsini N, et al
Sex differences in the prognostic role of achieving target doses of heart failure medications: Data from the Swedish Heart Failure Registry.
Eur J Heart Fail. 2024 May 2. doi: 10.1002/ejhf.3272.
PubMed Abstract available

CAFORIO ALP, Giordani AS, Baritussio A, Marcolongo D, et al
Long-term efficacy and safety of tailored immunosuppressive therapy in immune-mediated biopsy-proven myocarditis: A propensity-weighted study.
Eur J Heart Fail. 2024;26:1175-1185.
PubMed Abstract available

MATSUMOTO S, Yang M, Shen L, Henderson A, et al
Effects of sacubitril/valsartan according to polypharmacy status in PARAGON-HF.
Eur J Heart Fail. 2024;26:1125-1138.
PubMed Abstract available

KOBAYASHI M, Ferreira JP, Duarte K, Bresso E, et al
Proteomic profiles of left atrial volume and its influence on response to spironolactone: Findings from the HOMAGE trial and STANISLAS cohort.
Eur J Heart Fail. 2024;26:1231-1241.
PubMed Abstract available

DELMAS C, Ughetto A, Lebreton G, Roubille F, et al
Venting strategies for extracorporeal membrane oxygenation patients: More questions than answers but a plea for more clinical trials on the topic!
Eur J Heart Fail. 2024;26:1261-1264.
PubMed

April 2024

LIN YC, Sung YH, Tsai CH
Letter regarding the article 'Use of natriuretic peptides and echocardiography for diagnosing heart failure'.
Eur J Heart Fail. 2024 Apr 30. doi: 10.1002/ejhf.3273.
PubMed

RAKISHEVA A, Sliwa K, Bauersachs J, Van Linthout S, et al
Multidisciplinary care of peripartum heart failure: A scientific statement of the Heart Failure Association of the ESC.
Eur J Heart Fail. 2024 Apr 28. doi: 10.1002/ejhf.3246.
PubMed Abstract available

ARMENTARO G, Cassano V, Condoleo V, Magurno M, et al
Association of sodium-glucose cotransporter 2 inhibitors with changes in comprehensive geriatric assessment in elderly diabetic patients with heart failure: Data from MAGIC-HF.
Eur J Heart Fail. 2024 Apr 28. doi: 10.1002/ejhf.3262.
PubMed

RAO VN, Kozaily E, Tedford RJ
Letting go of restraint: Tricuspid valve intervention in heart failure with preserved ejection fraction.
Eur J Heart Fail. 2024 Apr 28. doi: 10.1002/ejhf.3254.
PubMed

HALAVINA K, Bartko PE, Nitsche C
Obese or lean: Whom to prescribe sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction?
Eur J Heart Fail. 2024 Apr 28. doi: 10.1002/ejhf.3261.
PubMed

NUNEZ E, Santas E, Merenciano H, Lorenzo-Hernandez M, et al
Differential sex-related effect of left ventricular ejection fraction trajectory on the risk of mortality and heart failure readmission following hospitalization for acute heart failure: A longitudinal study.
Eur J Heart Fail. 2024 Apr 28. doi: 10.1002/ejhf.3252.
PubMed Abstract available

GORTER TM, Hoendermis ES, van Veldhuisen DJ
Interatrial shunting as a treatment for heart failure: Where do we stand?
Eur J Heart Fail. 2024 Apr 25. doi: 10.1002/ejhf.3251.
PubMed

GRASSI G, Dell'Oro R, Quarti-Trevano F
Baroreceptors as a target of device-based neuromodulation in heart failure: Long-term outcomes.
Eur J Heart Fail. 2024 Apr 25. doi: 10.1002/ejhf.3258.
PubMed

PAGNESI M, Adamo M, Metra M
Is it NICE to measure natriuretic peptides after a hospitalization for heart failure?
Eur J Heart Fail. 2024 Apr 23. doi: 10.1002/ejhf.3257.
PubMed

LIEN T, Srikanth K, Ambrosy AP
Follow the EMPULSE: In-hospital initiation of empagliflozin for heart failure across the spectrum of left ventricular ejection fraction.
Eur J Heart Fail. 2024 Apr 23. doi: 10.1002/ejhf.3256.
PubMed

ANKER SD, Friede T, von Bardeleben RS, Butler J, et al
Randomized investigation of the MitraClip device in heart failure: Design and rationale of the RESHAPE-HF2 trial design.
Eur J Heart Fail. 2024 Apr 23. doi: 10.1002/ejhf.3247.
PubMed Abstract available

AMERI P, Mercurio V, Pollesello P, Anker MS, et al
A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function.
Eur J Heart Fail. 2024 Apr 19. doi: 10.1002/ejhf.3236.
PubMed Abstract available

DHONT S, van den Acker G, van Loon T, Verbrugge FH, et al
Mitral regurgitation in heart failure with preserved ejection fraction: The interplay of valve, ventricle, and atrium.
Eur J Heart Fail. 2024 Apr 17. doi: 10.1002/ejhf.3231.
PubMed Abstract available

JALLOH MB, Bot VA, Borjaille CZ, Thabane L, et al
Reporting quality of heart failure randomized controlled trials 2000-2020: Temporal trends in adherence to CONSORT criteria.
Eur J Heart Fail. 2024 Apr 16. doi: 10.1002/ejhf.3229.
PubMed Abstract available

PORCARI A, Fontana M
The changing landscape of heart failure treatment in transthyretin amyloid cardiomyopathy: Is the time ripe for clinical use of sodium-glucose cotransporter 2 inhibitors?
Eur J Heart Fail. 2024 Apr 16. doi: 10.1002/ejhf.3245.
PubMed

OEXNER RR, Ahn H, Theofilatos K, Shah RA, et al
Serum metabolomics improves risk stratification for incident heart failure.
Eur J Heart Fail. 2024 Apr 16. doi: 10.1002/ejhf.3226.
PubMed Abstract available

MULLENS W, Damman K, Dhont S, Banerjee D, et al
Dietary sodium and fluid intake in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC.
Eur J Heart Fail. 2024 Apr 12. doi: 10.1002/ejhf.3244.
PubMed Abstract available

SETTERGREN C, Benson L, Shahim A, Dahlstrom U, et al
Cause-specific death in heart failure across the ejection fraction spectrum: A comprehensive assessment of over 100 000 patients in the Swedish Heart Failure Registry.
Eur J Heart Fail. 2024 Apr 12. doi: 10.1002/ejhf.3230.
PubMed Abstract available

HEIDECKER B, Pagnesi M, Luscher TF
Heart failure and respiratory tract infection: Cause and consequence of acute decompensation?
Eur J Heart Fail. 2024 Apr 12. doi: 10.1002/ejhf.3209.
PubMed

LI J, Chen Y, Wang Y, Liu X, et al
Impact of guideline-directed medical therapy on systolic blood pressure and cardiovascular outcomes in patients with heart failure and low blood pressure: A systematic review and meta-analysis.
Eur J Heart Fail. 2024 Apr 12. doi: 10.1002/ejhf.3208.
PubMed Abstract available

ZILE MR, Lindenfeld J, Weaver FA, Zannad F, et al
Baroreflex activation therapy in patients with heart failure and a reduced ejection fraction: Long-term outcomes.
Eur J Heart Fail. 2024 Apr 12. doi: 10.1002/ejhf.3232.
PubMed Abstract available

PASCUAL-FIGAL DA, Hernandez-Vicente A, Pastor-Perez F, Martinez-Selles M, et al
N-terminal pro-B-type natriuretic peptide post-discharge monitoring in the management of patients with heart failure and preserved ejection fraction - a randomized trial: The NICE study.
Eur J Heart Fail. 2024 Apr 12. doi: 10.1002/ejhf.3222.
PubMed Abstract available

BEAVERS CJ, Bhatt DL, Gotter G
Reply to 'The pharmacist ally in heart failure: Useful when involved'.
Eur J Heart Fail. 2024 Apr 12. doi: 10.1002/ejhf.3242.
PubMed

UREY MA, Hibbert B, Jorde U, Eckman P, et al
Left atrial to coronary sinus shunting for treatment of heart failure with mildly reduced or preserved ejection fraction: The ALT FLOW Early Feasibility Study 1-year results.
Eur J Heart Fail. 2024 Apr 12. doi: 10.1002/ejhf.3241.
PubMed Abstract available

FERREIRA JP, Packer M, Sattar N, Butler J, et al
Insulin-like growth factor binding protein-7 concentrations in chronic heart failure: Results from the EMPEROR programme.
Eur J Heart Fail. 2024 Apr 8. doi: 10.1002/ejhf.3227.
PubMed Abstract available

BHATT AS, Vaduganathan M, Jena BP, Suminska S, et al
Comparative effectiveness of sacubitril/valsartan versus angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients with de novo heart failure with mildly reduced and preserved ejection fraction.
Eur J Heart Fail. 2024 Apr 7. doi: 10.1002/ejhf.3233.
PubMed

LENSELINK C, Ricken KWLM, Groot HE, de Bruijne TJ, et al
Incidence and predictors of heart failure with reduced and preserved ejection fraction after ST-elevation myocardial infarction in the contemporary era of early percutaneous coronary intervention.
Eur J Heart Fail. 2024 Apr 4. doi: 10.1002/ejhf.3225.
PubMed Abstract available

TROMP J, Kosiborod MN, Angermann CE, Collins SP, et al
Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction - Results from the EMPULSE trial.
Eur J Heart Fail. 2024 Apr 4. doi: 10.1002/ejhf.3218.
PubMed Abstract available

MORILLAS H, Nunez J, Moliner P
Circulating levels of carbohydrate antigen 125 in chronic heart failure: Useful or futile?
Eur J Heart Fail. 2024 Apr 1. doi: 10.1002/ejhf.3212.
PubMed

RODES-CABAU J, Lindenfeld J, Abraham WT, Zile MR, et al
Interatrial shunt therapy in advanced heart failure: Outcomes from the open-label cohort of the RELIEVE-HF trial.
Eur J Heart Fail. 2024 Apr 1. doi: 10.1002/ejhf.3215.
PubMed Abstract available

MOKRI H, Clephas PRD, de Boer RA, van Baal P, et al
Cost-effectiveness of remote haemodynamic monitoring by an implantable pulmonary artery pressure monitoring sensor (CardioMEMS-HF system) in chronic heart failure in the Netherlands.
Eur J Heart Fail. 2024 Apr 1. doi: 10.1002/ejhf.3213.
PubMed Abstract available

MARTENS P, Greene SJ, Mentz RJ, Li S, et al
Impact of baseline kidney dysfunction on oral diuretic efficacy following hospitalization for heart failure - insights from TRANSFORM-HF.
Eur J Heart Fail. 2024 Apr 1. doi: 10.1002/ejhf.3207.
PubMed Abstract available

HFA Winter Research Meeting on Translational Heart Failure 2024 In collaboration with the ESC Working Group on Myocardial Function, 11 - 14 May 2024, Lisbon & Online.
Eur J Heart Fail. 2024;26 Suppl 1:3-16.
PubMed

PATEL N, Yeboah J
Multimorbidity in the era of increasing life expectancy and aging population.
Eur J Heart Fail. 2024;26:869-870.
PubMed

ROMMEL KP, Bonnet G, Fortmeier V, Stolz L, et al
Congestion patterns in severe tricuspid regurgitation and transcatheter treatment: Insights from a multicentre registry.
Eur J Heart Fail. 2024;26:1004-1014.
PubMed Abstract available

COATS AJS
Sodium-glucose cotransporter 2 inhibitors and skeletal muscle.
Eur J Heart Fail. 2024;26:936-937.
PubMed

D'AMARIO D, Laborante R, Santangeli P
Comorbidities and cardiac resynchronization therapy: Do we talk the talk or should we walk the walk?
Eur J Heart Fail. 2024;26:1047-1050.
PubMed

SATTAR N, Butler J, Lee MMY, Harrington J, et al
Body mass index and cardiorenal outcomes in the EMPEROR-Preserved trial: Principal findings and meta-analysis with the DELIVER trial.
Eur J Heart Fail. 2024;26:900-909.
PubMed Abstract available

KERAMIDA K, Yang EH, Deswal A
Moving theory and reality closer together in cardio-oncology training.
Eur J Heart Fail. 2024;26:772-775.
PubMed

TANAKA T, Sugiura A, Kavsur R, Ozturk C, et al
Changes in right ventricular function and clinical outcomes following tricuspid transcatheter edge-to-edge repair.
Eur J Heart Fail. 2024;26:1015-1024.
PubMed Abstract available

RASTOGI T, Ferreira JP, Butler J, Kraus BJ, et al
Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Preserved.
Eur J Heart Fail. 2024;26:885-896.
PubMed Abstract available

FUDIM M, Dalgaard F, Friedman DJ, Abraham WT, et al
Comorbidities and clinical response to cardiac resynchronization therapy: Patient-level meta-analysis from eight clinical trials.
Eur J Heart Fail. 2024;26:1039-1046.
PubMed Abstract available

March 2024

RAO VS, Ivey-Miranda JB, Cox ZL, Moreno-Villagomez J, et al
Serial direct sodium removal in patients with heart failure and diuretic resistance.
Eur J Heart Fail. 2024 Mar 31. doi: 10.1002/ejhf.3196.
PubMed Abstract available

DONAL E, Gegout L, Lee KC
More than just a clinical syndrome: Biomarkers and echocardiography should be rapidly advised for anyone with suspected heart failure!
Eur J Heart Fail. 2024 Mar 27. doi: 10.1002/ejhf.3201.
PubMed

LIM J, Hashemian M, Blechter B, Roger VL, et al
Pre-diagnostic free androgen and estradiol levels influence heart failure risk in both women and men: A prospective cohort study in the UK Biobank.
Eur J Heart Fail. 2024 Mar 25. doi: 10.1002/ejhf.3189.
PubMed Abstract available

DEHARO F, Grapsa J
Global longitudinal strain as a predictor of risk in patients with heart failure with preserved ejection fraction: A deserved role?
Eur J Heart Fail. 2024 Mar 25. doi: 10.1002/ejhf.3211.
PubMed

VAN DER LINDEN L, Karapinar-Carkit F, Forsyth P
The pharmacist ally in heart failure: Useful when involved. Letter regarding the article 'Effective medications can work only in patients who take them: Implications for post-acute heart failure care'.
Eur J Heart Fail. 2024 Mar 25. doi: 10.1002/ejhf.3217.
PubMed

SAVARESE G, Lindberg F, Christodorescu RM, Ferrini M, et al
Physician perceptions, attitudes, and strategies towards implementing guideline-directed medical therapy in heart failure with reduced ejection fraction. A survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology Practice.
Eur J Heart Fail. 2024 Mar 22. doi: 10.1002/ejhf.3214.
PubMed Abstract available

DAVIS JA, Booth D, McEwan P, Solomon SD, et al
Cost-effectiveness of dapagliflozin for patients with heart failure across the spectrum of ejection fraction: A pooled analysis of DAPA-HF and DELIVER data.
Eur J Heart Fail. 2024 Mar 20. doi: 10.1002/ejhf.3197.
PubMed Abstract available

VANHENTENRIJK S, Tang WHW
Renal perturbations with sodium-glucose cotransporter 2 inhibitor in heart failure with preserved ejection fraction.
Eur J Heart Fail. 2024 Mar 19. doi: 10.1002/ejhf.3205.
PubMed

PANICHELLA G, Tomasoni D, Aimo A
Dissecting the heart failure phenotype through phenomics.
Eur J Heart Fail. 2024 Mar 19. doi: 10.1002/ejhf.3204.
PubMed

PEIKERT A, Vaduganathan M, Claggett BL, Kulac IJ, et al
Dapagliflozin in patients with heart failure and previous myocardial infarction: A participant-level pooled analysis of DAPA-HF and DELIVER.
Eur J Heart Fail. 2024 Mar 15. doi: 10.1002/ejhf.3184.
PubMed Abstract available

WOOD N, Straw S, Cheng CW, Hirata Y, et al
Sodium-glucose cotransporter 2 inhibitors influence skeletal muscle pathology in patients with heart failure and reduced ejection fraction.
Eur J Heart Fail. 2024 Mar 11. doi: 10.1002/ejhf.3192.
PubMed Abstract available

COX ZL, Testani JM
The salt paradox in heart failure.
Eur J Heart Fail. 2024 Mar 11. doi: 10.1002/ejhf.3194.
PubMed

KRESOJA KP, Rosch S, Schober AR, Fengler K, et al
Implications of tricuspid regurgitation and right ventricular volume overload in patients with heart failure with preserved ejection fraction.
Eur J Heart Fail. 2024 Mar 11. doi: 10.1002/ejhf.3195.
PubMed Abstract available

EZEKOWITZ J, Alemayehu W, Edelmann F, Ponikowski P, et al
Diuretic use and outcomes in patients with heart failure with reduced ejection fraction: Insights from the VICTORIA trial.
Eur J Heart Fail. 2024 Mar 7. doi: 10.1002/ejhf.3179.
PubMed Abstract available

ROUBILLE F, Mercier G, Lancman G, Pasche H, et al
Weight telemonitoring of heart failure versus standard of care in a real-world setting: Results on mortality and hospitalizations in a 6-month nationwide matched cohort study.
Eur J Heart Fail. 2024 Mar 7. doi: 10.1002/ejhf.3191.
PubMed Abstract available

PAGNESI M, Vilamajo OAG, Meirino A, Dumont CA, et al
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trial.
Eur J Heart Fail. 2024 Mar 5. doi: 10.1002/ejhf.3174.
PubMed Abstract available

BUTLER J, Mentz RJ, Hernandez AF
Iron replacement therapy in heart failure: Contextualizing the results of the HEART-FID trial.
Eur J Heart Fail. 2024 Mar 4. doi: 10.1002/ejhf.3193.
PubMed

TUBBEN A, Tingen HSA, Prakken NHJ, van Empel VPM, et al
Prevalence of wild-type transthyretin amyloidosis in a prospective heart failure cohort with preserved and mildly reduced ejection fraction: Results of the Amylo-VIP-HF study.
Eur J Heart Fail. 2024 Mar 4. doi: 10.1002/ejhf.3186.
PubMed

FERREIRA JP, Zannad F, Packer M, Filippatos G, et al
Empagliflozin and risk of lower respiratory tract infection in heart failure with mildly reduced and preserved ejection fraction: An EMPEROR-Preserved analysis.
Eur J Heart Fail. 2024 Mar 4. doi: 10.1002/ejhf.3180.
PubMed Abstract available

FERREIRA JP, Packer M, Sattar N, Butler J, et al
Carbohydrate antigen 125 concentrations across the ejection fraction spectrum in chronic heart failure: The EMPEROR programme.
Eur J Heart Fail. 2024 Mar 4. doi: 10.1002/ejhf.3166.
PubMed Abstract available

RICHARDS AM, Wang P, Wong LL
'Micro'-managing heart failure: Restoring that which was lost in translation.
Eur J Heart Fail. 2024 Mar 4. doi: 10.1002/ejhf.3188.
PubMed

CHUNAWALA ZS, Keshvani N, Segar MW, Patel KV, et al
Association of diabetes-specific heart failure risk score with presence of subclinical cardiomyopathy among individuals with diabetes: A prospective study.
Eur J Heart Fail. 2024 Mar 4. doi: 10.1002/ejhf.3176.
PubMed

BAUERSACHS J, Solomon SD, Anker SD, Antorrena-Miranda I, et al
Efficacy and safety of CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: Rationale and design of the HF-REVERT trial.
Eur J Heart Fail. 2024;26:674-682.
PubMed Abstract available

February 2024

SEGAR MW, Nair A, Pandey A
An exercise enigma: Unravelling the complexity of exercise intolerance in heart failure with preserved ejection fraction.
Eur J Heart Fail. 2024 Feb 27. doi: 10.1002/ejhf.3170.
PubMed

D'ALTO M, Di Maio M, Argiento P, Romeo E, et al
Right heart failure as a cause of pulmonary congestion in pulmonary arterial hypertension.
Eur J Heart Fail. 2024 Feb 26. doi: 10.1002/ejhf.3172.
PubMed Abstract available

PITT B, Iyer SPN, Humes HD
New opportunity for targeting systemic inflammation in patients with heart failure through leucocyte immunomodulation.
Eur J Heart Fail. 2024 Feb 23. doi: 10.1002/ejhf.3177.
PubMed

Correction to 'Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology'.
Eur J Heart Fail. 2024 Feb 20. doi: 10.1002/ejhf.3171.
PubMed

PELLICORI P, Felker GM, Cleland JGF
Reply to 'Vasodilators in congestive heart failure: The perfect weapon aiming just off the target?'.
Eur J Heart Fail. 2024 Feb 20. doi: 10.1002/ejhf.3159.
PubMed

TALHA KM, Januzzi JL Jr, Meng T, Greene SJ, et al
Use of natriuretic peptides and echocardiography for diagnosing heart failure.
Eur J Heart Fail. 2024 Feb 20. doi: 10.1002/ejhf.3165.
PubMed Abstract available

MINAMISAWA M, Inciardi RM, Claggett B, Cikes M, et al
Clinical implications of subclinical left ventricular dysfunction in heart failure with preserved ejection fraction: The PARAGON-HF study.
Eur J Heart Fail. 2024 Feb 18. doi: 10.1002/ejhf.3167.
PubMed Abstract available

KOK WE
Unravelling the gut hypothesis of heart failure with gut microbiota-derived metabolites.
Eur J Heart Fail. 2024 Feb 15. doi: 10.1002/ejhf.3164.
PubMed

MIN KH, Jackson SA, Ambrosy AP
A PACT for the future: Improving medication adherence in heart failure.
Eur J Heart Fail. 2024 Feb 12. doi: 10.1002/ejhf.3169.
PubMed

ZHAO Y, Sun J, Xie C
The gap between real-world and guidelines in the use of sodium-glucose cotransporter 2 inhibitors for heart failure patients with reduced ejection fraction: Is it underestimated or overestimated? Letter regarding the article 'Real-world use of sodium-
Eur J Heart Fail. 2024 Feb 8. doi: 10.1002/ejhf.3163.
PubMed

BO W, Cheng X
High blood pressure for heart failure patients: Where do the benefits come from? Letter regarding the article 'Blood pressure levels and adverse cardiovascular outcomes in heart failure: A systematic review and meta-analysis'.
Eur J Heart Fail. 2024 Feb 4. doi: 10.1002/ejhf.3161.
PubMed

VAN ESSEN BJ, Tharshana GN, Ouwerkerk W, Yeo PSD, et al
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: A phenomics approach.
Eur J Heart Fail. 2024 Feb 4. doi: 10.1002/ejhf.3156.
PubMed Abstract available

AVERBUCH T, Lee SF, Zagorski B, Mebazaa A, et al
Effect of a transitional care model following hospitalization for heart failure: 3-year outcomes of the Patient-Centered Care Transitions in Heart Failure (PACT-HF) randomized controlled trial.
Eur J Heart Fail. 2024 Feb 1. doi: 10.1002/ejhf.3134.
PubMed Abstract available

RICCARDI M, Pagnesi M, Chioncel O, Mebazaa A, et al
Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors.
Eur J Heart Fail. 2024;26:411-431.
PubMed Abstract available

SUBRAMANIAN V, Keshvani N, Segar MW, Kondamudi NJ, et al
Association of global longitudinal strain by feature tracking cardiac magnetic resonance imaging with adverse outcomes among community-dwelling adults without cardiovascular disease: The Dallas Heart Study.
Eur J Heart Fail. 2024;26:208-215.
PubMed Abstract available

GARCIA-PAVIA P, Grogan M, Kale P, Berk JL, et al
Impact of vutrisiran on exploratory cardiac parameters in hereditary transthyretin-mediated amyloidosis with polyneuropathy.
Eur J Heart Fail. 2024;26:397-410.
PubMed Abstract available

KRESOJA KP
Exercise haemodynamics in post-Fontan patients: Diastolic dysfunction, again and again?
Eur J Heart Fail. 2024;26:324-326.
PubMed

MAEDER MT
Natriuretic peptides - Biomarker companions through thick and thin.
Eur J Heart Fail. 2024;26:270-273.
PubMed

MONDA E, Limongelli G
Expanding the knowledge on transthyretin p.V142I variant-related cardiomyopathy.
Eur J Heart Fail. 2024;26:394-396.
PubMed

SCISCIOLA L, Paolisso P, Belmonte M, Gallinoro E, et al
Myocardial sodium-glucose cotransporter 2 expression and cardiac remodelling in patients with severe aortic stenosis: The BIO-AS study.
Eur J Heart Fail. 2024;26:471-482.
PubMed Abstract available

COUGHLAN JJ, Rossello X
Anaemia in patients with cardiogenic shock complicating acute myocardial infarction: Surrogate marker of poor outcome or therapeutic target?
Eur J Heart Fail. 2024;26:458-459.
PubMed

MERKELY B, Kosztin A
De novo versus upgrade cardiac resynchronization therapy: A different patient population and outcome?
Eur J Heart Fail. 2024;26:521-522.
PubMed

MEEKERS E, Petit T, Dauw J, Gruwez H, et al
Analysing the accuracy of pressure measurements during exercise with pulmonary artery pressure sensors - Insights from the ACTION-MEMS study.
Eur J Heart Fail. 2024;26:523-524.
PubMed

MIRANDA WR, Jain CC, Borlaug BA, Connolly HM, et al
Exercise catheterization in adults post-Fontan with normal and abnormal haemodynamic criteria: Insights into normal Fontan physiology.
Eur J Heart Fail. 2024;26:314-323.
PubMed Abstract available

OBRADOVIC D, Loncar G, Zeymer U, Poss J, et al
Impact of anaemia and iron deficiency on outcomes in cardiogenic shock complicating acute myocardial infarction.
Eur J Heart Fail. 2024;26:448-457.
PubMed Abstract available

RAZVI Y, Ioannou A, Patel RK, Chacko L, et al
Deep phenotyping of p.(V142I)-associated variant transthyretin amyloid cardiomyopathy: Distinct from wild-type transthyretin amyloidosis?
Eur J Heart Fail. 2024;26:383-393.
PubMed Abstract available

TRENSON S, Voros G, Martens P, Ingelaere S, et al
Long-term outcome after upgrade to cardiac resynchronization therapy: A propensity score-matched analysis.
Eur J Heart Fail. 2024;26:511-520.
PubMed Abstract available

January 2024

SEGAR MW, Pandey A
Understanding the language of the heart: The promise of natural language processing to diagnose heart failure with preserved ejection fraction.
Eur J Heart Fail. 2024 Jan 31. doi: 10.1002/ejhf.3154.
PubMed

PARIKH PB, Mack M, Stone GW, Anker SD, et al
Transcatheter aortic valve replacement in heart failure.
Eur J Heart Fail. 2024 Jan 31. doi: 10.1002/ejhf.3151.
PubMed Abstract available

LIN GM, Lloyd-Jones DM, Colangelo LA, Lima JAC, et al
Association between secondhand smoke exposure and incident heart failure: The Multi-Ethnic Study of Atherosclerosis (MESA).
Eur J Heart Fail. 2024 Jan 30. doi: 10.1002/ejhf.3155.
PubMed Abstract available

KHAN MS, Fonarow GC, Greene SJ
Guideline-directed medical therapy for heart failure: The key ingredient for successful in-hospital and post-discharge care.
Eur J Heart Fail. 2024 Jan 30. doi: 10.1002/ejhf.3152.
PubMed

PELLICORI P, Cleland JGF
Atrial myopathy and heart failure with preserved ejection fraction: When a label does more harm than good?
Eur J Heart Fail. 2024 Jan 28. doi: 10.1002/ejhf.3148.
PubMed

HULLIN R
Advantage of uptitration of foundational heart failure drugs in heart failure with reduced ejection fraction and low blood pressure.
Eur J Heart Fail. 2024 Jan 25. doi: 10.1002/ejhf.3144.
PubMed

MULLENS W, Dauw J, Gustafsson F, Mebazaa A, et al
Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC).
Eur J Heart Fail. 2024 Jan 25. doi: 10.1002/ejhf.3150.
PubMed Abstract available

ABDIN A, Lauder L, Fudim M, Abraham WT, et al
Neuromodulation interventions in the management of heart failure.
Eur J Heart Fail. 2024 Jan 21. doi: 10.1002/ejhf.3147.
PubMed Abstract available

GONZALEZ-DEL-HOYO M, Rossello X
Worsening heart failure comes into focus, chronic heart failure takes a backseat.
Eur J Heart Fail. 2024 Jan 21. doi: 10.1002/ejhf.3143.
PubMed

DAUW J, Meekers E, Martens P, Deferm S, et al
Sodium loading in ambulatory patients with heart failure with reduced ejection fraction: Mechanistic insights into sodium handling.
Eur J Heart Fail. 2024 Jan 21. doi: 10.1002/ejhf.3131.
PubMed Abstract available

DE LA ESPRIELLA R, Ortiz A, Nunez J
The blood urea nitrogen to creatinine ratio in chronic heart failure: 'When the past is prologue'.
Eur J Heart Fail. 2024 Jan 18. doi: 10.1002/ejhf.3146.
PubMed

PITT B, Brown JM, Vaidya A, Diez J, et al
Reassessing the management of hypertension: Time to prevent aldosterone-mediated heart failure.
Eur J Heart Fail. 2024 Jan 18. doi: 10.1002/ejhf.3141.
PubMed

GREENE SJ, Khan MS, Butler J
Why do clinicians not prescribe quadruple medical therapy for heart failure with reduced ejection fraction?
Eur J Heart Fail. 2024 Jan 18. doi: 10.1002/ejhf.3133.
PubMed

USMAN MS, Januzzi JL, Anker SD, Salman A, et al
The effect of sodium-glucose cotransporter 2 inhibitors on left cardiac remodelling in heart failure with reduced ejection fraction: Systematic review and meta-analysis.
Eur J Heart Fail. 2024 Jan 18. doi: 10.1002/ejhf.3129.
PubMed Abstract available

BAYES-GENIS A, Aimo A
Reply to the letter regarding the article 'Head-to-head comparison between recommendations by the ESC and ACC/AHA/HFSA heart failure guidelines'.
Eur J Heart Fail. 2024 Jan 16. doi: 10.1002/ejhf.3142.
PubMed

SEIDU S, Lawson CA, Kunutsor SK, Khunti K, et al
Blood pressure levels and adverse cardiovascular outcomes in heart failure: A systematic review and meta-analysis.
Eur J Heart Fail. 2024 Jan 12. doi: 10.1002/ejhf.3108.
PubMed Abstract available

Correction to 'Congestion in heart failure: A circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association' and articles listed below.
Eur J Heart Fail. 2024 Jan 11. doi: 10.1002/ejhf.3123.
PubMed

DE BOER RA, Diez J
Advancing the fight against fibrosis in patients with heart failure: The contribution of sodium-glucose cotransporter 2 inhibition.
Eur J Heart Fail. 2024 Jan 9. doi: 10.1002/ejhf.3125.
PubMed

SAITO Y, Obokata M
Diagnostic and therapeutic implications of obesity in heart failure with preserved ejection fraction.
Eur J Heart Fail. 2024 Jan 8. doi: 10.1002/ejhf.3128.
PubMed

KALOGEROPOULOS AP, Jang KH, Hall ME
Predicting heart failure: The promise of proteomics.
Eur J Heart Fail. 2024 Jan 8. doi: 10.1002/ejhf.3126.
PubMed

MCDONAGH TA, Metra M, Adamo M, Gardner RS, et al
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ES
Eur J Heart Fail. 2024 Jan 3. doi: 10.1002/ejhf.3024.
PubMed Abstract available

KHAN MS, Sperry BW, Butler J
Kidney involvement in transthyretin cardiac amyloidosis - Role of urinary albumin to creatinine ratio and need for further evidence generation.
Eur J Heart Fail. 2024;26:74-76.
PubMed

BERTERO E, Chiti C, Schiavo MA, Tini G, et al
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population.
Eur J Heart Fail. 2024;26:59-64.
PubMed Abstract available

SEOUDY H, Voran JC, Frank D
Growth differentiation factor-15 in sodium-glucose cotransporter 2 inhibition: Mechanistic insights from the EMPEROR program.
Eur J Heart Fail. 2024;26:165-166.
PubMed

RIVAS GARCIA S, Alvarez-Garcia J
Sacubitril/valsartan: Where mechanism meets evidence-based medicine.
Eur J Heart Fail. 2024;26:127-129.
PubMed

FERREIRA JP, Rossello X, Zannad F
Mineralocorticoid receptor antagonist indication and underuse in high-risk post-myocardial infarction patients.
Eur J Heart Fail. 2024;26:140-141.
PubMed

ARDISSINO M, Halliday BP, de Marvao A
The global landscape of peripartum cardiomyopathy: Morbidity, mortality, recovery and inequity.
Eur J Heart Fail. 2024;26:43-45.
PubMed

IOANNOU A, Rauf MU, Patel RK, Razvi Y, et al
Albuminuria in transthyretin cardiac amyloidosis: Prevalence, progression and prognostic importance.
Eur J Heart Fail. 2024;26:65-73.
PubMed Abstract available

MERLO M, Setti M, Sinagra G
Coronary artery disease and dilated cardiomyopathy: Where parallel universes merge.
Eur J Heart Fail. 2024;26:56-58.
PubMed

SCHOU M, Claggett B, Miao ZM, Fernandez A, et al
Sacubitril/valsartan compared to ramipril in high-risk post-myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: Insight from the PARADISE MI trial.
Eur J Heart Fail. 2024;26:130-139.
PubMed Abstract available

MAEDA D, Matsue Y, Dotare T, Sunayama T, et al
Clinical characteristics and prognosis of patients with isolated cardiac sarcoidosis: Insights from the ILLUMINATE-CS study.
Eur J Heart Fail. 2024;26:77-86.
PubMed Abstract available

JACKSON AM, Bauersachs J, Petrie MC, van der Meer P, et al
Outcomes at one year in women with peripartum cardiomyopathy: Findings from the ESC EORP PPCM Registry.
Eur J Heart Fail. 2024;26:34-42.
PubMed Abstract available

JONES RE, Hammersley DJ, Zheng S, McGurk KA, et al
Assessing the association between genetic and phenotypic features of dilated cardiomyopathy and outcome in patients with coronary artery disease.
Eur J Heart Fail. 2024;26:46-55.
PubMed Abstract available

December 2023

LARSON K, Omar M, Sorimachi H, Omote K, et al
Impact of Clinical Phenogroup Diversity and Multiplicity: Impact on Mechanisms of Exercise Intolerance in Heart Failure with Preserved Ejection Fraction.
Eur J Heart Fail. 2023 Dec 29. doi: 10.1002/ejhf.3105.
PubMed Abstract available

WU J, Biswas D, Ryan M, Bernstein B, et al
Artificial Intelligence methods for Improved Detection of undiagnosed Heart Failure with Preserved Ejection Fraction (HFpEF).
Eur J Heart Fail. 2023 Dec 28. doi: 10.1002/ejhf.3115.
PubMed Abstract available

KOKKINOS P, Faselis C, Pittaras A, Samuel IBH, et al
Cardiorespiratory Fitness and Risk of Heart Failure with Preserved Ejection Fraction.
Eur J Heart Fail. 2023 Dec 28. doi: 10.1002/ejhf.3117.
PubMed Abstract available

AMINI L, Kazmi S, Patel MJ
Letter Regarding the Article, "Head-to-Head Comparison Between Recommendations by the ESC and ACC/AHA/HFSA Heart Failure Guidelines"(1).
Eur J Heart Fail. 2023 Dec 28. doi: 10.1002/ejhf.3121.
PubMed

PATEL SM, Morrow DA, Bellavia A, Berg DD, et al
Natriuretic Peptides, Body Mass Index and Heart Failure Risk: Pooled Analyses of SAVOR-TIMI 53, DECLARE-TIMI 58 and CAMELLIA-TIMI 61.
Eur J Heart Fail. 2023 Dec 22. doi: 10.1002/ejhf.3118.
PubMed Abstract available

TOMASONI D, Vitale C, Guidetti F, Benson L, et al
The role of multimorbidity in patients with heart failure across the left ventricular ejection fraction spectrum: data from the Swedish Heart Failure Registry.
Eur J Heart Fail. 2023 Dec 22. doi: 10.1002/ejhf.3112.
PubMed Abstract available

ADAMO M, Chioncel O, Pagnesi M, Bayes-Genis A, et al
Epidemiology, Pathophysiology, Diagnosis and Management of Chronic Right-Sided Heart Failure and Tricuspid Regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular
Eur J Heart Fail. 2023 Dec 22. doi: 10.1002/ejhf.3106.
PubMed Abstract available

RANDHAWA VK, Baran DA
Unraveling Heart Failure Cardiogenic Shock Profiles and Pathways.
Eur J Heart Fail. 2023 Dec 20. doi: 10.1002/ejhf.3113.
PubMed

COTTER G, Davison BA, Adams KF Jr, Ambrosy AP, et al
Effective medications can work only in patients who take them: implications for post acute heart failure care.
Eur J Heart Fail. 2023 Dec 20. doi: 10.1002/ejhf.3109.
PubMed

TANG WHW, Nemet I, Li XS, Wu Y, et al
Prognostic Value of Gut Microbe-Generated Metabolite Phenylacetylglutamine in Patients with Heart Failure.
Eur J Heart Fail. 2023 Dec 20. doi: 10.1002/ejhf.3111.
PubMed Abstract available

TOLOMEO P, Butt JH, Kondo T, Campo G, et al
Independent prognostic importance of blood urea nitrogen (BUN) to creatinine ratio in heart failure.
Eur J Heart Fail. 2023 Dec 20. doi: 10.1002/ejhf.3114.
PubMed Abstract available

COLLINS NJ, Ngo DTM, Sverdlov AL
New cimlanod trial provides insights into mechanistic effects of vasodilators in heart failure.
Eur J Heart Fail. 2023 Dec 20. doi: 10.1002/ejhf.3110.
PubMed

BOCCHINO PP, Gallone G, Frea S, De Ferrari GM, et al
Vasodilators in congestive heart failure: The perfect weapon aiming just off the target?
Eur J Heart Fail. 2023 Dec 20. doi: 10.1002/ejhf.3122.
PubMed

DE LA ESPRIELLA R, Wahlberg KJ, Infeld M, Palau P, et al
Effect of paced heart rate on quality of life and natriuretic peptides for stage B or C heart failure with preserved ejection fraction: A secondary analysis of the myPACE trial.
Eur J Heart Fail. 2023 Dec 20. doi: 10.1002/ejhf.3107.
PubMed Abstract available

BAUDRY G, Pereira O, Duarte K, Ferreira JP, et al
Risk of readmission and death after hospitalization for worsening heart failure: Role of post-discharge follow-up visits in a real-world study from the Grand Est Region of France.
Eur J Heart Fail. 2023 Dec 7. doi: 10.1002/ejhf.3103.
PubMed Abstract available

OMOTE K, Sorimachi H, Obokata M, Verbrugge FH, et al
Biatrial Myopathy in Heart Failure with Preserved Ejection Fraction.
Eur J Heart Fail. 2023 Dec 7. doi: 10.1002/ejhf.3104.
PubMed Abstract available

FERREIRA JP, Butler J, Anker SD, Januzzi JL, et al
Effects of empaglifozin on collagen biomarkers in patients with Heart Failure. Findings from the EMPEROR trials.
Eur J Heart Fail. 2023 Dec 1. doi: 10.1002/ejhf.3101.
PubMed Abstract available

TOMASONI D, Adamo M, Metra M
December 2023 at a glance: Focus on medical therapy in chronic and acute heart failure.
Eur J Heart Fail. 2023;25:2099-2101.
PubMed

D'AMARIO D, Borovac JA, Patti G
A machine-learning-based prediction model in patients with takotsubo syndrome: 'You can't stop change any more than you can stop the suns from setting!'.
Eur J Heart Fail. 2023;25:2312-2315.
PubMed

CANNATA A, Bromage DI, McDonagh TA
When observation meets randomization: 'Don't let a crisis go to waste'.
Eur J Heart Fail. 2023;25:2189-2190.
PubMed

DELMAS C, Vandenbriele C, Pappalardo F, Roubille F, et al
What about current recommendations for extracorporeal life support in acute myocardial infarction-associated cardiogenic shock: Stay or go? or time to revise?
Eur J Heart Fail. 2023;25:2102-2104.
PubMed

RUSSO G, Badano LP, Adamo M, Alessandrini H, et al
Characteristics and outcomes of patients with atrial versus ventricular secondary tricuspid regurgitation undergoing tricuspid transcatheter edge-to-edge repair - Results from the TriValve registry.
Eur J Heart Fail. 2023;25:2243-2251.
PubMed Abstract available

POLOVINA M, Tschope C, Rosano G, Metra M, et al
Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies.
Eur J Heart Fail. 2023;25:2144-2163.
PubMed Abstract available

MARTYN T, Saef J, Khot UN, Martinez KA, et al
The utilization and impact of cardiovascular specialists on guideline-directed medical scores: An analysis of a diverse, multi-state, electronic health record-based registry.
Eur J Heart Fail. 2023;25:2333-2336.
PubMed

KOURANOS V, Khattar RS, Okafor J, Ahmed R, et al
Predictors of outcome in a contemporary cardiac sarcoidosis population: Role of brain natriuretic peptide, left ventricular function and myocardial inflammation.
Eur J Heart Fail. 2023;25:2287-2298.
PubMed Abstract available

DE FILIPPO O, Cammann VL, Pancotti C, Di Vece D, et al
Machine learning-based prediction of in-hospital death for patients with takotsubo syndrome: The InterTAK-ML model.
Eur J Heart Fail. 2023;25:2299-2311.
PubMed Abstract available

November 2023

PELLICORI P, Cleland JGF, Borentain M, Taubel J, et al
Impact of vasodilators on diuretic response in patients with congestive heart failure: a mechanistic trial of cimlanod (BMS-986231).
Eur J Heart Fail. 2023 Nov 21. doi: 10.1002/ejhf.3077.
PubMed Abstract available

LUND LH, Crespo-Leiro MG, Laroche C, Garcia-Pinilla JM, et al
Rationale and Design of the ESC Heart Failure III Registry - Implementation and Discovery.
Eur J Heart Fail. 2023 Nov 21. doi: 10.1002/ejhf.3087.
PubMed Abstract available

LITWIN SE, Komtebedde J, Seidler T, Borlaug BA, et al
Obesity in Heart Failure with Preserved Ejection Fraction: Insights from the REDUCE LAP-HF II Trial.
Eur J Heart Fail. 2023 Nov 21. doi: 10.1002/ejhf.3092.
PubMed Abstract available

FERREIRA JP, Packer M, Butler J, Filippatos G, et al
GDF-15 and the Effect of Empagliflozin in Heart Failure: Findings from the EMPEROR Program.
Eur J Heart Fail. 2023 Nov 14. doi: 10.1002/ejhf.3078.
PubMed Abstract available

RIDDELL CW, Chan C, McGrinder H, Earle NJ, et al
College-level reading is required to understand ChatGPT's answers to lay questions relating to heart failure.
Eur J Heart Fail. 2023 Nov 14. doi: 10.1002/ejhf.3083.
PubMed

BOBROWSKI D, Dorovenis A, Abdel-Qadir H, McNaughton CD, et al
Association of Neighborhood-Level Material Deprivation with Adverse Outcomes and Processes of Care Among Patients with Heart Failure in a Single-Payer Healthcare System: A Population-Based Cohort Study.
Eur J Heart Fail. 2023 Nov 13. doi: 10.1002/ejhf.3090.
PubMed Abstract available

PITT B, Zannad F
The Use Of Mineralocorticoid Receptor Antagonists For Patients With Heart Failure With A Reduced Ejection Fraction: A Time For Reassessment.
Eur J Heart Fail. 2023 Nov 13. doi: 10.1002/ejhf.3091.
PubMed

SUNDERMEYER J, Kellner C, Beer BN, Besch L, et al
Clinical presentation, shock severity and mortality in patients with de novo versus acute-on-chronic heart failure-related cardiogenic shock.
Eur J Heart Fail. 2023 Nov 8. doi: 10.1002/ejhf.3082.
PubMed Abstract available

MCDOWELL K, Adamson C, Jackson C, Campbell R, et al
Neuropeptide Y is elevated in heart failure and is an independent predictor of outcomes.
Eur J Heart Fail. 2023 Nov 8. doi: 10.1002/ejhf.3085.
PubMed Abstract available

EMILSSON V, Jonsson BG, Austin TR, Gudmundsdottir V, et al
Proteomic prediction of incident heart failure and its main subtypes.
Eur J Heart Fail. 2023 Nov 8. doi: 10.1002/ejhf.3086.
PubMed Abstract available

TOMASONI D, Pagnesi M, Colombo G, Chiarito M, et al
Guideline directed medical therapy in severe heart failure with reduced ejection fraction: an analysis from the HELP-HF Registry.
Eur J Heart Fail. 2023 Nov 7. doi: 10.1002/ejhf.3081.
PubMed Abstract available

MILLER RJ, Howlett JG
Un(b)locking Therapeutic Options: Potential for Calcium Channel Blockers in Heart Failure with non-Reduced LVEF.
Eur J Heart Fail. 2023 Nov 6. doi: 10.1002/ejhf.3080.
PubMed

TOMASONI D, Adamo M, Metra M
November 2023 at a glance: Focus on cardiogenic shock, post-discharge outcomes and cardiomyopathies.
Eur J Heart Fail. 2023;25:1887-1890.
PubMed

LOBEEK M, Rienstra M, Gorter TM
Epicardial adipose tissue and cardiac dysfunction: Progress in knowledge but questions remain.
Eur J Heart Fail. 2023;25:1944-1946.
PubMed

DELMAS C, Vandenbriele C, Pappalardo F
Persistent high mortality in acute myocardial infarction-associated cardiogenic shock despite early mechanical circulatory support: Need for stepwise and integrated approach of care.
Eur J Heart Fail. 2023;25:2034-2036.
PubMed

MOLLER JE, Kjaergaard J, Hassager C
Contemporary use of temporary mechanical circulatory support in infarct-related cardiogenic shock: Time to stop and reflect?
Eur J Heart Fail. 2023;25:2032-2033.
PubMed

VISHRAM-NIELSEN JKK, Gustafsson F
Watchful waiting for venting in venoarterial extracorporeal membrane oxygenation.
Eur J Heart Fail. 2023;25:2047-2049.
PubMed

HAMMERSLEY DJ, Jones RE, Owen R, Mach L, et al
Phenotype, outcomes and natural history of early-stage non-ischaemic cardiomyopathy.
Eur J Heart Fail. 2023;25:2050-2059.
PubMed Abstract available

BOGERD M, Ten Berg S, Peters EJ, Vlaar APJ, et al
Impella and venoarterial extracorporeal membrane oxygenation in cardiogenic shock complicating acute myocardial infarction.
Eur J Heart Fail. 2023;25:2021-2031.
PubMed Abstract available

CHIN JF, Aga YS, Abou Kamar S, Kroon D, et al
Association between epicardial adipose tissue and cardiac dysfunction in subjects with severe obesity.
Eur J Heart Fail. 2023;25:1936-1943.
PubMed Abstract available

PARK H, Yang JH, Ahn JM, Kang DY, et al
Early left atrial venting versus conventional treatment for left ventricular decompression during venoarterial extracorporeal membrane oxygenation support: The EVOLVE-ECMO randomized clinical trial.
Eur J Heart Fail. 2023;25:2037-2046.
PubMed Abstract available

SEFEROVIC PM, Polovina M, Rosano G, Bozkurt B, et al
State-of-the-art document on optimal contemporary management of cardiomyopathies.
Eur J Heart Fail. 2023;25:1899-1922.
PubMed Abstract available

October 2023

DOEHNER W, Bohm M, Boriani G, Christersson C, et al
Interaction of Heart Failure and Stroke: A clinical consensus statement of the ESC Council on Stroke, the Heart Failure Association (HFA) and the ESC Working Group on Thrombosis.
Eur J Heart Fail. 2023 Oct 31. doi: 10.1002/ejhf.3071.
PubMed Abstract available

TER MAATEN JM, Mebazaa A, Davison B, Edwards C, et al
Early changes in renal function during rapid uptitration of guideline directed medical therapy following an admission for acute heart failure.
Eur J Heart Fail. 2023 Oct 31. doi: 10.1002/ejhf.3074.
PubMed Abstract available

NESTEROV SV, Raty J, Nammas W, Maaniitty T, et al
The short-term effects of sacubitril/valsartan therapy on myocardial oxygen consumption and energetic efficiency of cardiac work in heart failure with reduced ejection fraction. A randomized controlled study.
Eur J Heart Fail. 2023 Oct 31. doi: 10.1002/ejhf.3072.
PubMed Abstract available

GIRERD N, Coiro S, Benson L, Savarese G, et al
Hypotension in heart failure is less harmful if associated with high or increasing doses of heart failure medication: Insights from the Swedish Heart Failure Registry.
Eur J Heart Fail. 2023 Oct 26. doi: 10.1002/ejhf.3066.
PubMed Abstract available

PACKER M
Qiliqiangxin: a Multifaceted Holistic Treatment for Heart Failure or a Pharmacological Probe for the Identification of Cardioprotective Mechanisms?
Eur J Heart Fail. 2023 Oct 25. doi: 10.1002/ejhf.3068.
PubMed Abstract available

WUSSLER D, Belkin M, Maeder MT, Walter J, et al
Comprehensive Vasodilation in Women with Acute Heart Failure: Novel Insights from the GALACTIC randomized controlled trial.
Eur J Heart Fail. 2023 Oct 23. doi: 10.1002/ejhf.3065.
PubMed Abstract available

MOLLOY CD, Long L, Mordi IR, Bridges C, et al
Exercise-based cardiac rehabilitation for adults with heart failure - 2023 Cochrane systematic review and meta-analysis.
Eur J Heart Fail. 2023 Oct 18. doi: 10.1002/ejhf.3046.
PubMed Abstract available

SAVARESE G, Butler J, Ponikowki P, Anker SD, et al
SGLT2 inhibitors on top of intravenous iron in patients with heart failure and iron deficiency: any incremental effect?
Eur J Heart Fail. 2023 Oct 17. doi: 10.1002/ejhf.3064.
PubMed

SHAHIM A, Shahim B, Lund LH
Reply by Shahim et al. to Letter "Aortic regurgitation for adverse cardiovascular events: really harmless or just hidden?" Regarding Article "Prevalence, Characteristics and Prognostic Impact of Aortic Valve Disease in Patients with Heart Failure and
Eur J Heart Fail. 2023 Oct 12. doi: 10.1002/ejhf.3062.
PubMed

PARK JJ, Jang SY, Adler E, Ahmad F, et al
A Machine Learning Derived Risk Score Predicts Mortality in East Asian Patients with Acute Heart Failure.
Eur J Heart Fail. 2023 Oct 12. doi: 10.1002/ejhf.3059.
PubMed

MORICI N, Pappalardo F
Heart Failure-Cardiogenic Shock: A Need for Time-Dependent Quality Indicators.
Eur J Heart Fail. 2023 Oct 12. doi: 10.1002/ejhf.3058.
PubMed

CASTAGNA F, Simitsis P, Mehra MR
Overcoming Vulnerability in Heart Failure: Transitional Tactical Toughness.
Eur J Heart Fail. 2023 Oct 12. doi: 10.1002/ejhf.3054.
PubMed

SHAKOOR A, Abou Kamar S, Malgie J, Kardys I, et al
The Different Risk of New-onset, Chronic, Worsening, and Advanced Heart Failure A Systematic Review and Meta-Regression Analysis.
Eur J Heart Fail. 2023 Oct 12. doi: 10.1002/ejhf.3048.
PubMed Abstract available

SCOTTI A, Slipczuk L, Latib A
Aortic stenosis and heart failure with preserved ejection fraction: A shared phenotypic puzzle.
Eur J Heart Fail. 2023 Oct 12. doi: 10.1002/ejhf.3050.
PubMed

GUIDETTI F, Lund LH, Benson L, Hage C, et al
Safety of Continuing Mineralocorticoid Receptor Antagonists Treatment in Patients with Heart Failure with Reduced Ejection Fraction and Severe Kidney Disease: Data from Swedish Heart Failure Registry.
Eur J Heart Fail. 2023 Oct 5. doi: 10.1002/ejhf.3049.
PubMed Abstract available

TUBBEN A, Nienhuis HLA, van der Meer P
Tafamidis in Patients with Severe Heart Failure Due to Transthyretin Amyloidosis Cardiomyopathy: Improved Long-term Survival.
Eur J Heart Fail. 2023 Oct 4. doi: 10.1002/ejhf.3053.
PubMed

PASCUAL-FIGAL D, Fuster JJ, Bayes-Genis A
Personalizing Anti-Inflammatory Therapy in Heart Failure: A New Way.
Eur J Heart Fail. 2023 Oct 4. doi: 10.1002/ejhf.3052.
PubMed

BIEGUS J, Ponikowski P
Striving for the "Perfect" Definition of Iron Deficiency in Heart Failure.
Eur J Heart Fail. 2023 Oct 4. doi: 10.1002/ejhf.3051.
PubMed

TOMASONI D, Adamo M, Metra M
October 2023 at a glance: From prevention to diagnosis, prognosis and treatment of acute decompensation and comorbidities.
Eur J Heart Fail. 2023;25:1719-1721.
PubMed

MARTENS P, Mullens W
Using combinational diuretics across the spectrum of renal function.
Eur J Heart Fail. 2023;25:1794-1796.
PubMed

BEER BN, Schrage B
REMIniscence of aldosterone's role in myocardial remodelling.
Eur J Heart Fail. 2023;25:1753-1754.
PubMed

REDDY YNV, Borlaug BA
Provocative testing in the evaluation of heart failure with preserved ejection fraction: Not all stresses are created equal.
Eur J Heart Fail. 2023;25:1781-1783.
PubMed

LEVI N, Hasin T
Myocardial injury related to SARS-CoV-2 mRNA vaccination: The plot thickens.
Eur J Heart Fail. 2023;25:1882-1883.
PubMed

VAN BERGEIJK KH, Voors AA, Wykrzykowska JJ
Prevalence and predictive value of fluid overload in patients with severe symptomatic aortic valve stenosis.
Eur J Heart Fail. 2023;25:1819-1821.
PubMed

ABBASI K, Ali P, Barbour V, Bibbins-Domingo K, et al
Reducing the risks of nuclear war-the role of health professionals.
Eur J Heart Fail. 2023;25:1722-1723.
PubMed

MONZO L, Huttin O, Ferreira JP, Lamiral Z, et al
Role of aldosterone in mid- and long-term left ventricular remodelling after acute myocardial infarction: The REMI study.
Eur J Heart Fail. 2023;25:1742-1752.
PubMed Abstract available

BUERGIN N, Lopez-Ayala P, Hirsiger JR, Mueller P, et al
Sex-specific differences in myocardial injury incidence after COVID-19 mRNA-1273 booster vaccination.
Eur J Heart Fail. 2023;25:1871-1881.
PubMed Abstract available

HALAVINA K, Koschutnik M, Dona C, Autherith M, et al
Quantitative fluid overload in severe aortic stenosis refines cardiac damage and associates with worse outcomes.
Eur J Heart Fail. 2023;25:1808-1818.
PubMed Abstract available

September 2023

BHATT AS, Kosiborod MN, Claggett BL, Miao ZM, et al
Impact of COVID-19 in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction Enrolled in the DELIVER Trial.
Eur J Heart Fail. 2023 Sep 28. doi: 10.1002/ejhf.3043.
PubMed Abstract available

SAITO Y, Obokata M
Reply to 'Phenotypic characterization of heart failure with preserved ejection fraction'.
Eur J Heart Fail. 2023 Sep 28. doi: 10.1002/ejhf.3040.
PubMed

HAGE C, Lund LH
Sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction and chronic obstructive pulmonary disease - No heterogeneity.
Eur J Heart Fail. 2023 Sep 28. doi: 10.1002/ejhf.3041.
PubMed

MATSUMOTO S, Kondo T, Yang M, Campbell RT, et al
Calcium channel blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction.
Eur J Heart Fail. 2023 Sep 28. doi: 10.1002/ejhf.3044.
PubMed Abstract available

ELLIOTT P, Gundapaneni B, Garcia-Pavia P
Reply to 'Effects of tafamidis on heart failure hospitalization: The tale of the dog that did not bark.
Eur J Heart Fail. 2023 Sep 28. doi: 10.1002/ejhf.3042.
PubMed

CHIONCEL O, Davison B, Adamo M, Antohi LE, et al
Noncardiac comorbidities and intensive up-titration of oral treatment in patients recently hospitalized for heart failure: insights from the STRONG-HF trial.
Eur J Heart Fail. 2023 Sep 20. doi: 10.1002/ejhf.3039.
PubMed Abstract available

BAYES-GENIS A, Doherty KF, Petrie MC, Januzzi JL, et al
Practical Algorithms for Early Diagnosis of Heart Failure and Heart Stress using NT-proBNP: A Clinical Consensus Statement from the Heart Failure Association of the ESC.
Eur J Heart Fail. 2023 Sep 15. doi: 10.1002/ejhf.3036.
PubMed Abstract available

FEUERSTEIN A, Schoenrath F, Belyavskiy E, Knierim J, et al
Supervised exercise training in patients with advanced heart failure and left ventricular assist device: a multicenter randomized controlled trial (Ex-VAD trial).
Eur J Heart Fail. 2023 Sep 13. doi: 10.1002/ejhf.3032.
PubMed Abstract available

AGOSTONI P, Pluchinotta FR, Salvioni E, Mapelli M, et al
Heart failure patients with improved ejection fraction: insights from the MECKI Score database.
Eur J Heart Fail. 2023 Sep 13. doi: 10.1002/ejhf.3031.
PubMed Abstract available

SEGAR MW, Keshvani N, Pandey A
From Prediction to Prevention: The Role of Heart Failure Risk Models.
Eur J Heart Fail. 2023 Sep 13. doi: 10.1002/ejhf.3034.
PubMed

AMERI P, Vaduganathan M
When and how? Two simple questions to determine cancer status and inform therapeutic decisions and trial design in heart failure.
Eur J Heart Fail. 2023 Sep 13. doi: 10.1002/ejhf.3035.
PubMed

BURGER PM, Savarese G, Tromp J, Adamson C, et al
Personalized lifetime prediction of survival and treatment benefit in patients with heart failure with reduced ejection fraction: the LIFE-HF model.
Eur J Heart Fail. 2023 Sep 10. doi: 10.1002/ejhf.3028.
PubMed Abstract available

SHERROD CF, Ikemura N, Spertus JA
Knowledge is Power, Can It Be Leveraged to Improve Heart Failure Care?
Eur J Heart Fail. 2023 Sep 6. doi: 10.1002/ejhf.3027.
PubMed

KALRA R
SGLT2 Inhibitors in Hospitalized Heart Failure Patients: No Time Like Now.
Eur J Heart Fail. 2023 Sep 4. doi: 10.1002/ejhf.3022.
PubMed

ABDIN A, Anker SD, Cowie MR, Filippatos GS, et al
Associations between baseline heart rate and blood pressure and time to events in heart failure with reduced ejection fraction patients: Data from the QUALIFY international registry.
Eur J Heart Fail. 2023 Sep 4. doi: 10.1002/ejhf.3023.
PubMed Abstract available

YOGASUNDARAM H, Zheng Y, Ly E, Ezekowitz J, et al
Relationship Between Baseline Electrocardiographic Measurements and Outcomes in Patients with High-Risk Heart Failure: Insights from the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial.
Eur J Heart Fail. 2023 Sep 1. doi: 10.1002/ejhf.3021.
PubMed Abstract available

HAGE C, Stahlberg M, Thorvaldsen T, Faxen UL, et al
Acyl ghrelin infusion increases circulating growth hormone in patients with heart failure and reduced ejection fraction.
Eur J Heart Fail. 2023 Sep 1. doi: 10.1002/ejhf.3019.
PubMed

DE BIASE N, Mazzola M, Del Punta L, Di Fiore V, et al
Haemodynamic and metabolic phenotyping of patients with aortic stenosis and preserved ejection fraction: a specific phenotype of heart failure with preserved ejection fraction?
Eur J Heart Fail. 2023 Sep 1. doi: 10.1002/ejhf.3018.
PubMed Abstract available

TOMASONI D, Adamo M, Metra M
September 2023 at a glance: focus on acute heart failure and health status.
Eur J Heart Fail. 2023;25:1473-1476.
PubMed

HARRINGTON J, Udell JA, Jones WS, Anker SD, et al
Baseline characteristics of patients enrolled in the EMPACT-MI trial.
Eur J Heart Fail. 2023;25:1708-1715.
PubMed Abstract available

YANG M, Kondo T, Adamson C, Butt JH, et al
Impact of comorbidities on health status measured using the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with reduced and preserved ejection fraction.
Eur J Heart Fail. 2023;25:1606-1618.
PubMed Abstract available

ANKER MS, Potthoff SK, Lena A, Porthun J, et al
Cardiovascular health-related quality of life in cancer: a prospective study comparing the ESC HeartQoL and EORTC QLQ-C30 questionnaire.
Eur J Heart Fail. 2023;25:1635-1647.
PubMed Abstract available

August 2023

PAPADOPOULOU C, Reinhold J, Gruner-Hegge N, Kydd A, et al
Prognostic value of three iron deficiency definitions in patients with advanced heart failure.
Eur J Heart Fail. 2023 Aug 27. doi: 10.1002/ejhf.2949.
PubMed Abstract available

ZHU Q, Wang S
Aortic regurgitation for adverse cardiovascular events: Really harmless or just hidden? Letter regarding the article 'Prevalence, characteristics and prognostic impact of aortic valve disease in patients with heart failure and reduced, mildly reduced,
Eur J Heart Fail. 2023 Aug 27. doi: 10.1002/ejhf.3016.
PubMed

SANDEEP B, Huang X, Xiao Z
Artificial intelligence in heart failure improving the efficiency or dependency on it? Letter regarding the article 'Artificial intelligence and heart failure: A state-of-the-art review'.
Eur J Heart Fail. 2023 Aug 27. doi: 10.1002/ejhf.3017.
PubMed

DONAL E, Neveu A, Fontes-Carvalho R
Global longitudinal strain: Ready for 'prime time' in heart failure characterization.
Eur J Heart Fail. 2023 Aug 27. doi: 10.1002/ejhf.3012.
PubMed

AIMO A, Vergaro G, Emdin M
Effects of tafamidis on heart failure hospitalization: the tale of the dog that did not bark.
Eur J Heart Fail. 2023 Aug 27. doi: 10.1002/ejhf.3015.
PubMed

FAUVEL C, Giraldo CIS, Barassa A, Shchendrygina A, et al
Differences between heart failure specialists and non-specialists regarding heart failure drug implementation and up-titration.
Eur J Heart Fail. 2023 Aug 27. doi: 10.1002/ejhf.3010.
PubMed

POLZL G, Altenberger J, Comin-Colet J, Delgado JF, et al
Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period: the multinational randomized LeoDOR trial.
Eur J Heart Fail. 2023 Aug 27. doi: 10.1002/ejhf.3006.
PubMed Abstract available

BUTT JH, Lu H, Kondo T, Bachus E, et al
Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: Insights from DELIVER.
Eur J Heart Fail. 2023 Aug 26. doi: 10.1002/ejhf.3000.
PubMed Abstract available

PABON M, Claggett BL, Wang X, Miao ZM, et al
Influence of background medical therapy on efficacy and safety of dapagliflozin in patients with heart failure with improved ejection fraction in the DELIVER trial.
Eur J Heart Fail. 2023 Aug 26. doi: 10.1002/ejhf.3001.
PubMed Abstract available

KESHVANI N, Shah S, Ayodele I, Chiswell K, et al
Sex differences in long-term outcomes following acute heart failure hospitalization: Findings from the Get With The Guidelines-Heart Failure registry.
Eur J Heart Fail. 2023 Aug 26. doi: 10.1002/ejhf.3003.
PubMed Abstract available

NANAYAKKARA S, Kaye DM
No Longer From Pillar to Post: The First Effective Step in Treating Heart Failure with Preserved Ejection Fraction.
Eur J Heart Fail. 2023 Aug 22. doi: 10.1002/ejhf.3007.
PubMed

BUCKLEY LF, Dorbala P, Claggett BL, Libby P, et al
Circulating Neutrophil-Related Proteins Associate with Incident Heart Failure and Cardiac Dysfunction: The ARIC Study.
Eur J Heart Fail. 2023 Aug 22. doi: 10.1002/ejhf.3008.
PubMed Abstract available

FATIMA K, Butler J, Fonarow GC
Residual Risk in Heart Failure and the Need for Simultaneous Implementation and Innovation.
Eur J Heart Fail. 2023 Aug 22. doi: 10.1002/ejhf.3005.
PubMed

RIPAMONTI CI, Chelazzi C
Is Palliative care in Heart Failure Patients Coming Up?
Eur J Heart Fail. 2023 Aug 22. doi: 10.1002/ejhf.3002.
PubMed

MOURA B, Aimo A, Al-Mohammad A, Keramida K, et al
Diagnosis and Management of Patients with Left Ventricular Hypertrophy: Role of Multimodality Cardiac Imaging. A Scientific Statement of the Heart Failure Association of the ESC.
Eur J Heart Fail. 2023 Aug 15. doi: 10.1002/ejhf.2997.
PubMed Abstract available

CHIONCEL O, Tomasoni D, Metra M
Addressing Comorbidities in Heart Failure: When Feeling Better and Living Longer Go in the Same Direction.
Eur J Heart Fail. 2023 Aug 15. doi: 10.1002/ejhf.2998.
PubMed

PIERCE JB, Butler J, Greene SJ
Implementation of SGLT2 Inhibitors for Heart Failure with Reduced Ejection Fraction: Where We Are Versus Where We Need To Be.
Eur J Heart Fail. 2023 Aug 15. doi: 10.1002/ejhf.2999.
PubMed

BRENNAN AC, Campbell RT, Lee MMY
Influenza vaccination: a simple, safe, and effective treatment for patients with ischaemic heart disease and heart failure.
Eur J Heart Fail. 2023 Aug 15. doi: 10.1002/ejhf.2993.
PubMed

KHAN MS, Arshad MS, Greene SJ, Van Spall HGC, et al
Artificial Intelligence and Heart Failure: A State-of-the-Art Review.
Eur J Heart Fail. 2023 Aug 10. doi: 10.1002/ejhf.2994.
PubMed Abstract available

JHA AK
Phenotypic characterization of heart failure with preserved ejection fraction.
Eur J Heart Fail. 2023 Aug 10. doi: 10.1002/ejhf.2996.
PubMed

VAZIR A, Kapelios CJ, Agaoglu E, Metra M, et al
Decongestion Strategies in patients presenting with acutely decompensated heart failure: a worldwide survey among physicians.
Eur J Heart Fail. 2023 Aug 10. doi: 10.1002/ejhf.2985.
PubMed Abstract available

WERNHART S, Goertz A, Hedderich J, Papathanasiou M, et al
Diastolic Exercise Stress Testing in Heart Failure with Preserved Ejection Fraction - The DEST HF study.
Eur J Heart Fail. 2023 Aug 10. doi: 10.1002/ejhf.2995.
PubMed Abstract available

MARQUES P, Matias P, Packer M, Vieira JT, et al
Erythropoietic response after intravenous iron in patients with heart failure and reduced ejection fraction with and without background treatment with sodium-glucose cotransporter 2 inhibitors.
Eur J Heart Fail. 2023 Aug 10. doi: 10.1002/ejhf.2992.
PubMed Abstract available

FERREIRA JP, Blatchford JP, Teerlink JR, Kosiborod MN, et al
Mineralocorticoid receptor antagonist use and the effects of empagliflozin on clinical outcomes in patients admitted for acute heart failure: findings from EMPULSE.
Eur J Heart Fail. 2023 Aug 4. doi: 10.1002/ejhf.2982.
PubMed Abstract available

TRULLAS JC, Morales-Rull JL, Casado J, Carrera-Izquierdo M, et al
Combining loop and thiazide diuretics for acute heart failure across the estimated glomerular filtration rate spectrum: a post-hoc analysis of the CLOROTIC trial.
Eur J Heart Fail. 2023 Aug 4. doi: 10.1002/ejhf.2988.
PubMed Abstract available

NOUHRAVESH N, Strange JE, Holt A, Tonnesen J, et al
Patient mortality following new-onset heart failure stratified by cancer type and status.
Eur J Heart Fail. 2023 Aug 3. doi: 10.1002/ejhf.2984.
PubMed Abstract available

PAGNESI M, Serafini L, Adamo M
Moving towards a comprehensive heart failure management beyond ejection fraction.
Eur J Heart Fail. 2023 Aug 2. doi: 10.1002/ejhf.2987.
PubMed

COHEN-SOLAL A, Logeart D
Exercise hypoxaemia in heart failure with preserved ejection fraction.
Eur J Heart Fail. 2023 Aug 2. doi: 10.1002/ejhf.2989.
PubMed

PACKER M
Foetal recapitulation of nutrient surplus signalling by O-GlcNAcylation and the failing heart.
Eur J Heart Fail. 2023;25:1199-1212.
PubMed Abstract available

CHATUR S, Ezekowitz JA
Give a nudge a shot: NUDGE-FLU bridging the cardiovascular quality chasm.
Eur J Heart Fail. 2023;25:1459-1463.
PubMed

MYHRE PL, Liu Y, Kulac IJ, Claggett BL, et al
Changes in mid-regional pro-adrenomedullin during treatment with sacubitril/valsartan.
Eur J Heart Fail. 2023;25:1396-1405.
PubMed Abstract available

MONDA E, Limongelli G
Thromboembolic events in peripartum cardiomyopathy: Current dilemmas and future perspectives.
Eur J Heart Fail. 2023;25:1467-1469.
PubMed

ROSSELLO X
Globalization does not lead to homogenization in randomized controlled trials: Impact on sample size estimation.
Eur J Heart Fail. 2023;25:1243-1245.
PubMed

MCDOWELL K, Campbell R, Simpson J, Cunningham JW, et al
Incremental prognostic value of biomarkers in PARADIGM-HF.
Eur J Heart Fail. 2023;25:1406-1414.
PubMed Abstract available

TROMP J, Jackson AM, Abdelhamid M, Fouad D, et al
Thromboembolic events in peripartum cardiomyopathy: Results from the ESC EORP PPCM registry.
Eur J Heart Fail. 2023;25:1464-1466.
PubMed

DHONT S, Martens P, Meekers E, Dauw J, et al
Sodium and potassium changes during decongestion with acetazolamide - A pre-specified analysis from the ADVOR trial.
Eur J Heart Fail. 2023;25:1310-1319.
PubMed Abstract available

BUTT JH, Claggett BL, Miao ZM, Jering KS, et al
Geographic differences in patients with acute myocardial infarction in the PARADISE-MI trial.
Eur J Heart Fail. 2023;25:1228-1242.
PubMed Abstract available

July 2023

BLUM M, Goldstein NE, Jaarsma T, Allen LA, et al
Palliative Care in Heart Failure Guidelines - A Comparison of the 2021 ESC and the 2022 AHA/ACC/HFSA Guidelines on Heart Failure.
Eur J Heart Fail. 2023 Jul 26. doi: 10.1002/ejhf.2981.
PubMed Abstract available

BIEGUS J, Fudim M, Salah HM, Heerspink HJL, et al
SGLT-2 inhibitors in heart failure: potential decongestive mechanisms and current clinical studies.
Eur J Heart Fail. 2023 Jul 21. doi: 10.1002/ejhf.2967.
PubMed

HILL L, Baruah R, Beattie JM, Bistola V, et al
Culture, ethnicity, and socio-economic status as determinants of the management of patients with advanced heart failure who need palliative care: A Clinical Consensus Statement from the Heart Failure Association (HFA) of the ESC, the ESC Patient Forum
Eur J Heart Fail. 2023 Jul 21. doi: 10.1002/ejhf.2973.
PubMed Abstract available

WARNER B, Bruhn EJ, Olson TP, Bissen TG, et al
Inspiratory Muscle Strength is Related to Exertional Dyspnea in Heart Failure with Preserved Ejection Fraction.
Eur J Heart Fail. 2023 Jul 21. doi: 10.1002/ejhf.2980.
PubMed

LUND LH, Lam CSP, Pizzato PE, Gabrielsen A, et al
Rationale and design of ENDEAVOR: a sequential phase 2b-3 randomized clinical trial to evaluate the effect of myeloperoxidase inhibition on symptoms and exercise capacity in heart failure with preserved or mildly reduced ejection fraction.
Eur J Heart Fail. 2023 Jul 20. doi: 10.1002/ejhf.2977.
PubMed Abstract available

HARRINGTON J, Butler J
Heart Failure after Myocardial Infarction: Glass Emptier Than Full.
Eur J Heart Fail. 2023 Jul 18. doi: 10.1002/ejhf.2961.
PubMed

BELDHUIS IE, Damman K, Pang PS, Greenberg B, et al
Mineralocorticoid receptor antagonist initiation during admission is associated with improved outcomes irrespective of ejection fraction in patients with acute heart failure.
Eur J Heart Fail. 2023 Jul 18. doi: 10.1002/ejhf.2975.
PubMed Abstract available

ELLIOTT P, Gundapaneni B, Sultan MB, Ines M, et al
Improved long-term survival with tafamidis treatment in patients with transthyretin amyloid cardiomyopathy and severe heart failure symptoms.
Eur J Heart Fail. 2023 Jul 11. doi: 10.1002/ejhf.2974.
PubMed Abstract available

STOLFO D, Lund LH, Benson L, Lindberg F, et al
Real-world use of sodium-glucose co-transporter 2 inhibitors in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure Registry.
Eur J Heart Fail. 2023 Jul 7. doi: 10.1002/ejhf.2971.
PubMed Abstract available

NADARAJAH R, Younsi T, Romer E, Raveendra K, et al
Prediction models for heart failure in the community: a systematic review and meta-analysis.
Eur J Heart Fail. 2023 Jul 5. doi: 10.1002/ejhf.2970.
PubMed Abstract available

PACKER M, Butler J
Similarities and Distinctions Between Acetazolamide and SGLT2 Inhibitors in Patients With Acute Heart Failure: Key Insights Into ADVOR and EMPULSE.
Eur J Heart Fail. 2023 Jul 5. doi: 10.1002/ejhf.2968.
PubMed Abstract available

PIESKE B, Armstrong PW
Reply to 'Vericiguat in heart failure with reduced ejection fraction: the right choice above all else?'.
Eur J Heart Fail. 2023 Jul 5. doi: 10.1002/ejhf.2964.
PubMed

VOORDES G, Damman K
Sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction: Treat the heart, cherish the kidney.
Eur J Heart Fail. 2023 Jul 5. doi: 10.1002/ejhf.2963.
PubMed

WU CK, Yang LT, Hung CL
Exercise left atrial compliance: One more tool in the heart failure with preserved ejection fraction assistance toolbox?
Eur J Heart Fail. 2023 Jul 5. doi: 10.1002/ejhf.2966.
PubMed

CHANG AJ, Bhatt AS, Ambrosy AP
Understanding Cardiohepatic Interactions in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
Eur J Heart Fail. 2023 Jul 4. doi: 10.1002/ejhf.2960.
PubMed

DOCHERTY KF, Jackson AM, Macartney M, Campbell RT, et al
Declining risk of heart failure hospitalization following first acute myocardial infarction in Scotland between 1991-2016.
Eur J Heart Fail. 2023 Jul 4. doi: 10.1002/ejhf.2965.
PubMed Abstract available

GUSTAFSON SE, Ambrosy AP, Bhatt AS
Special DELIVERy: Reducing High-Complexity Hospitalizations in Heart Failure.
Eur J Heart Fail. 2023 Jul 4. doi: 10.1002/ejhf.2958.
PubMed

OSKOUIE S, Michael F, Whitelaw S, Bozkurt B, et al
A Scoping Review of Heart Failure Transitional Care Quality Indicators and Outcomes for Use in Clinical Care and Research.
Eur J Heart Fail. 2023 Jul 4. doi: 10.1002/ejhf.2955.
PubMed Abstract available

BAYES-GENIS A, Lupon J, Codina P
Quality Over Quantity: Assessing the Need for Multiple Biomarkers in Predicting Heart Failure Outcomes.
Eur J Heart Fail. 2023 Jul 4. doi: 10.1002/ejhf.2956.
PubMed

Abstracts of the Heart Failure 2023 and the World Congress on Acute Heart Failure, 20 - 23 May 2023, Prague, Czechia.
Eur J Heart Fail. 2023;25 Suppl 2:3-457.
PubMed

TOMASONI D, Adamo M, Metra M
July 2023 at a glance: heart failure with preserved ejection fraction and comorbidities.
Eur J Heart Fail. 2023;25:925-928.
PubMed

GREUTMANN M, Tobler D, Engel R, Heg D, et al
Effect of phosphodiesterase-5 inhibition on SystEmic Right VEntricular size and function. A multicentre, double-blind, randomized, placebo-controlled trial: SERVE.
Eur J Heart Fail. 2023;25:1105-1114.
PubMed Abstract available

GOLDSMITH AJ, Jin M, Lucassen R, Duggan NM, et al
Comparison of pulmonary congestion severity using artificial intelligence-assisted scoring versus clinical experts: A secondary analysis of BLUSHED-AHF.
Eur J Heart Fail. 2023;25:1166-1169.
PubMed Abstract available

BHATT AS, Kosiborod MN, Vaduganathan M, Claggett BL, et al
Effect of dapagliflozin on health status and quality of life across the spectrum of ejection fraction: Participant-level pooled analysis from the DAPA-HF and DELIVER trials.
Eur J Heart Fail. 2023;25:981-988.
PubMed Abstract available

KHAN MS, Grayburn PA, Butler J
Cardiac reverse remodelling with vericiguat: Victory or no victory?
Eur J Heart Fail. 2023;25:1022-1024.
PubMed

June 2023

MONZO L, Girerd N, Duarte K, Ferreira JP, et al
Time to clinical benefit of eplerenone among patients with heart failure and reduced ejection fraction: a subgroups analysis from EMPHASIS-HF trial.
Eur J Heart Fail. 2023 Jun 27. doi: 10.1002/ejhf.2952.
PubMed Abstract available

MODIN D, Lassen MCH, Claggett B, Johansen ND, et al
Influenza vaccination and cardiovascular events in patients with ischaemic heart disease and heart failure: A meta-analysis.
Eur J Heart Fail. 2023 Jun 27. doi: 10.1002/ejhf.2945.
PubMed Abstract available

JOURY A
Optimizing Heart Rate with Ivabradine in Heart Failure with Reduced Ejection Fraction: Insights from a Post-hoc Analysis of SHIFT Trial.
Eur J Heart Fail. 2023 Jun 27. doi: 10.1002/ejhf.2953.
PubMed

BAYES-GENIS A, Rosano G
Unlocking the Potential of Natriuretic Peptide Testing in Primary Care: A Roadmap for Early Heart Failure Diagnosis.
Eur J Heart Fail. 2023 Jun 27. doi: 10.1002/ejhf.2950.
PubMed

YANG M, Kondo T, Adamson C, Butt JH, et al
Knowledge about self-efficacy and outcomes in patients with heart failure and reduced ejection fraction.
Eur J Heart Fail. 2023 Jun 27. doi: 10.1002/ejhf.2944.
PubMed Abstract available

BRANN A, Miller J, Eshraghian E, Park JJ, et al
Global Longitudinal Strain Predicts Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
Eur J Heart Fail. 2023 Jun 27. doi: 10.1002/ejhf.2947.
PubMed Abstract available

DOCHERTY KF, Lam CSP, Rakisheva A, Coats AJS, et al
Heart Failure Diagnosis in the General Community - Who, How and When? A clinical consensus statement of the Heart Failure Association (HFA) of the ESC.
Eur J Heart Fail. 2023 Jun 27. doi: 10.1002/ejhf.2946.
PubMed Abstract available

KERWAGEN F, Koehler K, Vettorazzi E, Stangl V, et al
Remote patient management of heart failure across the ejection fraction spectrum: A prespecified analysis of the TIM-HF2 trial.
Eur J Heart Fail. 2023 Jun 27. doi: 10.1002/ejhf.2948.
PubMed Abstract available

ADAMO M, Chioncel O, Benson L, Shahim B, et al
Prevalence, clinical characteristics and outcomes of heart failure patients with or without isolated or combined mitral and tricuspid regurgitation: insight from the ESC-HFA EORP Heart Failure Long-Term Registry.
Eur J Heart Fail. 2023 Jun 26. doi: 10.1002/ejhf.2929.
PubMed Abstract available

STRACHINARU M, Roussoulieres A, Manintveld OC
SGLT2i for Chronic Heart Failure: The Ultimate Solution?
Eur J Heart Fail. 2023 Jun 22. doi: 10.1002/ejhf.2942.
PubMed

SINAGRA G, Gigli M, Dal Ferro M
Heart failure with reduced ejection fraction and monogenic dilated cardiomyopathy: distinct diseases? Insights from randomized controlled trials.
Eur J Heart Fail. 2023 Jun 22. doi: 10.1002/ejhf.2943.
PubMed

NAITO R, Kasai T
One step towards tailor-made medicine for patients with heart failure.
Eur J Heart Fail. 2023 Jun 21. doi: 10.1002/ejhf.2941.
PubMed

BOOTH D, Davis JA, McEwan P, Solomon SD, et al
The cost-effectiveness of dapagliflozin in heart failure with preserved or mildly reduced ejection fraction: A European health-economic analysis of the DELIVER trial.
Eur J Heart Fail. 2023 Jun 21. doi: 10.1002/ejhf.2940.
PubMed Abstract available

DONAL E, Cosyns B
Moving forwards from clinical trials to a more individualized management of treatments in heart failure? Great value of echocardiography-Doppler data.
Eur J Heart Fail. 2023 Jun 20. doi: 10.1002/ejhf.2938.
PubMed

GIRERD N
Combating Therapeutic Inertia: Optimizing Iron Deficiency Treatment in Heart Failure.
Eur J Heart Fail. 2023 Jun 20. doi: 10.1002/ejhf.2933.
PubMed

GIRERD N
Beyond Loop Diuretics: Unlocking the Potential of Codiuretics in Heart Failure Management.
Eur J Heart Fail. 2023 Jun 16. doi: 10.1002/ejhf.2936.
PubMed

BUTTE Z, Ambrosy AP
Acetazolamide as a Decongestion Strategy in Acute Decompensated Heart Failure: Balancing Fluid Removal and Electrolyte Disturbances.
Eur J Heart Fail. 2023 Jun 16. doi: 10.1002/ejhf.2935.
PubMed

NGUYEN NV, Lindberg F, Benson L, Ferrannini G, et al
Eligibility for vericiguat in a real-world heart failure population according to trial, guidelines, and label criteria: Data from the Swedish Heart Failure Registry.
Eur J Heart Fail. 2023 Jun 16. doi: 10.1002/ejhf.2939.
PubMed Abstract available

WANG S, Sun Q, Wang L
Vericiguat in HFrEF: the right choice above all else? The answer may lie in time. Letter regarding the article 'Effect of Vericiguat on Left Ventricular Structure and Function in Patients with Heart Failure with Reduced Ejection Fraction: The VICTORIA
Eur J Heart Fail. 2023 Jun 15. doi: 10.1002/ejhf.2931.
PubMed

BAYES-GENIS A, Lupon J, Revuelta-Lopez E, Llibre C, et al
Evolocumab has no effects on heart failure with reduced ejection fraction injury biomarkers: The EVO-HF trial.
Eur J Heart Fail. 2023 Jun 15. doi: 10.1002/ejhf.2932.
PubMed Abstract available

OMAR M, Omote K, Sorimachi H, Popovic D, et al
Hypoxemia in Patients with Heart Failure and Preserved Ejection Fraction.
Eur J Heart Fail. 2023 Jun 14. doi: 10.1002/ejhf.2930.
PubMed Abstract available

SCHRAGE B, Lund LH, Benson L, Braunschweig F, et al
Association between a hospitalization for heart failure and the initiation/discontinuation of guideline-recommended treatments - An analysis from the Swedish heart failure registry.
Eur J Heart Fail. 2023 Jun 14. doi: 10.1002/ejhf.2928.
PubMed Abstract available

SAKANIWA R, Tromp J, Streng KW, Suthahar N, et al
Trajectories of renal biomarkers and new onset heart failure in the general population: Findings from the PREVEND study.
Eur J Heart Fail. 2023 Jun 7. doi: 10.1002/ejhf.2925.
PubMed Abstract available

BOHM M, Butler J, Krawczyk M, Mahfoud F, et al
Liver tests, cardiovascular outcomes and effects of empagliflozin in patients with heart failure and preserved ejection fraction: the EMPEROR-Preserved Trial.
Eur J Heart Fail. 2023 Jun 6. doi: 10.1002/ejhf.2922.
PubMed Abstract available

Corrigendum to 'Weight change and clinical outcomes in heart failure with reduced ejection fraction: Insights from EMPEROR-Reduced' [Eur J Heart Fail 2023;25:117-127].
Eur J Heart Fail. 2023 Jun 5. doi: 10.1002/ejhf.2910.
PubMed

ZIMERMAN A, da Silveira AD, Solomon SD, Rohde LE, et al
NYHA Classification for Decision-Making in Heart Failure: Time to Reassess?
Eur J Heart Fail. 2023 Jun 1. doi: 10.1002/ejhf.2923.
PubMed

TOMASONI D, Adamo M, Metra M
June 2023 at a glance: focus on worsening heart failure, heart failure with preserved ejection fraction and valvular heart disease.
Eur J Heart Fail. 2023;25:773-775.
PubMed

MULLER SA, Oerlemans MIFJ
Implementing clinical pathways to enable early diagnosis and treatment of wild-type transthyretin amyloid cardiomyopathy.
Eur J Heart Fail. 2023;25:854-856.
PubMed

KARAM N, Hausleiter J
Hypoalbuminaemia and secondary mitral regurgitation mortality: an inevitable fate?
Eur J Heart Fail. 2023;25:888-889.
PubMed

SCOTTI A, Jorde UP, Latib A
Transcatheter edge-to-edge repair: fix the heart, heal the liver.
Eur J Heart Fail. 2023;25:885-887.
PubMed

STOLZ L, Orban M, Karam N, Lubos E, et al
Cardio-hepatic syndrome in patients undergoing mitral valve transcatheter edge-to-edge repair.
Eur J Heart Fail. 2023;25:872-884.
PubMed Abstract available

TINI G, Milani P, Zampieri M, Caponetti AG, et al
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study.
Eur J Heart Fail. 2023;25:845-853.
PubMed Abstract available

May 2023

ARRIGO M, Biegus J, Asakage A, Mebazaa A, et al
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: a sub-analysis of the STRONG-HF randomized clinical trial.
Eur J Heart Fail. 2023 May 29. doi: 10.1002/ejhf.2920.
PubMed Abstract available

HAVAKUK O, Topilsky Y
Secondary Tricuspid Regurgitation in Heart Failure - Not Merely an Innocent Bystander?
Eur J Heart Fail. 2023 May 25. doi: 10.1002/ejhf.2919.
PubMed

ALVAREZ-GARCIA J
SGLT2 inhibitors for Heart Failure: time's up for indulging in wishful thinking.
Eur J Heart Fail. 2023 May 23. doi: 10.1002/ejhf.2917.
PubMed

CHIONCEL O, Adamo M, Nikolaou M, Parissis J, et al
Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of
Eur J Heart Fail. 2023 May 23. doi: 10.1002/ejhf.2918.
PubMed Abstract available

COTTER G, Davison B
Acute heart failure is a remitting-relapsing disorder and not a step towards advanced heart failure: Implications for decongestion therapy.
Eur J Heart Fail. 2023 May 22. doi: 10.1002/ejhf.2916.
PubMed

CHATUR S, Cunningham JW, Vaduganathan M, Mc Causland FR, et al
Renal and Blood Pressure Effects of Dapagliflozin in Recently Hospitalized Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Insights from the DELIVER Trial.
Eur J Heart Fail. 2023 May 22. doi: 10.1002/ejhf.2915.
PubMed Abstract available

IACONELLI A, Pellicori P, Dolce P, Busti M, et al
Coronary revascularization for heart failure with coronary artery disease: a systematic review and meta-analysis of randomized trials.
Eur J Heart Fail. 2023 May 22. doi: 10.1002/ejhf.2911.
PubMed Abstract available

JOHANSEN ND, Vaduganathan M, Bhatt AS, Lee SG, et al
Electronic nudges to increase influenza vaccination uptake among patients with heart failure: a prespecified analysis of the NUDGE-FLU trial.
Eur J Heart Fail. 2023 May 21. doi: 10.1002/ejhf.2913.
PubMed Abstract available

PASCUAL-FIGAL DA, Zamorano JL, Domingo M, Morillas H, et al
Impact of Dapagliflozin on cardiac remodeling in patients with chronic heart failure: DAPA-MODA study.
Eur J Heart Fail. 2023 May 21. doi: 10.1002/ejhf.2884.
PubMed Abstract available

SHAHIM B, Shahim A, Adamo M, Chioncel O, et al
Prevalence, Characteristics and Prognostic Impact of Aortic Valve Disease in Patients with Heart Failure and Reduced, Mildly Reduced, and Preserved Ejection Fraction: An Analysis of the ESC Heart Failure Long-Term Registry.
Eur J Heart Fail. 2023 May 21. doi: 10.1002/ejhf.2908.
PubMed Abstract available

CHATUR S, Kondo T, Claggett BL, Docherty K, et al
Effects of Dapagliflozin on Heart Failure Hospitalizations According to Severity of Inpatient Course: Insights from DELIVER and DAPA-HF.
Eur J Heart Fail. 2023 May 21. doi: 10.1002/ejhf.2912.
PubMed Abstract available

MUSELLA F, Rosano GMC, Hage C, Benson L, et al
Patient profiles in heart failure with reduced ejection fraction: prevalence, characteristics, treatments and outcomes in a real-world heart failure population.
Eur J Heart Fail. 2023 May 21. doi: 10.1002/ejhf.2892.
PubMed Abstract available

ANKER SD, Usman MS, Anker MS, Butler J, et al
Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association and the European Heart Rhythm Association of the European Society of Cardiology
Eur J Heart Fail. 2023 May 19. doi: 10.1002/ejhf.2894.
PubMed Abstract available

GUAZZI M
The Biventricular Paths to Exercise Dyspnea in Heart Failure Preserved Ejection Fraction: The Future is Now.
Eur J Heart Fail. 2023 May 18. doi: 10.1002/ejhf.2914.
PubMed

METRA M, Adamo M, Tomasoni D, Mebazaa A, et al
Pre-discharge and early post-discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC.
Eur J Heart Fail. 2023 May 18. doi: 10.1002/ejhf.2888.
PubMed Abstract available

HORIUCHI Y, Asami M, Ide T, Yahagi K, et al
Prevalence, Characteristics and Cardiovascular and Non-cardiovascular Outcomes in Patients with Heart Failure with Supra-normal Ejection Fraction; Insight from the JROADHF Study.
Eur J Heart Fail. 2023 May 16. doi: 10.1002/ejhf.2895.
PubMed Abstract available

CERLINSKAITE-BAJORE K, Lam CSP, Sliwa K, Adamo M, et al
Sex-specific analysis of the rapid up-titration of guideline-directed medical therapies after a hospitalisation for acute heart failure: insights from the STRONG-HF trial.
Eur J Heart Fail. 2023 May 16. doi: 10.1002/ejhf.2882.
PubMed Abstract available

HARRINGTON J, Mentz RJ
Ironing out the Wrinkles: Unanswered Questions in Intravenous Iron Repletion in Heart Failure.
Eur J Heart Fail. 2023 May 16. doi: 10.1002/ejhf.2893.
PubMed

RICHARDS AM
Plasma Markers to Risk Stratify for Heart Failure in Atrial Fibrillation.
Eur J Heart Fail. 2023 May 16. doi: 10.1002/ejhf.2885.
PubMed

BAUDRY G, Lescroart M, Kimmoun A
Are LVEF phenotypes meaningful in acute heart failure?
Eur J Heart Fail. 2023 May 16. doi: 10.1002/ejhf.2889.
PubMed

BORIANI G, Mei DA, Imberti JF
Therapeutic effects of sodium-glucose cotransporter 2 inhibitors in patients with heart failure with preserved ejection fraction: from outcome improvement to potentially favourable influences on atrial fibrillation burden, atrial fibrillation progress
Eur J Heart Fail. 2023 May 16. doi: 10.1002/ejhf.2891.
PubMed

BARAT A, Chen CW, Patel-Murray N, McMurray JJV, et al
Clinical characteristics of heart failure with reduced ejection fraction patients with rare pathogenic variants in dilated cardiomyopathy-associated genes: A subgroup analysis of the PARADIGM-HF trial.
Eur J Heart Fail. 2023 May 16. doi: 10.1002/ejhf.2886.
PubMed Abstract available

TOMASONI D, Adamo M, Metra M
May 2023 at a glance: focus on pathophysiology, comorbidities and devices.
Eur J Heart Fail. 2023;25:599-601.
PubMed

POETSCH MS, Palus S, Van Linthout S, von Haehling S, et al
The small molecule ACM-001 improves cardiac function in a rat model of severe cancer cachexia.
Eur J Heart Fail. 2023;25:673-686.
PubMed Abstract available

JAVED S, Halliday BP
Implantable cardioverter-defibrillator implantation in non-ischaemic cardiomyopathy: towards individualized risk stratification.
Eur J Heart Fail. 2023;25:751-753.
PubMed

ARRIGO M, Blet A, Morley-Smith A, Aissaoui N, et al
Current and future trial design in refractory cardiogenic shock.
Eur J Heart Fail. 2023;25:609-615.
PubMed

FONTANA M, Ioannou A, Bandera F
Non-invasive left ventricle pressure-volume loops: a new tool to track treatment response in cardiac transthyretin amyloidosis?
Eur J Heart Fail. 2023;25:737-739.
PubMed

GIANNONI A, Borrelli C, Gentile F, Sciarrone P, et al
Autonomic and respiratory consequences of altered chemoreflex function: clinical and therapeutic implications in cardiovascular diseases.
Eur J Heart Fail. 2023;25:642-656.
PubMed Abstract available

SHERIDAN WS, Wetterling F, Testani JM, Borlaug BA, et al
Safety and performance of a novel implantable sensor in the inferior vena cava under acute and chronic intravascular volume modulation.
Eur J Heart Fail. 2023;25:754-763.
PubMed Abstract available

DI MARCO A, Brown P, Mateus G, Faga V, et al
Late gadolinium enhancement and the risk of ventricular arrhythmias and sudden death in NYHA class I patients with non-ischaemic cardiomyopathy.
Eur J Heart Fail. 2023;25:740-750.
PubMed Abstract available

ROSENBLUM HR, Griffin JM, Minamisawa M, Prasad N, et al
Effect of patisiran on stroke volume in hereditary transthyretin-mediated amyloidosis: insights from pressure-volume analysis of the APOLLO study.
Eur J Heart Fail. 2023;25:727-736.
PubMed Abstract available

April 2023

CAPPELLETTO C, Stolfo D, Savarese G
Reply to Letter to the Editor "Why do obese patients with heart failure reduced ejection fraction have better outcomes from pharmacological treatments?".
Eur J Heart Fail. 2023 Apr 28. doi: 10.1002/ejhf.2880.
PubMed

LINDBERG F, Lund LH, Benson L, Linde C, et al
Iron deficiency in heart failure: screening, prevalence, incidence and outcome Data from the Swedish Heart Failure registry and the Stockholm CREAtinine Measurements collaborative project.
Eur J Heart Fail. 2023 Apr 28. doi: 10.1002/ejhf.2879.
PubMed Abstract available

REDDY YNV, Borlaug BA
Exercise Echocardiography to Diagnose Heart Failure with preserved Ejection Fraction - Are Two Measures Better than One?
Eur J Heart Fail. 2023 Apr 27. doi: 10.1002/ejhf.2876.
PubMed

MYON F, Curtis E, L'official G, Donal E, et al
Heart Failure with Preserved ejection Fraction: a haemodynamic explanation of exertional dyspnoea.
Eur J Heart Fail. 2023 Apr 27. doi: 10.1002/ejhf.2877.
PubMed

KAPLON-CIESLICKA A, Benson L, Chioncel O, Crespo-Leiro MG, et al
Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in-hospital and long-term outcomes - from the ESC HFA EORP Heart Failure Long-Term Registry.
Eur J Heart Fail. 2023 Apr 27. doi: 10.1002/ejhf.2873.
PubMed Abstract available

SCHROEDER M, Lim YMF, Savarese G, Suzart-Woischnik K, et al
Sex Differences in the Generalizability of Randomized Clinical Trials in Heart Failure with Reduced Ejection Fraction.
Eur J Heart Fail. 2023 Apr 26. doi: 10.1002/ejhf.2868.
PubMed Abstract available

TSUTSUI H, Albert NM, Coats AJS, Anker SD, et al
Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society.
Eur J Heart Fail. 2023 Apr 26. doi: 10.1002/ejhf.2848.
PubMed Abstract available

METRA M, Tomasoni D, Adamo M, Bayes-Genis A, et al
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology.
Eur J Heart Fail. 2023 Apr 26. doi: 10.1002/ejhf.2874.
PubMed Abstract available

BOHM M, Abdin A, Slawik J, Mahfoud F, et al
Time to benefit of heart rate reduction with ivabradine in patients with heart failure and reduced ejection fraction.
Eur J Heart Fail. 2023 Apr 24. doi: 10.1002/ejhf.2870.
PubMed Abstract available

PEIGH G, Patel RB
The Left Atrium: A Window into Cardiopulmonary Hemodynamics in Heart Failure with Preserved Ejection Fraction.
Eur J Heart Fail. 2023 Apr 24. doi: 10.1002/ejhf.2872.
PubMed

D'AMARIO D, Meerkin D, Restivo A, Ince H, et al
Safety, usability, and performance of a wireless left atrial pressure monitoring system in patients with heart failure: the VECTOR-HF trial.
Eur J Heart Fail. 2023 Apr 24. doi: 10.1002/ejhf.2869.
PubMed Abstract available

ALOGNA A, Omar M, Popovic D, Sorimachi H, et al
Biventricular Cardiac Power Reserve in Heart Failure and Preserved Ejection Fraction.
Eur J Heart Fail. 2023 Apr 17. doi: 10.1002/ejhf.2867.
PubMed Abstract available

KOBAYASHI M, Huttin O, Ferreira JP, Duarte K, et al
A machine learning derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: findings from the HOMAGE trial.
Eur J Heart Fail. 2023 Apr 16. doi: 10.1002/ejhf.2859.
PubMed Abstract available

HARADA T, Kagami K, Shina T, Sorimachi H, et al
Diagnostic Value of Reduced Left Atrial Compliance during Ergometry Exercise in Heart Failure with Preserved Ejection Fraction.
Eur J Heart Fail. 2023 Apr 16. doi: 10.1002/ejhf.2862.
PubMed Abstract available

ANKER SD, Shahzeb Khan M, Butler J, von Haehling S, et al
Effect of Intravenous Iron Replacement on Recurrent Heart Failure Hospitalizations and Cardiovascular Mortality in Patients with Heart Failure and Iron Deficiency: A Bayesian Meta-Analysis.
Eur J Heart Fail. 2023 Apr 16. doi: 10.1002/ejhf.2860.
PubMed Abstract available

FILIPPATOS G, Farmakis D, Butler J, Zannad F, et al
Empagliflozin in heart failure with preserved ejection fraction with and without atrial fibrillation.
Eur J Heart Fail. 2023 Apr 16. doi: 10.1002/ejhf.2861.
PubMed Abstract available

TALHA KM, Butler J, Greene SJ, Aggarwal R, et al
Potential Global Impact of Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure.
Eur J Heart Fail. 2023 Apr 16. doi: 10.1002/ejhf.2864.
PubMed Abstract available

HEITZINGER G, Pavo N, Koschatko S, Jantsch C, et al
Contemporary insights into the epidemiology, impact and treatment of secondary tricuspid regurgitation across the heart failure spectrum.
Eur J Heart Fail. 2023 Apr 16. doi: 10.1002/ejhf.2858.
PubMed Abstract available

BO W, Yanchun C, Cheng X
Why do obese patients with heart failure reduced ejection fraction have better outcomes from pharmacological treatments?
Eur J Heart Fail. 2023 Apr 16. doi: 10.1002/ejhf.2865.
PubMed

SHARMA A, Ferreira JP, Zannad F, Pocock SJ, et al
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights from the EMPEROR-Preserved Trial.
Eur J Heart Fail. 2023 Apr 16. doi: 10.1002/ejhf.2857.
PubMed Abstract available

DEWAN P, Ferreira JP, Butt JH, Petrie MC, et al
Impact of multimorbidity on mortality in heart failure with reduced ejection fraction: which comorbidities matter most? An analysis of PARADIGM-HF and ATMOSPHERE.
Eur J Heart Fail. 2023 Apr 16. doi: 10.1002/ejhf.2856.
PubMed Abstract available

BIEGUS J, Zymlinski R, Testani J, Fudim M, et al
The blunted loop diuretic response in acute heart failure is driven by reduced tubular responsiveness rather than insufficient tubular delivery.
Eur J Heart Fail. 2023 Apr 11. doi: 10.1002/ejhf.2852.
PubMed Abstract available

POCOCK SJ, Ferreira JP, Collier TJ, Angermann CE, et al
The Win Ratio Method in Heart Failure Trials: Lessons Learnt From Empulse.
Eur J Heart Fail. 2023 Apr 10. doi: 10.1002/ejhf.2853.
PubMed Abstract available

BUTLER J, Siddiqi TJ, Zannad F, Ferreira JP, et al
Interaction of Natriuretic Peptide Levels and Ejection Fraction on Outcomes with Dapagliflozin and Empagliflozin in Heart Failure.
Eur J Heart Fail. 2023 Apr 10. doi: 10.1002/ejhf.2854.
PubMed

HOGAN J
9th March 2023, 25in25 Summit - reducing heart failure mortality by 25% in the next 25 years.
Eur J Heart Fail. 2023 Apr 4. doi: 10.1002/ejhf.2835.
PubMed

GUALANDRO DM, Puelacher C, Mueller C
Reply to the Letter regarding the article "Acute heart failure after non-cardiac surgery: incidence, phenotypes, determinants and outcomes".
Eur J Heart Fail. 2023 Apr 3. doi: 10.1002/ejhf.2850.
PubMed

ROSANO G, Bayes-Genis A, Metra M
The Heart Failure Association endorses the 25in25 initiative.
Eur J Heart Fail. 2023 Apr 3. doi: 10.1002/ejhf.2847.
PubMed

PACKER M
A Reclassification of Heart Failure Based on Recognition of Heart Failure With Normal to Supranormal Ejection Fraction, a Clinically Common Form of Cardiac Contracture, With Distinctive Pathophysiological and Therapeutic Features.
Eur J Heart Fail. 2023 Apr 3. doi: 10.1002/ejhf.2849.
PubMed

HFA Winter Research Meeting on Translational Heart Failure 2023 In collaboration with the ESC Working Group on Myocardial Function, 20-23 May 2023.
Eur J Heart Fail. 2023;25 Suppl 1:3-34.
PubMed

TOMASONI D, Adamo M, Metra M
April 2023 at a glance: focus on diagnosis and comorbidities.
Eur J Heart Fail. 2023;25:445-447.
PubMed

DELMAS C, Bonello L, Roubille F
For the best management, please ask for assistance!
Eur J Heart Fail. 2023;25:573-575.
PubMed

AIMO A, Tomasoni D, Porcari A, Vergaro G, et al
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis.
Eur J Heart Fail. 2023;25:510-514.
PubMed Abstract available

DIEZ J, Rosano GMC, Butler J
Time to reconsider the perception and management of hypertensive heart disease.
Eur J Heart Fail. 2023;25:450-453.
PubMed

ITZHAKI BEN ZADOK O, Falk RH
Variant and wild type transthyretin amyloidosis: two sides of the same coin or different currencies in different pockets?
Eur J Heart Fail. 2023;25:525-527.
PubMed

SCHRAGE B, Sundermeyer J, Beer BN, Bertoldi L, et al
Use of mechanical circulatory support in patients with non-ischaemic cardiogenic shock.
Eur J Heart Fail. 2023;25:562-572.
PubMed Abstract available

PORCARI A, Razvi Y, Masi A, Patel R, et al
Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy.
Eur J Heart Fail. 2023;25:515-524.
PubMed Abstract available

March 2023

POPOVIC D, Alogna A, Omar M, Sorimachi H, et al
Ventricular Stiffening and Chamber Contracture in Heart Failure with Higher Ejection Fraction.
Eur J Heart Fail. 2023 Mar 30. doi: 10.1002/ejhf.2843.
PubMed Abstract available

PIESKE B, Pieske-Kraigher E, Lam CSP, Melenovsky V, et al
Effect of Vericiguat on Left Ventricular Structure and Function in Patients with Heart Failure with Reduced Ejection Fraction: The VICTORIA Echocardiographic Substudy.
Eur J Heart Fail. 2023 Mar 30. doi: 10.1002/ejhf.2836.
PubMed Abstract available

PUGLIESE NR, De Biase N, Del Punta L, Balletti A, et al
Deep phenotype characterization of hypertensive response to exercise: implications on functional capacity and prognosis across the heart failure spectrum.
Eur J Heart Fail. 2023 Mar 29. doi: 10.1002/ejhf.2827.
PubMed Abstract available

ROZENTRYT P, Niedziela JT, Gasior M
Bones in heart failure - missing piece of the body wasting puzzle.
Eur J Heart Fail. 2023 Mar 29. doi: 10.1002/ejhf.2846.
PubMed

OYAMA K, Giugliano RP, Ruff CT, Berg DD, et al
Serial assessment of biomarkers and heart failure outcomes in patients with atrial fibrillation.
Eur J Heart Fail. 2023 Mar 29. doi: 10.1002/ejhf.2844.
PubMed Abstract available

D'AMARIO D, Rodolico D, Savarese G
Reply to: Xie et al. What is the optimal dose of neurohormonal modulators in patients with heart failure? The higher the better?
Eur J Heart Fail. 2023 Mar 29. doi: 10.1002/ejhf.2837.
PubMed

PAGNESI M, Baldetti L, Adamo M
Inferior vena cava monitoring in heart failure: don't wait until the last drop makes the cup run over.
Eur J Heart Fail. 2023 Mar 29. doi: 10.1002/ejhf.2839.
PubMed

FARMAKIS D, Tromp J, Marinaki S, Ouwerkerk W, et al
Impact of left ventricular ejection fraction phenotypes on healthcare-resource utilization in hospitalized heart failure: A secondary analysis of REPORT-HF.
Eur J Heart Fail. 2023 Mar 28. doi: 10.1002/ejhf.2833.
PubMed Abstract available

CARBONE S, Elagizi A, Lavie CJ
Better Pharmacotherapy in Heart Failure with Reduced Ejection Fraction May Partly Explain the Obesity Paradox.
Eur J Heart Fail. 2023 Mar 28. doi: 10.1002/ejhf.2832.
PubMed

SIDDIQI TJ, Anker SD, Filippatos G, Ferreira JP, et al
Health Status Across Major Subgroup of Patients with Heart Failure and Preserved Ejection Fraction.
Eur J Heart Fail. 2023 Mar 28. doi: 10.1002/ejhf.2831.
PubMed Abstract available

FUDIM M, Parikh K, Ganesh A, Molinger J, et al
Splanchnic Nerve Block with Botulinum Toxin for Therapy of Chronic Heart Failure - Mechanism of Action (SPONGE-HF).
Eur J Heart Fail. 2023 Mar 16. doi: 10.1002/ejhf.2829.
PubMed

ZANNAD F, Alikhaani J, Alikhaani S, Butler J, et al
PATIENT REPORTED OUTCOME MEASURES AND PATIENT ENGAGEMENT IN HEART FAILURE CLINICAL TRIALS: MULTI-STAKEHOLDER PERSPECTIVES.
Eur J Heart Fail. 2023 Mar 16. doi: 10.1002/ejhf.2828.
PubMed Abstract available

AKTAA S, Gale CP, Brida M, Giannakoulas G, et al
European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology.
Eur J Heart Fail. 2023 Mar 16. doi: 10.1002/ejhf.2830.
PubMed Abstract available

DOBBIN SJH, Shen L, Petrie MC, Packer M, et al
Characteristics and outcomes of patients with a history of cancer recruited to heart failure trials.
Eur J Heart Fail. 2023 Mar 15. doi: 10.1002/ejhf.2818.
PubMed Abstract available

PANDEY AK, Dhingra NK, Pandey A, Puar P, et al
Efficacy of sodium-glucose cotransporter 2 inhibitors and angiotensin receptor-neprilysin inhibitors for heart failure in black patients: a systematic review and meta-analysis of randomized controlled trials.
Eur J Heart Fail. 2023 Mar 15. doi: 10.1002/ejhf.2825.
PubMed

SAITO Y, Obokata M, Harada T, Kagami K, et al
Disproportionate exercise-induced pulmonary hypertension in relation to cardiac output in heart failure with preserved ejection fraction: a non-invasive echocardiographic study.
Eur J Heart Fail. 2023 Mar 13. doi: 10.1002/ejhf.2821.
PubMed Abstract available

PAGNESI M, Adamo M, Ter Maaten JM, Beldhuis IE, et al
Impact of mitral regurgitation in patients with acute heart failure: insights from the RELAX-AHF-2 trial.
Eur J Heart Fail. 2023 Mar 13. doi: 10.1002/ejhf.2820.
PubMed Abstract available

LUDWIG S, Kalbacher D, Ali WB, Weimann J, et al
Transcatheter mitral valve replacement or repair for secondary mitral regurgitation: a propensity score-matched analysis.
Eur J Heart Fail. 2023;25:399-410.
PubMed Abstract available

SCOTTI A, Latib A
MitraClip evolution: EXPANDed options for a bespoke treatment.
Eur J Heart Fail. 2023;25:422-424.
PubMed

ROSSIGNOL P, Pitt B
Mineralocorticoid receptor antagonist use in renal dialysis: will evidence from prospective randomized trials confirm the results from 'real-world' evidence?
Eur J Heart Fail. 2023;25:361-363.
PubMed

CODINA P, Zamora E, Bayes-Genis A
Reply to 'The frail patient and the frailing heart'.
Eur J Heart Fail. 2023;25:441-442.
PubMed

SCHRAGE B, Westermann D
Cardiogenic shock is not a sprint, but a marathon.
Eur J Heart Fail. 2023;25:436-437.
PubMed

PATOULIAS D, Fragakis N
The frail patient and the frailing heart. Letter regarding the article 'Barcelona Bio-HF calculator version 3.0: recalibration and incorporation of sodium-glucose cotransporter 2 inhibitor treatment'.
Eur J Heart Fail. 2023;25:441.
PubMed

SCHUSTER A, Schulz A, Lange T, Evertz R, et al
Concomitant latent pulmonary vascular disease leads to impaired global cardiac performance in heart failure with preserved ejection fraction.
Eur J Heart Fail. 2023;25:322-331.
PubMed Abstract available

VERGARO G, Castiglione V, Aimo A, Prontera C, et al
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis.
Eur J Heart Fail. 2023;25:335-346.
PubMed Abstract available

February 2023

BLUMER V, Truby LK, Zieroth S
Sex Differences in Heart Failure: The Evolving Use of Biomarkers.
Eur J Heart Fail. 2023 Feb 28. doi: 10.1002/ejhf.2817.
PubMed

PACKER M
Dosing of Iron Supplementation for Iron-Deficient Patients With Heart Failure: Should We Prefer More Intensive or Less Intensive Repletion Targets?
Eur J Heart Fail. 2023 Feb 28. doi: 10.1002/ejhf.2816.
PubMed

GUSTAFSSON F, Damman K, Nalbantgil S, Van Laake LW, et al
Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the ESC.
Eur J Heart Fail. 2023 Feb 27. doi: 10.1002/ejhf.2814.
PubMed Abstract available

GARD EK, Beale AL, Telles F, Silvestry FE, et al
Left atrial enlargement is associated with pulmonary vascular disease in heart failure with preserved ejection fraction.
Eur J Heart Fail. 2023 Feb 27. doi: 10.1002/ejhf.2805.
PubMed Abstract available

ABBASI MA, Borlaug BA
Pulmonary vascular disease in heart failure with preserved ejection fraction: the evidence grows.
Eur J Heart Fail. 2023 Feb 15. doi: 10.1002/ejhf.2800.
PubMed

PATEL L, Keshvani N, Pandey A
Are post-influenza vaccine reactions truly 'adverse'?
Eur J Heart Fail. 2023;25:311-312.
PubMed

DOMINGUEZ F, Cabrera E
Mavacamten in obstructive hypertrophic cardiomyopathy - Are beta-blockers blocking part of its shine?
Eur J Heart Fail. 2023;25:271-273.
PubMed

LIM HS, Yim IHW
De novo aortic regurgitation related to left ventricular assist device therapy: the difficult questions in need of new perspectives.
Eur J Heart Fail. 2023;25:295-298.
PubMed

OMOTE K, Verbrugge FH, Sorimachi H, Omar M, et al
Central haemodynamic abnormalities and outcome in patients with unexplained dyspnoea.
Eur J Heart Fail. 2023;25:185-196.
PubMed Abstract available

URIEL N, Milano C, Agarwal R, Lee S, et al
Incidence and clinical correlates of de-novo aortic regurgitation with a fully magnetically levitated left ventricular assist device: a MOMENTUM 3 trial portfolio analysis.
Eur J Heart Fail. 2023;25:286-294.
PubMed Abstract available

WHEELER MT, Jacoby D, Elliott PM, Saberi S, et al
Effect of beta-blocker therapy on the response to mavacamten in patients with symptomatic obstructive hypertrophic cardiomyopathy.
Eur J Heart Fail. 2023;25:260-270.
PubMed Abstract available

PEIKERT A, Claggett BL, Kim K, Udell JA, et al
Association of post-vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high-risk cardiovascular disease: the INVESTED trial.
Eur J Heart Fail. 2023;25:299-310.
PubMed Abstract available

LEVI N, Moravsky G, Weitsman T, Amsalem I, et al
A prospective study on myocardial injury after BNT162b2 mRNA COVID-19 fourth dose vaccination in healthy persons.
Eur J Heart Fail. 2023;25:313-318.
PubMed Abstract available

January 2023

MAEDER MT
The beta3-adrenoreceptor agonist mirabegron for the treatment of combined pre- and post-capillary pulmonary hypertension: new pathway or dead end?
Eur J Heart Fail. 2023 Jan 24. doi: 10.1002/ejhf.2780.
PubMed

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum